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Address: CRUK lab., MMC, Western General Hospital, University of Edinburgh 
Degree: PhD 
Title of Thesis: Investigation of a novel Erccl transcript predominant in skin 
The integrity of an organism's genome is constantly threatened due to the damaging 
effects of external and internal environmental factors. Additionally, the DNA 
molecule also has an inherent chemical instability. All these factors contribute to the 
formation of DNA lesions which, if not repaired, could develop into permanent 
mutations and malignancy. Fortunately, many DNA repair systems exist to prevent 
the accumulation of lesions. Of these, the nucleotide excision repair system (NER) is 
capable of repairing the greatest range of lesions, including those caused by UV 
irradiation, cross -linking agents and free radicals. Defects in the NER pathway 
disrupt DNA repair and one human disorder characterised by defective NER is 
xeroderma pigmentosum (XP). Exposure to UV is extremely dangerous for 
individuals with XP since their disorder predisposes them to a greatly increased risk 
of developing skin cancer. The gene ERCC1, which has an essential role in the NER 
pathway, has not been linked to a human disorder but mice in which the Erccl gene 
has been inactivated are DNA repair deficient. These mice die, prior to weaning, of 
liver failure. 
Earlier work in the Melton laboratory had demonstrated that there was tissue -specific 
Erccl expression in the mouse and an additional, novel, Erccl transcript was 
identified in the skin. The skin has a higher biological demand for repair of UV 
damaged DNA than other body tissues. As Erccl is required for repair of UV 
damaged DNA the novel transcript may be involved in meeting the increased 
demand for repair in this tissue. The difference between the skin -specific and normal 
transcripts was localised to the 5' end and is caused by differential initiation of 
transcription, with the skin -specific transcript initiating 5' to the normal transcript's 
xiv 
promoter. This indicated the likely presence of a separate skin -specific promoter. 
To facilitate more detailed analysis of the upstream promoter region and the 
identification of sequences responsible for regulation of the skin -specific Erccl 
expression pattern a number of Erccl minigenes were constructed. 
In this project the skin -specific pattern of expression was studied by transfecting 
Erccl null cells with the minigenes. The Erccl null cells used were murine 
embryonic fibroblasts, PF24 + #2D -4; Chinese hamster ovary cells, CH043.3B; and 
murine keratinocytes, Ker. ( -/ -). UV survival studies were performed on transfected 
cells and RT -PCR was used to study the pattern of Erccl expression. Transfection 
with the Erccl minigenes corrected the UV sensitivity of the null cell lines. The 
Erccl expression pattern was usually, but not always, appropriate for the cell type 
transfected. 
Comparisons between the Erccl transcription of in vitro cultures and in vivo tissues 
taken from various stages of murine development were made by means of northern 
blotting. Irradiation of transfected cells and primary cultures with UV -B, UV -C and 
visible light was performed in an attempt to of transcript 
induction. Changes in Erccl transcription following irradiation of primary cultures 
were observed, but these changes did not conclusively prove that UV could induce 
Erccl transcription. Serum starvation experiments were performed upon primary 
cultures to further study differences in Erccl transcription in vitro. Release from 
serum starvation resulted in increased skin -specific transcript production and total 
Erccl expression. The size of the skin -specific Erccl transcript in keratinocytes was 
found to be larger than that of fibroblasts. Sequencing demonstrated that the size 
difference was in the CT repeat region of the gene. This region was deleted from one 
of the Erccl minigenes mentioned and results indicated that it may be required for 
correct expression of the novel transcript. 
Word count (excluding table of contents and references): 64,637 
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DNA is the fundamental substance of which genes are composed and is often 
referred to as the `genetic blueprint' of life. As a chemical data store, DNA has to be 
stable yet some flexibility is required. Occasionally DNA mutations may occur that 
confer advantages to the host organism and, in this way, the instability of the DNA 
molecule is the substrate of evolutionary progression. There is a balance between the 
data of the genome being stored as an incorruptible medium yet also allowing for 
change. 
Rarely a mutation may indeed be advantageous to an organism but most DNA 
mutations have either no effect whatsoever or are deleterious in nature. When lesions 
are not repaired, DNA damage can lead to the formation of permanent mutations, 
resulting in genome instability, carcinogenesis and ageing. Because of the likelihood 
of life -threatening outcomes such as carcinogenesis, it is of utmost importance to an 
organism that mutations are repaired quickly and for irreparable DNA damage to be 
removed via cellular apoptosis. The likelihood of mutations being deleterious has 
exerted a selection pressure over time and a number of DNA repair mechanisms have 
evolved. The complexity and number of an organism's DNA repair mechanisms is 
dependent upon the size of the organism's genome. 
DNA mutations can occur spontaneously as a result of the inherent instability of the 
chemical bonds of the nucleotides at normal physiological temperature and pH. The 
genome is a dynamic molecule, undergoing replication and recombination; mutations 
can arise due to errors in these processes. Further mutation can occur as a result of 
incorrect repair of DNA damage and the chemical reactions taking place in the 
cellular environment, such as oxidation, hydrolysis and non -enzymatic methylation, 
can result in DNA mutations. Chemicals entering an organism's system from the 
environment, be they naturally occurring or man-made, can result in DNA damage if 
they are capable of altering cellular chemistry or directly interacting with DNA. In 
the natural environment, ultra violet (UV) radiation from the Sun is a major source of 
DNA mutation in many organisms. 
2 
The study of DNA repair mechanisms began in prokaryotic systems. However, the 
greater complexity and size of the eukaryotic genome meant that the research in 
prokaryotic systems could lead to greater understanding of eukaryotic DNA repair in 
some cases but was not directly applicable. For example, the multicellular nature of 
higher eukaryotes resulted in the evolution of pathways that prevent cells with 
damaged DNA passing through the cycle of division before repair has taken place, 
reducing the risk of carcinogenesis. Cancer is one of the leading causes of death in 
the United Kingdom, so research of mammalian DNA repair mechanisms is vital to 
the improvement of cancer prevention and treatment. 
1.2 DNA damage and causal factors 
DNA damage may be classified in a number of ways. If damage is classified by 
source then DNA damage is either from an exogenous source (caused by external, 
environmental factors) or an endogenous source (caused by internal factors). When 
the `environment' is that of the organism rather than the DNA molecule then cellular 
sources of DNA damage are endogenous. DNA damage may also be classified by 
whether the damage occurs spontaneously or is induced; spontaneous damage arises 
due to the inherent instability of the DNA molecule while damage caused by other 
factors is induced. However, the classification of damage is complicated by the fact 
that different sources of DNA damage can result in identical chemical changes to the 
DNA. Because of the large number of DNA damaging agents, both physical and 
chemical, a table (Table 1.1) of those most commonly encountered is provided along 
with the type of DNA damage resulting from exposure to such agents (reviewed by 
Friedberg, Walker and Siede, 1995). There are two categories into which DNA 
mutations can be divided and the categories are essentially opposites; the first is 
when the nucleotide is structurally intact but in the wrong structural context, the 
second is when the nucleotide is in the correct part of the DNA sequence but is 
chemically abnormal. Only the second category is classified as DNA damage or 
lesion and examples are fragmented, cross -linked or modified nucleotides (Smear, 
1995). 
3 
Table 1.1 Types of DNA damage induced by chemical and physical 
agents 
Table shows a selection of DNA damaging agents, the source of such agents and the 
types of DNA damage arising from exposure. 
DNA damaging agent Source Resulting DNA damage 




Cyclobutane pyrimidine dimer 
(CPD) 
(6 -4) pyrimidine pyrimidone 
photoproduct (6 -4PP) 
Interstrand cross -linking (minor 
product) 
Strand breaks 
Ionising radiation (IR) Physical 
environment 
Strand breaks 
Base and sugar damage 
Reactive Oxygen species 




Minor by- products 
of exposure to UV, 
IR 
Strand breaks 
Oxidised bases and sugars 
Abasic sites (AB sites) 
Alkylating agents Environmental Addition of bulky adducts e.g. 
methyl groups to nucleophilic 
centres of bases and 
phosphodiester backbone 
Cross -linking agents 
(special category of 
alkylating agents) 
e.g. mitomycin C 
Environment 
(chemical) 
Intrastrand cross -links due to 
nucleotide modification 
Interstrand cross links if alkylating 
agent is bifunctional 
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1.3 Cellular responses to DNA damage 
Because the genome of a cell encodes the genes required for production of protein in 
the cell, the viability of a cell is directly related to the condition of its DNA. Damage 
to the genome can lead to alterations in the proteins encoded by mutated genes, 
leading to loss of protein function. DNA lesions may also result in incorrect 
temporal or spatial gene expression, complete loss of gene expression or disruption 
of signalling pathways. Cells that accumulate mutations affecting their growth rate 
and responses to cell division check -points may divide in an uncontrolled manner, 
giving rise to tumour formation in the body. Because of the possible negative 
outcomes arising from DNA mutation and lesion formation it is crucial that a cell 
responds to DNA damage. 
There are three possible ways in which a living cell can respond to DNA damage; 
damage reversal, excision or tolerance. The DNA damage is only repaired in the 
processes of reversal and excision. Repair of the damage occurs where the abnormal 
change in DNA chemistry or sequence is reversed by means of direct repair or 
excision of damage and consequent synthesis of replacement nucleotides. Where 
cellular tolerance of DNA damage takes place the damage is not repaired but is 
instead bypassed during the processes of DNA synthesis and replication. The 
complexity of DNA repair mechanisms is related to the size of the genome they are 
associated with as well as the nature of DNA mutation they repair and the context in 
which the DNA mutation is encountered in, i.e. the urgency of the repair. 
1.4 DNA damage tolerance mechanisms 
Unrepaired DNA damage can block replication forks, as bases cannot be inserted 
opposite the damage site by the normal replicative polymerases. In the following 
models of DNA damage tolerance mechanisms, referred to as postreplication repair, 
the DNA damage on the template strand is not repaired but bypassed during DNA 
synthesis. There are three models for how this can take place, template strand 
switching, recombination and translesion synthesis (reviewed in Friedberg et al., 
1995). In template strand switching the DNA polymerase (DNA pol) switches to the 
template daughter strand of the complementary DNA strand to bypass the lesion by 
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copying the newly synthesised daughter strand and then switches back. In the 
recombinational repair model, the sister chromatid provides the template for 
bypassing the lesion. In eukaryotes, the primary mechanism for postreplication 
repair is thought to be translesion synthesis (TLS) (Lehmann, 2000; Kunz et al., 
2000). In the TLS model, damage -bypass DNA polymerases can either perform 
mutagenic or non -mutagenic TLS. The human disorder xeroderma pigmentosum 
variant (XP -V) is mentioned in the section on human inherited disorders (1.9.1). The 
disorder in XP -V is caused by mutation in the XPV gene, which encodes the bypass 
DNA polymerase TI (Masutani et al., 1999). The DNA -damage bypass polymerase ri 
performs non -mutagenic TLS while DNA pol Ç is a mutagenic bypass polymerase. 
In non -mutagenic bypass the DNA damage is bypassed and synthesis resumes 
downstream of the DNA damage resulting in a gap in the daughter strand that is 
repaired using the undamaged sister strand as a template. The repair of the gap has 
been referred to as daughter -strand gap repair to emphasise the fact that repair of the 
original DNA damage does not take place but repair of the resultant gap in the 
daughter strand does (Hanawalt, et al., 1979). In mutagenic TLS the damage bypass 
polymerase inserts bases opposite the lesion. 
1.5 Direct Reversal of DNA damage 
The most simple way to repair damaged DNA is with an enzyme consisting of a 
single protein that is capable of directly reversing the DNA damage. Such a 
mechanism is likely to carry less risk of introducing DNA damage than a complex 
multi -step, multi -protein repair mechanism but is not capable of recognising and 
repairing as wide a variety of DNA damage. 
1.5.1 Photoreactivation of DNA 
An example of a DNA damage direct reversal reaction is a mechanism called 
photoreactivation. Photoreactivation (PR) reverses the most common type of DNA 
damage that occurs following UV irradiation, the cyclobutane pyrimidine dimer 
(Cook, 1970). As shown in table 1.1, irradiation of DNA with UV of a wavelength 
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near the absorption maximum of the molecule leads to the formation of cyclobutane 
pyrimidine dimers and 6 -4 pyrimidine -pyrimidones. Such base damage causes 
disruption of DNA transcription and replication because dimerization of the bases 
produces distortion in the DNA helix. (Moore and Strauss, 1979; Setlow et al., 1963; 
Swenson and Setlow, 1966; Villani et al., 1978). The photoreactivation repair 
mechanism is present in many prokaryotes and eukaryotes but it is not found above 
the evolutionary level of marsupials in mammals (Li et al., 1993; Yasui et al., 1988), 
although light- dependent loss of pyrimidine dimers from DNA has been observed in 
cultured cells (Sutherland and Oliver, 1976). The most widely studied DNA 
photolyase is that of E. coli and under normal growth conditions there are only 10 to 
20 molecules of DNA photolyase in each E. coli. (Harm, 1970). In Escherichia coli 
(E. coli), monomerization of the pyrimidine dimers by PR takes place via the action 
of the DNA photolyase enzyme; the catalytic activity of the enzyme depends upon 
absorption of light by its two chromophore co- factors. The reaction mechanism 
involves excitation of one chromophore by absorption of a single photon followed by 
transfer of excitation energy to the second chromophore. Excitation of the second 
chromophore results in electron transfer to the cyclobutane pyrimidine dimer and this 
electron transfer makes the dimer revert to a monomeric state. This monomerization 
process is referred to as cycloreversion (Sancar, 1994 and 1996). 
1.5.2 Removal of alkylation damage 
Examples of DNA alkylating agents are methylnitro -nitrosoguanidine (MNNG) and 
methylnitrosourea (MNU). Alkylation of DNA bases results in the formation of 06- 
alkylguanine and 04- alkylthymine; the alkylating agents are mutagenic because the 
formation of 06- alkylguanine and 04- alkylthymine lesions can result in mismatching 
of bases during semi -conservative DNA synthesis (Swann, 1990). Methyltransferase 
enzymes, that remove the methyl group from the base, directly reverse the alkylation. 
For example, in repair of 06- methylguanine lesions the methyl group attached to the 
06 of the alkylguanine is transferred to a cysteine residue of the 06- methylguanine 
transferase enzyme (06 -MGT). The 06 -MGT enzyme is classified as a `suicide 
enzyme' because it is permanently inactivated by transfer of the methyl group to the 
cysteine residue (catalysts are, by definition, not consumed by the reactions they 
catalyse) (Sancar, 1996; Teo et al., 1984). 
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1.5.3 Single strand break repair 
A final example of direct reversal of DNA damage is the repair of single strand 
breaks which result from hydrolysis of the phosphodiester bonds of the DNA sugar - 
phosphate backbone. The breaks can only be directly repaired if the damage results 
in a clean break with juxtaposed 3' OH and 5' P termini. Where this is the case, 
DNA ligase catalyses the reconnection of the strand ends. This process has only 
been observed in a limited number of organisms and damage by ionising radiation 
more commonly results in extensive damage to the bases and sugars at the break- 
point, necessitating more complicated repair prior to ligation (Sancar, 1996). 
1.6 Double Strand Break repair 
Double -strand breaks (DSBs) in DNA are a serious threat to genome integrity. This 
is because if they are not repaired then the part of the chromosome that has broken 
off (and is no longer attached to the centromere) is lost during cellular mitosis. For 
this reason, a single DSB can be lethal to a cell. DSBs may be formed by exposure 
to a number of DNA -damaging agents or during normal cellular processes. 
Environmental causes of DSBs include ionising radiation, free radicals, endonuclease 
activity (part of DNA repair process) and mechanical stress. DSBs can also occur 
due to a number of recombinational events that are part of normal cellular processes 
such as meiotic or V(D)J recombination (lymphoid site -specific recombination). If 
DSBs are not repaired or missrepaired then mutations or chromosome 
rearrangements may take place and eventually lead to cell death. (Reviewed by 
Wood, 1996). 
1.6.1 Non -homologous end joining 
Nonhomologous end joining (NHEJ) is the major pathway for repair of DSBs in 
multicellular eukaryotes, the other being homologous recombination (HR). In 
mammals the main pathway for DSB repair is NHEJ while in lower eukaryotes, such 
as yeast, the main pathway is HR. Depending upon the extent of damage at the site 
of a DSB, there may be a requirement for additional repair before ligation of the 
DSB can take place. The term `nonhomologous' is a reference to the lack of 
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extended regions of homology between the DNA strands at the repair site. Unlike the 
situation in HR, regions of homology at the site of the DSB are not required for 
NHEJ to take place, so blunt ends as well as protruding complementary and non - 
complementary protruding ends can be repaired by NHEJ. Where regions of 
microhomology are available, in overhanging single strands at the double strand 
break, they may be utilised by NHEJ. Even a single complementary base pair 
between overhanging ends of DNA is sufficient for NHEJ to take place, although 
strands are aligned to make the maximum number of base pairs. NHEJ is also 
required to rejoin site -specific DSBs introduced during V(D)J recombination (Roth 
and Wilson 1986). Mammalian cells deficient in NHEJ are hypersensitive to 
ionising radiation (which causes DSBs) and are immunodeficient because of their 
inability to complete V(D)J recombination (Baumann et al., 1998, Pastwa et al., 
2003). 
The main components required for NHEJ in eukaryotes have been identified via in 
vitro studies. Each of the proteins involved in NHEJ either binds the ends of linear 
DNA directly or through protein associations. X -ray irradiation leads to DSB 
study of X -ray mouse cell lines led to discovery of the 
XRCC genes. The following proteins are required for NHEJ; DNA Ku protein, 
DNA -PK(cs), XRCC4 protein and DNA ligase IV. Studies on yeast mutants have 
shown that a complex of RAD50, Mrel l/Xrs2 and a family of Sir proteins (Sir2p, 
Sir3p and Sir4p) are also required for NHEJ. The DNA Ku protein is a heterodimer 
of Ku70 and Ku80 and is responsible for recruiting DNA -PK(cs) to the site of the 
DSB. DNA -PK(cs) is the catalytic subunit of DNA protein kinase and the whole 
DNA protein kinase complex is composed of the DNA Ku heterodimer plus this 
catalytic subunit. The DNA protein kinase regulates kinase activity through its 
association with the DNA. XRCC4 and DNA ligase IV associate to form a complex 
that is able to ligate one strand of the DNA with minimal base pairing to the 
antiparallel strand. Murine `knockouts' lacking DNA ligase IV and XRCC4 are 
embryonic lethal because of their inability to perform NHEJ (Lieber, 1999). 
Depending upon whether repair requires removal of overhanging DNA 
(exonucleolytic degradation) at the site of the DSB or resynthesis of a missing region 
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(gap filling), a nuclease or a polymerase is required (Ma et al., 2004; Pastwa and 
Blasiak, 2003; Jeggo, 1998; Lewis and Resnick, 2000). The single DNA strands 
cannot be individually ligated (no single strand DNA ligases have been identified) so 
an alignment protein is probably required to hold the strands in place while any 
necessary repairs are performed prior to ligation of both strands with DNA ligase IV. 
DNA polymerase has been proposed as the alignment protein (King et al, 1994). 
NHEJ commonly results in small deletions that extend in both directions from the 
DSB site and end within the region of microhomology (misjoining). ` Misjoining' 
typically occurs in regions of short repeats around the DSB. When the DNA is 
aligned according to microhomology there may be overhanging DNA sequences that 
extend beyond the end of the homologous region and these overhanging ends need to 
be removed by the action of a nuclease. The polarity of the DNA strand determines 
the type of nuclease required; 5' nucleases FEN1 and EXO 1 and the 3' nuclease 
MRE 11 have been proposed as likely candidates (Wu et al., 1999; Lieber, 1999). 
1.6.2 Classical homologous recombination 
DSB repair by means of homologous recombination, in contrast to NHEJ, results in 
faithful restoration of the sequence at the break point. Because extensive damage 
can be present at a DSB point, repair by homologous recombination requires a non - 
damaged template (the homologous chromosome to the one containing the damaged 
DNA) for restoration of any damaged or missing sequence. Because of the 
requirement for interaction between DNA strands from the DSB and those of the 
template this is a more biologically complex repair process than NHEJ. The 5' strand 
ends at the DSB are digested by nuclease activity to yield 3' single- stranded 
overhanging tails that may be up to lkb in length. In Saccharomyces. cerevisiae (S. 
cerevisiae), the RAD52 epistasis group of genes encode a protein that binds to these 
3' ssDNA ends and this complex then invades the homologous intact duplex DNA 
sequences of the undamaged chromosome that acts as the template for repair. This 
strand invasion initiates strand exchange which leads to formation of joint molecules 
between the damaged invading strands and the undamaged template strands called 
Holliday junctions. The invading strands initiate repair synthesis and once the 
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missing DNA has been replaced the Holliday junctions are resolved by a resolvase 
that cleaves and separates the duplexes. 
1.6.3 Single strand annealing 
Single -strand annealing (SSA) is a special type of homologous recombination but, 
unlike classical homologous recombination, repair of DSBs by SSA is a non - 
conservative mechanism (reviewed by Pastink et al., 2001). Although SSA does not 
involve the formation of Holliday junctions the process does depend upon regions of 
homology (direct repeats flanking both sides of the DSB) for alignment of the 
damaged strands prior to repair and ligation. The 5' strand end digestion that takes 
place prior to homologous recombination leads to production of 3' single stranded 
overhangs. These overhangs can be used to prime homologous recombination if a 
region of homology in the corresponding intact chromosome is located. However, if 
short regions of homology between the 3' overhangs can be found then annealing can 
take place, resulting in repair by the SSA mechanism. The regions of homology may 
be as small as a 30óp repeat and SSA can take place with repeats as distant as 15kb 
from the DSB (Sugawara et al., 2000). Although the factors required for SSA have 
been identified in yeast (only in S. cerevisiae) the genes involved in SSA in higher 
eukaryotes have yet to be determined. 
Once annealing of homologous regions in the single stranded 3' ends has taken place 
the non -homologous regions of the 3' ends must be removed prior to ligation. If the 
3' non -homologous overhanging tails are shorter than 30nt then they are removed by 
a mechanism dependent upon the 3' to 5' proofreading ability of DNA polymerase S 
(Paques and Haber, 1997). Tails longer than 30nt are removed by a different 
mechanism, requiring the use of a number of proteins. The endonuclase activity of 
the RAD 1/RAD 10 complex (homologous to the mammalian ERCC1/XPF complex) 
is necessary (Ivanov and Haber, 1995). RAD52 and RAD59 as well as the 
RAD50/Xrs2/Mre l l complex are also involved (Ivanov et al., 1996; Sugawara et al., 
2000). RAD52 and RAD59 both anneal complementary DNA strands. The proteins 
in the RAD50/Xrs2/Mre 11 complex all have endo- and exonuclease activity (Pastwa 
and Blasiak, 2003). The mismatch repair protein complex, MSH2/MSH3, is 
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necessary for SSA if the length of the annealed region is less than 1.2kb. This 
complex initiates incision of the DNA by RAD1/RAD10. Following annealing, 
RAD 1 /RAD 10 make an incision at the junction between the annealed and non - 
annealed regions of the 3' tails. Therefore, the role of MSH2/MSH3 when the 
annealed region is small may be the stabilisation of intermediate structures prior to 
nuclease activity and/or recognition of single- stranded loops at regions of non - 
homology (Sugawara et al., 1997). The Srs2 protein is also required for SSA and 
this protein has a 5' to 3' helicase activity (Paques and Haber, 1997). Once the non - 
homologous 3' ends have been removed ligation takes place. Because the region 
between the two repeats used for annealing is deleted, repair of DSBs by SSA is non - 
conservative. 
1.6.4 Interstrand DNA Cross -links 
Interaction between DNA and a number of chemical agents can lead to formation of 
cross -links. DNA cross -links can either form within or between DNA strands, 
respectively termed intrastrand and interstrand cross -links. Of the two types of 
cross -link it is the interstrand cross -link that is particularly damaging as it prevents 
DNA strand separation, blocking DNA replication and transcription. A single 
unrepaired DNA cross -link may result in cell death. Molecules that react with DNA 
to make a cross -link form a molecular bridge between the DNA molecule(s) and so 
such chemicals either have two reactive groups capable of covalently bonding to 
DNA or a dimer forms between two molecules that each have a reactive group. 
Cross -linking agents are alkylating agents and they react with nucleophilic centres in 
the DNA. The most nucleophilic parts of the DNA bases are the ring nitrogens. A 
number of chemicals induce cross -link formation and these include Mitomycin C, 
nitrogen mustard, sulphur mustard and photoactivated psoralens. Cross -links can 
also form as minor DNA damage products of UV radiation (- X254nm) and ionizing 
radiation. 
For repair of an interstrand cross -link the DNA adduct(s) must be removed from both 
of the DNA strands. In the E. coli incision -recombination model, the UvrABC 
endonuclease complex of the nucleotide excision repair (NER) pathway makes 
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incisions either side of the cross -link on one of the DNA strands. An incision is 
made 3' to the initial incision on the 3' side of the cross -link of the DNA strand. At 
this stage three incisions have been made in one of the DNA strands, one 5' to the 
cross -link and two 3' to the cross -link. The oligomer between the pair of 3' incisions 
is lost and the resulting gap is the substrate for RecA- mediated recombinational 
repair. Invasion by the homologous DNA strand during recombinational repair 
displaces the cross -linked oligomer. The oligomer remains attached to the other 
DNA strand via the cross -link. The cross -link- attached oligomer is then removed 
from the other DNA strand by a second round of NER and the gap generated is 
repaired by normal repair synthesis prior to ligation. This repair model is 
conservative due to the recombinational repair (Sladek et al., 1989; Van Houten, 
1990). In S. cerevisiae, repair of interstrand cross -links involves the production of a 
DSB. NER proteins make incisions either side of the cross -link on both DNA 
strands resulting in a DSB and release of the oligomers attached by the cross -link. 
Repair then involves the recombination proteins RAD51 and RAD52 (Dardalhon and 
Averbeck, 1995; Greenberg et al. 2001; Wang et al. 2001). Removal of cross -links 
in higher eukaryotes is not clearly understood. 
In mammals interstrand cross -link removal is dependent upon the ERCC1/XPF 
complex. ERCC1/XPF deficient cells are hypersensitive to cross- linking agents 
while cells deficient in other NER genes are less sensitive (Hoy et al., 1985). Two 
possible mechanisms have been proposed and these differ in a number of ways. The 
first mechanism is an error -prone translesion synthesis mechanism in which dual 
incisions are made, flanking the cross -link, on one of the DNA strands. DNA 
polymerase would then resynthesize DNA to fill the gap and the cross -link and 
attached oligomer would be removed by NER. In this mechanism the role of 
ERCC1/XPF is as part of the NER process. The second mechanism is a conservative 
repair mechanism in which the ERCC1/XPF complex, independent of its role in 
NER, makes dual incisions on one strand that flank the cross -link. Strand transfer 
from the intact duplex (the sister chromatid) and ligation is followed by dual incision 
to release the cross -link from the other DNA strand and then repair synthesis takes 
place. The requirement for the sister chromatid in the second mechanism means it 
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`unhook' one side of the cross -link by making dual flanking incisions and the other 
side of the cross -link could then be removed by the same process (it would also act 
as a substrate for NER) (Kuraoka et al., 2000). The cross -link `unhooking' rate of 
ERCC1 and XFP mutants is much slower than other NER mutants and wild type 
when measured by comet assay, suggesting that ERCC1 and XPF are required for 
this process independently of other NER proteins (de Silva et al., 2000). 
Two lines of evidence suggest that there may be a third, minor, mechanism that does 
not require ERCC1/XPF. Firstly, survival curves of Erccl null fibroblasts indicated 
an interstrand cross -link resistant population. Secondly, mouse Erccl mutants are 
more sensitive to the cross -linking agent mitomycin C than hamster mutants, 
suggesting that a pathway in hamster mutants is providing the increased resistance to 
interstrand cross -links in comparison to mice (Mellon et al., 1998; Weeda et al., 
1997). An ERCC1/XPF independent mechanism could involve the activity of 
glycosylase to `unhook' the cross -link (Bridges and von Wright, 1981). 
The 60 -fold increased sensitivity of XRCC2 and XRCC3 (RAD51 homologues) 
mutants to mitomycin C suggest that these proteins are involved in the removal of 
cross -links (Cui et al., 1999; Liu et al., 1998). Because comet assays show that these 
mutants `unhook' interstrand cross -links at the same rate as wild type the proteins 
must be involved in repair of cross -links downstream of the `unhooking' step (de 
Silva et al., 2000). A model for cross -link removal has been proposed that 
incorporates evidence of the involvement of ERCC1IXPF and XRCC2 and XRCC3. 
In this model the interstrand cross -link halts replication and an unknown process 
makes a DSB. XRCC2 and XRCC3 dependent recombination is initiated but the 
presence of the cross -link stalls this process. The cross -link is 'unhooked' by 
ERCC1/XPF (possibly resulting in a DSB if incisions are also made to free the cross - 
link completely) allowing recombination and repair to be completed (de Silva et al., 
2000). Erccl knockout mice (section 1.12.8) die prematurely from liver failure and 
the accumulation of DNA damage in the liver of the knock -out mice, supports the 
role for Erccl in recombinational repair of endogenous DNA damage (Chipchase et 
al., 2003; Núñez et al.; Weeda et al., 1997). 
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1.7 Base excision repair 
Base excision repair (BER) is a pathway for the removal of damaged or inappropriate 
DNA bases (reviewed by Friedberg, Walker and Siede, 1995; Wood, 1996; Lindahl 
et al., 1997; Fortini et al., 2003). The pathway is so named because free bases are 
produced following excision. BER removes small DNA adducts, fragmented bases 
oxidised and reduced bases and apurinic /apyrimidinic (AP) sites. The damage 
repaired by this pathway results from a range of sources. Methylation causes 
formation of DNA adducts (methyl groups), oxidised, reduced or fragmented bases 
may arise due to the effects of free radical attack (due to normal metabolic processes) 
or IR. BER also repairs apurinic /apyrimidinic (AP) sites. Such sites may arise due 
to spontaneous hydrolysis or oxidative damage. There are two BER pathways, one 
for the repair of single bases (short patch BER) and one for tracts of bases (long 
patch BER). Although most of the proteins involved in BER are common to both 
pathways, some are specific to a particular pathway. 
In short patch BER, recognition of the damaged base and initiation of BER is 
performed by one of several DNA glycosylases, with specific glycosylases targeting 
different types of base damage. For example, uracil is an inappropriate base to find 
in DNA and the glycosylase that recognises uracil is uracil -DNA glycosylase. In 
contrast, methylated adenine is specifically recognised by 3- methyladenine -DNA 
glycosylase. Following recognition of the base by the glycosylase, the N- glycosylic 
bond between the base and the deoxyribose- phosphate backbone is hydrolysed 
(Dianov and Lindahl, 1994; Frosina et al., 1996; Lindahl, 1995; Memisoglu and 
Samson, 1988). This releases the base, forming an AP site (which is also a type of 
DNA damage). The next step in repair is removal of the AP site. REF1, an AP 
endonuclease, is required to make an incision by hydrolysis of the bond in the 
phosphodiester backbone 5' to the AP site (Demple and Harrison, 1994; Sancar and 
Sancar, 1988; Wallace, 1988). Complex glycosylases have intrinsic AP 
endonuclease activity but the nick resulting from REF1 is required for repair 
synthesis to take place. The action of the AP endonuclease results in a strand break 
with a 5' terminal deoxyribose- phosphate moiety (dRP). Before repair synthesis can 
take place this 5' terminal deoxyribose- phosphate moiety must be removed. During 
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short-patch BER, the deoxyribose 5'- phosphatase (dRPase) activity of DNA 
polymerase ß (pol ß) removes the dRP and pol ß then performs repair synthesis. 
Ligation in short patch BER is performed by DNA ligase III and XRCC 1. 
The long patch BER (2 to 10 nucleotides) pathway uses the same proteins as short 
patch repair until after the production of incision 5' of the AP site. In long patch 
BER the dRP moiety, along with several downstream nucleotides, is removed by 
flap -endonuclease (FEN1). The damaged tract being repaired by long path BER is 
displaced and this displaced parental tract becomes a 5' terminal overhanging region 
(a flap). FEN1 binds and tracks along the overhanging region from the 5' end until it 
reaches the cleavage site where it makes an incision that results in release of the 
overhanging region. Proliferating cell nuclear antigen (PCNA) interacts with FEN1 
to enhance its binding and cleavage ability. p21 is thought to then displace FEN1 
from PCNA, releasing FEN1 from the replication fork so that it can perform removal 
of the dRP. In short patch BER the pol f3 performs this task but in long patch BER 
the replicative polymerases (pol 8/6) are preferentially utilised and these polymerases 
lack the intrinsic dRPase activity of pol ß. The ligation step of long patch BER is 
performed by DNA ligase I. Pol ß may also have a role in long patch BER because 
FEN1 stimulates strand displacement repair synthesis by pol 13 but subsequent 
recruitment of DNA ligase I halts pol ß activity, limiting repair synthesis to a single 
nucleotide (Fortini et al., 2003; Klungland and Lindahl, 1997). 
1.8 Mismatch repair 
Mismatched bases are introduced into DNA by a number of processes. There are 
two obvious ways of introducing mismatches. The first is by incorrect base 
incorporation during DNA synthesis and this is likely to occur opposite bases that 
have been damaged by oxidation or UV (Earley and Crouse, 1998). The second is 
during DNA recombination if there are differences between the sequences of the 
DNA strands that form the heteroduplex (such differences may arise due to divergent 
evolution) (Wagner and Meselson, 1976). Mismatches may also occur when 
imperfect palindromes in the DNA sequence form a hairpin structure and when 
deamination of methylated cytosine (5- methylcytosine) in a GC pair leads to 
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mismatching of a T opposite the G. There are two important differences between 
mismatch repair (MMR) and other DNA repair processes; that of damage 
recognition and repair. In mismatch recognition the mismatched nucleotide need not 
be chemically altered/damaged but is in the wrong structural location. In addition, 
depending upon the source of the mismatch there may be a requirement for an ability 
to distinguish which nucleotide in a mismatched pair is the mutation. For example, 
in the case of a mismatch introduced during DNA synthesis the newly synthesised 
strand contains the error while the parental strand must be used as a repair template. 
The genes involved in MMR are highly conserved between prokaryotes and 
eukaryotes and there is interaction between proteins of NER and MMR. The size of 
the excised DNA containing the mismatched nucleotide may either be <10 
nucleotides (short-patch repair) or long -patch repair (as large as 103). The mismatch 
repair process is reviewed in detail in Friedberg, Walker and Siede, 1995. 
1.8.1 Recognition and repair of mismatched bases in prokaryotes 
When DNA synthesis or recombination produces a mismatch the genetic fidelity of 
the code is threatened. The incorrectly matched base of the pair must be identified 
and excised so that the correct sequence is used as a template for re- synthesis. If the 
base from the original sequence were to be incorrectly excised then repair would lead 
to permanent fixation of the mutation. In prokaryotes discrimination between DNA 
strands takes place following replication using the methylation state of the newly 
synthesised DNA. This can occur because of a delay between synthesis and 
methylation of DNA. In this way, mismatches in the daughter strand of DNA can be 
identified after replication because the daughter stand is under -methylated relative to 
the original, parental strand. Such MMR is referred to as methyl- directed MMR. A 
number of genes are involved in methyl -directed MMR and these are conserved 
between prokaryotes and eukaryotes. When a mismatch occurs the sequence 
surrounding the mismatch and the type of mismatch affect how quickly it is repaired. 
The way that mismatches are repaired means that certain types of mismatch can have 
more serious consequences in terms of maintenance of genetic fidelity than others. 
For example in a GT mismatch, where a T had been substituted for a C, repair could 
lead to reversal of the mismatch (GC >GT >GC) or production of an AT transition 
mutation (GC >GT >AT); such mismatches are repaired very efficiently because of 
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the danger to genetic fidelity. The second type of mismatch is one that could result 
in a swap of DNA code between strands, a transversion mutation. Transversions can 
result from repair of identical mismatched bases e.g. where the G has been 
incorporated in place of a C in a GC pair, GG may be repaired back to the original 
sequence or the parental G may be swapped for a C resulting in a transversion 
(GC >GG >CG). 
Recognition and repair of mismatched bases in prokaryotes involves a number of 
steps and proteins. Recognition, unwinding, excision, synthesis and ligation are 
required if a mismatch is to be repaired. In E. coli mismatches are recognised by the 
proteins MutS, MutL and MutH (Rydberg, 1978). Mismatches are initially 
recognised and bound by MutS (primary recognition). Due to the ability of MutL to 
bind MutS- bound -heteroduplex- mismatches it is thought that MutL is the secondary 
recognition factor in MMR. MutH has the ability to distinguish between strands on 
the basis of their methylation state (hemimethylated strands) and also has some 
endonuclease activity, meaning that it can identify the parental strand and cut the 
daughter strand 5' of the mismatch. The methylation state of a specific sequence of 
the parental DNA, a GATC sequence where the A is methylated, allows the MutH to 
recognise the parental strand in comparison to the daughter strand and the GATC 
signal need not be close to the mismatch for recognition by MutH (a GATC - specific 
endonuclease). Following recognition of the mismatch and strand discrimination the 
DNA around the mismatch needs to be unwound and this unwinding is performed by 
DNA helicase II (the protein encoded by the gene uvrD+). Single- stranded -DNA- 
binding protein (SSB) is also required for excision of the mismatch. Exonucleases I, 
VII and RecJ are required for excision of nucleotides and repair synthesis is 
performed by DNA polymerase III holoenzyme. It is likely that DNA ligase is 
required to seal the nicks following resynthesis and the co- substrate for DNA ligase, 
NAD+ is known to be required for MMR to take place (reviewed in Friedberg, 
Walker and Siede, 1995). 
1.8.2 Eukaryotic homologues of prokaryotic MMR proteins 
Homologues of the prokaryotic MMR genes have been identified in eukaryotes and 
are highly conserved, indicating the importance of the process. In yeast (S. 
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cerevisiae) there are six homologues of the E. coli mutS protein (MSH1 -6) and five 
MutL homologues (PMS1 -2, MLH1 -3) and they take part in recombination and/or 
MMR following DNA synthesis. The presence of both MutS and MutL homologues 
is required for MMR. There is interaction between a MutS complex and 
heterodimers of two MutL homologues. In yeast there are multiple MutS and MutL 
homologues and this is thought to be due to functional specialisation. Mismatches 
are initially recognised and bound by a MSH2/MSH3 or MSH2/MSH6 heterodimer. 
Combinations of MutS homologues form heterodimers that are involved in different 
tasks. During MMR MLH1 and either PMS1, MLH2 or MLH3 form a heterodimer 
that binds MSH2- heterodimer- bound -heteroduplex- mismatches (Kolodner and 
Marsischky, 1999; Marsischky et al., 1996). This is homologous to the situation in 
E. coli with MutL binding MutS- bound -heteroduplex- mismatches. Excision and 
repair of the mismatch is likely to involve NER proteins as interaction between 
MSH2 and NER proteins has been reported (Bertrand et al., 1998). 
Human homologues of the MMR genes of yeast have also been identified. A gene 
called Duc -1 in humans is thought to encode a protein very similar in amino acid 
sequence to the E. coli MutS (encoded by mutr) but has not yet been shown to have 
a role in MMR. There are two human MutS heterodimer complexes, hMutSa and 
hMutS 3. hMutSa is composed of hMSH2 and hMSH6 (homologues of MutS) and is 
the recognition factor for small mismatches. hMutS 13 is composed of hMSH2 and 
hMSH3 (homologues of MutS) and is the recognition factor for larger mismatches. 
Once the damage has been bound by one of the hMutS complexes, the hMutL 
complex is recruited to the site. This heterodimer is composed of hMLH1 and 
hPMS2 (homologues of MutL). Mutations in the human MLH1 and PMS1 
homologues are associated with hereditary nonpolyposis colorectal cancer (HNPCC) 
(Lindahl et al., 1997). Following binding of hMutL, excision of the mismatch and 
surrounding sequence takes place and is followed by repair synthesis using the 
template strand. These interactions enable recruitment of other proteins involved in 
repair to the site. 
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1.8.3 MMR and recombination 
As mentioned earlier, differences between the sequences of the DNA strands that 
form the heteroduplex during recombination can lead to mismatches. Such 
differences arise due to mutation or because of evolutionary divergence. Loops in 
the DNA form where bases are mismatched and the size of the loop structure 
depends upon the number of adjacent mismatches. Recombination is inhibited when 
mismatches are encountered during heteroduplex formation. Such mismatches 
inhibit recombination in eukaryotes and prokaryotes and the MMR proteins are 
responsible for reversal or destruction of recombination intermediates. The MutS 
homologues of yeast (MSH1 -6) are all induced during meiosis. The MSH2/MSH6 
heterodimer has anti -recombinational activity where mismatches are present. The 
MSH4/MSH5 heterodimer and PMS2 are required at chromosome synapsis (close 
pairing of homologous chromosomes) during meiosis. The MSH4/MSH5 
heterodimer along with MLH 1 and MLH3 are involved in crossing -over during 
meiosis. All these roles demonstrate the functional specialisation of the MutS and 
MutL homologues. 
1.9 Human hereditary disorders associated with defects in NER 
Study of DNA repair in mammals had been limited by the lack of available mutant 
cell lines but in 1968 xeroderma pigmentosum (XP) became the first hereditary 
human disorder to be associated with defective DNA damage repair. Because 
patients with XP are hypersensitive to UV and have a predisposition to cancer 
development, fibroblasts derived from the skin of a patient with this disorder were 
studied to discover the basis of the UV hypersensitivity. The cells were reported to 
be unable to perform NER following UV irradiation. This observation led to 
examination of the response of cells derived from patients with similar human 
hereditary disorders (associated with chromosomal abnormalities and increased 
cancer incidence) to DNA damaging agents. Cockayne's syndrome (CS) and 
trichothiodystrophy (TTD) were found to be associated with defective DNA damage 
repair. Such studies led to the identification of other genes involved in DNA damage 
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repair. The three diseases, XP, CS and TTD are all rare, autosomal, recessive 
disorders. The clinical features and genetic basis of these diseases are described 
below. (Friedberg, 2004; reviewed in Friedberg, Walker and Siede, 1995). 
1.9.1 Xeroderma pigmentosum 
Xeroderma pigmentosum is an autosomal recessive disorder. Xeroderma means 
`parchment skin' and pigmentosum refers to the freckling that occurs in sun -exposed 
areas of the body. This is a rare disorder and incidence varies according to 
geographical location. The XP phenotype is severe photosensitivity and 
pigmentation abnormalities in exposed areas of the body, high incidence (2000 -fold 
increase) of skin cancers with early onset, increased rate of tumour development in 
other UV exposed areas such as the tip of the tongue and the eyes and increased 
incidence of internal tumour development (20 -fold increase). Neurological 
abnormalities are present in 20% of XP cases. The photosensitivity is due to 
defective NER, which results in accumulation of photoproducts that are converted to 
mutations during semi -conservative DNA synthesis. Neurological damage is thought 
to occur due to an inability to repair oxidative DNA damage in the brain. There are 
seven XP complementation groups (XPA - XPG) and a variant form, XPV. In XPE 
and variant XP NER is either normal or only slightly reduced. The genes for XPA, B, 
C, D, F and G have been cloned. 
1.9.2 Cockayne's syndrome 
Cockayne's syndrome (CS) is a rare disorder and affected individuals have a number 
of developmental abnormalities. The primary requirements for diagnostic features of 
the disease are dwarfism due to arrested growth and development (despite normal 
growth hormone levels) accompanied by neurological abnormalities. Other classical 
features of the CS phenotype are photosensitivity, cataracts, deafness, dental caries, 
intracranial calcifications and abnormally large facial features and limbs in 
proportion to body size. Five complementation groups are associated with CS but 
only those not also associated with XP are formally recognised as CS. The two CS 
complementation groups, CS -A and CS -B have the classical CS symptoms but lower 
photosensitivity and no predisposition to skin cancer, unlike CS associated with XP. 
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The genes mutated in CS -A and CS -B have been cloned. CS that is associated with 
XP is referred to as XP -B /CS, XP -D /CS and XP -G /CS depending on the mutations 
involved. 
The photosensitivity of CS patients suggested that there may be an abnormality in the 
ability of these individuals to repair UV induced DNA damage. Fibroblasts isolated 
from CS patients are hypersensitive to UV radiation of A254nm and this is due to a 
defect in NER. There is a defect in removal of UV induced cyclobutane pyrimidine 
dimers (but not other photoproducts) from the template strand in actively transcribed 
DNA (defective transcription coupled repair). In normal mammalian cells, RNA 
synthesis is depressed following UV irradiation and levels recover following repair 
of DNA damage. The defect in transcription coupled repair in CS cells means that 
the damage in the actively transcribed genes is not repaired so RNA levels cannot 
return to normal levels following DNA damage introduction. The defective recovery 
of RNA synthesis following UV irradiation is now used as a clinical method of CS 
diagnosis. 
The defect in CS -B cells is complemented by ERCC6, suggesting that CSB and 
the same genes. a the polypeptide of 
the putative CSB gene that has homology to transcription coupling -repair factor and 
this protein is thought to recruit NER proteins to transcription sites where 
transcription has stalled due to DNA damage in the template strand. CSA would 
likely also encode such a protein. When an individual has CS associated with XP 
their risk of developing skin cancer is increased when compared to cases of simple 
CS. This is thought to be due to the defect caused by mutation of the XP gene and 
may be because of an inability to repair photoproducts other than cyclobutane 
pyrimidine dimers. 
1.9.3 Trichothiodystrophy 
Trichothiodystrophy (TTD) is an autosomal recessive disorder characterised by 
sulphur -deficient, brittle hair (trichoschisis or trichorrhexis nodosa); fish -like scales 
on the skin (ichthyosis); mental and physical retardation and distinctive facial 
features (large ears and receding chin). A number of brittle -hair syndromes are 
associated with TTD and have acronyms which indicate the phenotype; BIDS 
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patients have brittle hair, intellectual impairment, decreased fertility and short 
stature. The additional symptoms of ichthyosis and photosensitivity are indicated in 
the acronyms IBIDS and PIBIDS. 
Photosensitivity is a feature of 50% of TTD cases. Although patients with 
photosensitive forms of TTD do not have a higher risk of developing skin cancer 
than normal, cells from patients with photosensitivity have defective NER with an 
inability to repair UV- induced DNA damage. The repair defect is associated with 
XP complementation group D. TTD associated with XP complementation group D, 
this defect is complemented by XPD. XPD has two roles; it is involved in NER and 
RNA polymerase II- dependent basal transcription. TTD is probably caused by 
defective transcription because of the association of XPD with the disorder. 
There is a hypothesis that TTD is a `transcription syndrome' and is caused by 
mutation of genes involved in RNA polymerase II basal transcription. There are three 
complementation groups associated with photosensitive TTD; TTD group A is not 
complemented by any of the XP genes and is likely to be due to mutation in a gene 
that encodes a subunit of TFIIH complex; the second group is complemented by 
XPB; the third group is complemented by XPD. XPB and XPD both encode subunits 
of the RNA polymerase II basal transcription complex TFIIH which is required for 
both transcription and DNA damage repair. 
1.9.4 Genetic complementation groups 
NER genes were identified by work on human cell lines from NER deficient patients. 
Similar work on NER deficient rodent cell lines had led to identification of 11 rodent 
complementation groups (10 from Chinese hamster and one from a murine cell line). 
Transfection of these cell lines with human genomic DNA led to identification and 
cloning of genes involved in NER. The rodent cell lines were used preferentially 
over human cell lines because the transfected DNA was more stably integrated into 
the rodent cells. As the human genes were `cross complementing' the NER 
deficiency of the rodent cell lines they were given the prefix ERCC (excision repair 
cross complementing). Of the six human genes discovered by this method, ERCCJ - 
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ERCC6, all except ERCC1 were found to be mutated in human NER disorders. 
Several were also found to be identical to those that had already been discovered in 
XP, CS and TTD. Where this was the case the name of the ERCC gene was changed 
to the name associated with the human disorder. The ERCC2, ERCC3, ERCC4, 
ERCC5 and ERCC6 genes are referred to as XPD, XPB, XPF, XPG and CSB. 
Because ERCC1 has not been found to be mutated in any of the patients with CS, XP 
and TTD it is likely that mutations in ERCC1 are either associated with another 
human disorder or are developmentally lethal. The genes mentioned and the function 
of their encoded proteins are summarised in table 1.2. 
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Table 1.2 NER genes, protein function and associated human diseases. 
Table shows human NER disorders, associated genes and protein function. 
Gene Corresponding 
ERCC gene 
Associated disorder Protein function 
XPA - XP DNA damage recognition 
XPB ERCC3 XP/XP -CS/TTD DNA helicase, subunit of 
TFIIH 
XPC - XP Global genome repair 
XPD ERCC2 XP/XP -CS/TTD DNA helicase, subunit of 
TFIIH 
XPE - XP Role in NER 
Gene not cloned 
XPF ERCC4 XP 5' Endonuclease 
XPG ERCC5 XP/XP -CS 3' Endonuclease 
XPV - XP Lesion bypass DNA 
Polymerase i 
CSA - CS Role in Transcription - 
coupled repair 
(Gene not cloned) 
CSB ERCC6 CS Transcription -coupled 
repair 
TTDA - TTD TFIIH subunit 
- ERCCJ - 5' Endonuclease 
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1.10 Nucleotide excision repair pathway 
Because the work detailed in this thesis is based upon the role of ERCC 1 in the 
nucleotide excision repair (NER) pathway, it is necessary to explain this pathway in 
greater detail than the other repair pathways mentioned. The NER pathway was 
discovered by study of UV sensitive mutant cells and a number of human disorders. 
Of all the repair pathways mentioned, NER is capable of recognising and repairing 
the greatest range of DNA damage. The types of DNA damage recognised by NER 
are UV- induced damage (CPDs and 6- 4PPs), intrastrand cross -links, damaged bases 
and undamaged bases in the wrong structural context (mismatched bases and short 
loops). NER is the only repair pathway capable of removing large chemical adducts 
such as psoralen -thymine adducts. The lesions recognised by the NER pathway tend 
to be large and DNA helix- distorting. The importance of this pathway is reflected by 
the high degree of structural homology between NER genes between lower 
eukaryotes and higher eukaryotes, indicating strong selection pressure during 
evolution. The lack of structural homology between genes in the NER pathway of 
prokaryotes in comparison to eukaryotes suggests that convergent evolution has led 
to functional similarity. Because of the greater size and complexity of the eukaryotic 
genome, the NER pathway in eukaryotes involves between 20 and 30 proteins while 
that of prokaryotes requires only 3. However, the general mechanism of action in 
NER in both prokaryotes and eukaryotes is the same; damage recognition, dual 
incision, excision, repair synthesis and ligation (Friedberg, 1995; Sancar 1996; 
Wood, 1996; Lindahl et al., 1997. 
1.10.1 NER in prokaryotes 
Early work on removal of CPDs following UV irradiation in E. coli revealed the 
presence of two separate repair mechanisms. As mentioned in section 1.5.1, the 
photoreactivation mechanism removes such dimers and, being dependent upon the 
presence of visible light, this was referred to as `light repair'. The second 
mechanism capable of repairing these lesions was classified as `dark repair' and this 
was the NER reaction (Friedberg et al., 1995). The proteins required for NER in 
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prokaryotes are UvrA, UvrB, UvrC, UvrD (also known as DNA heiicase It) and Poi. 
I. UvrA and UvrB form a complex, (UvrA)-2(UvrB)u. that recognises and binds DNA 
damage. This complex has ATE'- DNA helicase activity. The (jv 
subunits dissociate following DNA 1...v leaving the UvrB subunit hound to the 
DNA. UvrC is recruited by the UvrB- il,) mid DNA lal induces .: conformational 
change that enables UvrB to make a 3" incision 4 nnucleotides from the DNA lesion.. 
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DNA damage affinity as there is in GGR (Tornaletti and Hanawalt, 1999). Probably 
for this reason, XPC is not essential to TCR (Venema et al., 1991). For this reason, 
the `bipartite recognition model' in which the genome is scanned for DNA distorting 
lesions and then the lesions are localised to a particular strand refers more to the case 
of GGR than TCR. 
Table 1.3 NER genes in eukaryotes 
Table of cloned human NER genes and their names in the mouse and S. cerevisíae 
Human Mouse Yeast (S. cerevisiae) 
ERCC1 Erccl RADIO 
XPA XPA RAD14 
XPB Ercc3 RAD25 
XPC XPC RAD4 
XPD Ercc2 RAD3 
XPE DDB1-DDB2 
XPF Ercc4 RADI 
XPG Ercc5 RAD2 
CSA Ercc8 RAD28 
CSB Ercc6 RAD26 
As in prokaryotic NER, the stages involved in lesion excision are damage 
recognition, dual incision, excision, repair synthesis and ligation. The current model 
involves 25 proteins and has been reconstituted in vitro (Aboussekhra et al., 1995). 
The damage recognition and dual incision stages of NER were reconstituted with 
RPA, XPA, TFIIH (containing XPB and XPD), the ERCC1/XPF complex and a 
factor designated 1F7. To achieve the final stages of NER, replication factor (RFC), 
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proliferating cell nuclear antigen (PCNA), DNA polymerase e and b and DNA ligase 
I are required. 
The type of DNA lesion recognised by the NER pathway generally causes distortion 
of the DNA helix. Most investigations of NER use UV-damaged DNA as the 
substrate. The primary lesions resulting from UV irradiation, CPDs and (6 -4)PPs 
both cause distortion of the DNA helix, with the degree of conformational change 
depending upon the type and orientation of the lesion. For illustrative purposes, 
cyclobutane pyrimidine dimer causes unwinding of the DNA helix by 19.7® and 
results in a 27 ° -30° kink that protrudes into the major groove of the DNA. The 
differences between the distortions caused by the two types of DV induced 
intrastrand crosslinks, CPDs and (6- 4)PPs, may be the reason why NER removes 
them at different rates, with CPDs being removed more slowly than (6 -4)PPs (Gunn 
et al., 1996; Husain, et al., 1988; Pearlman and Holbrook, 1985; Ramiro et al., 2004; 
Reardon and Sancar, 2003). In NER the DNA lesion must be excised ithout 
causing damage to the opposite DNA strand, as the undamaged strand is required as 
the template for repair synthesis. The DNA strand containing the lesion must, 
therefore, be identified following detection of the distorted DNA at the damage site.. 
These requirements have led to the bipartite substrate discrimination model in which 
the general location of the lesion is first detected by the degree of disparity between 
the shape of the normal DNA duplex and distortion due 
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The order of assembly, especially the order that the damage recognition proteins 
assemble, is not yet clear. It may be that the initial order of assembly varies 
depending upon the substrate as several of the proteins have been implicated in the 
initial damage recognition step of NER. XPA and RPA form a recognition complex. 
There is some specificity in the type of damage these proteins have affinity for and 
this has led to three models; "XPC first" (Evans et al., 1997; Naegli, 1995; Sugasawa 
et al., 1998; Volker, 2001), "RPA/XPA first" (Wakasugi and Sancar, 1998) and 
"RPA first" (de Laat et al., 1998). In these models, which refer to the GGR pathway, 
either XPC (bound to hHR23B - the human homologue of RAD23), RPA/XPA or 
RPA alone binds to the damage and subsequently recruits the other components of 
the NER complexes. There is evidence to support all three models so it is likely that 
depending upon the type of damage and whether it is encountered during GGR or 
TCR, either XPC or RPA/XPA or RPA is the primary molecular recognition 
component. Although XPC has a higher affinity for most types of DNA damage than 
XPA and RPA no affinity for CPDs has been detected (Batty et al., 2000; Reardon et 
al., 1996; Sugasawa et al., 2001). RPA, but not XPA nor XPC, is recruited to 
psoralen adducts. It has been suggested that all three of the proteins function 
cooperatively to identify damage and recruit factors for repair to the site 
and Sancar, 2003). The role of XPE in NER is unclear. Damaged DNA binding 
protein (DDB) has an affinity for damaged DNA and the heterodimer has a 48kDa 
subunit encoded by the XPE gene. This subunit is mutated in all known cases of XP 
complementation group E. DDB has a high affinity for CPDs and when it binds to 
these lesions it induces a 55° bend in the DNA helix (Fujiwara et al., 1999; Hwang 
and Chu, 1993; Payne and Chu, 1994; Reardon et al., 1993). It may be that this 
results in binding by XPC (or XPA) (Dip et al., 2004). 
Following detection of damage, the basal transcription factor TFIIH is recruited. 
This factor has nine subunits, two of which are the DNA helicases XPB and XPD 
(van Vuuren et al., 1994). TFIIH probes and unwinds the helix around the lesion, 
RPA binds the undamaged strand and the localised unwinding of the DNA allows 
access to the lesion by the endonucleases. Aside from the ability of TFIIH to unwind 
the DNA at the lesion, it is possible that this factor also has some DNA damage 
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recognition capability; the XPD subunit TFIIH is located very close to the lesion in 
the fully assembled recognition/excision complex (Reardon and Sancar, 2002; 
Ramiro et al., 2004). TFIIH interacts with XPA and recruits the endonuclease, XPG. 
The endonuclease, XPG interacts with RPA and XPA recruits the endonuclease 
heterodimer ERCC1/XPF. XPG makes the incision 3' of the lesion while 
ERCC1/XPF makes the 5' incision. XPG makes an incision 6 -9 nucleotides 3' to the 
lesion (O'Donovan et al.; 1994, Huang et al., 1992; Moggs et al., 1997). 
ERCC1/XPF then makes an incision 16 to 25 nucleotides 5' to the lesion (Sijbers et 
al., 1996). These incisions are not, therefore, equidistant from the lesion. Following 
dual incision the 22 -30 base oligonucleotide is excised, leaving a single stranded gap 
bound by RPA (Mu et al., 1996). RPA is then involved in dissociation of the 
damage recognition and excision proteins and recruitment of the repair synthesis 
proteins (Reidl et al., 2003). RFC binds to the RPA -bound single stranded gap and 
recruits PCNA, a sliding clamp for DNA polymerase s and S (Shivji et al., 1995). 
Repair synthesis of the gap follows and the newly synthesised DNA is ligated by 
DNA ligase I. 
As mentioned earlier, TCR does not require XPC because the DNA damage is 
located when the RNA polymerase II holoenzyme is stalled by the DNA lesion. 
Detection of a lesion in this way leads to recruitment of XPA, RPA, CSA and CSB. 
Some mismatch repair proteins and the UVSS protein (UVSS is mutated in a UV- 
sensitive syndrome distinct from XP and CS) are also required for TCR (Le Page et 
al., 2000; Mellon et al., 1996; Spivak et al., 2002). TFIIH is able to move from its 
location in the RNA polymerase II enzyme to take part in recruitment of the 
endonucleases and NER proceeds as in GGR from the dual incision stage onwards 
(Dip et al., 2004; Drapkin and Reinberg, 1994). 
1.11 Cloning and characterisation of ERCC1 
Because ERCCI is the focus of this thesis, the gene and its protein will now be 
described in detail. As described earlier, the ERCC genes (ERCCI -6) were 
identified in genetic complementation studies of 11 UV- hypersensitive rodent cell 
lines. Subsequent analysis revealed that all but one of the ERCC genes 
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complemented the human XP and CS complementation groups. ERCC3,4 and 5 
complemented XP groups and ERCC 6 complemented CS group B. The fact that 
humans exist with these disorders indicates that deficiency in ERCC genes 2 -6 is not 
lethal. No human disorder has yet been associated with deficiency in ERCCI , 
indicating that ERCC1 deficiency is embryonic lethal in humans or deficiency is 
compatible with survival but the associated human disorder has not yet been 
identified (van Duin et al., 1989). Since the NER diseases are very rare, this is a 
possibility. However, because XP patients completely deficient in NER survive it 
may be that an accessory role of ERCC1 is so important to viability that deletion of 
ERCC1 is incompatible with survival in humans. Erccl knockout mice perish 
shortly after birth due to liver failure that has been attributed to the lack of Erccl 
leading to a deficiency in recombinational repair. 
ERCC1 complements the mutation in CHO43 -3B cells (Westerveld, 1984). These 
cells are UV hypersensitive and the ERCC1 mutation is a missense mutation in the 
98th reside (Hayashi, 1998). In humans the gene has 10 exons and spans 15kb of 
chromosome 19. The mouse gene was cloned using human cDNA and this gene also 
has 10 exons, the gene is located on chromosome 7 (van Duin et al., 1988). There is 
82% sequence homology between the mouse and human gene and both are driven by 
a promoter that lacks classical promoter elements (discussed in introduction to 
chapter 3). The 3' end of the gene overlaps with the 3' end of the antisense ERCC1 
gene, ASEI , the function of which is unknown (van Duin et al., 1989). The gene is 
expressed constitutively at low levels throughout the body with the primary transcript 
being 1.1kb (with the exception of a novel skin transcript of 1.5kb, described later). 
Alternative splicing and polyadenylation results in production of additional 
transcripts including a lkb transcript lacking exon 8 that does not encode a repair 
proficient protein (van Duin et al., 1986), a 4.3kb and a 3.8 kb transcript. The 
constitutive expression of this gene is in common with the other NER genes and the 
transcript was detected at all developmental stages studied (van Oostrom et al., 
1994), although recent work in this laboratory demonstrated that the transcript is 
absent in early mouse embryos or is expressed at levels too low to detect by northern 
blot and RT -PCR (unpublished data). Studies to date indicated that the gene was not 
33 
induced by UV. The gene is highly conserved in evolution; there is even a 
homologue in plants that can complement mitomycin C sensitivity of ERCC1 
deficient mammalian cells (Xu et al., 1992). 
1.11.1 The ERCC1 protein 
The ERCC1 protein in humans is 297 amino acids long while in mice it is 298 and 
the weight is 33kDa. There is 85% homology between the mouse and human 
proteins overall. The first 100 amino acids of the C- terminus have 70% homology, 
the next 100 have 97% homology and the final 98 amino acids have 89% homology. 
The middle region of the protein is, therefore, the most conserved region and a 
putative DNA binding domain has been assigned to amino acids 134 to 156 in this 
area ( Hoeijmakers et al., 1986). The middle part of the S. cerevisiae RAD 10 protein 
shares 35% homology with 110 amino acids of the C- terminal of the mammalian 
ERCC1 protein and in the middle of this homologous region there is 56% homology 
over a stretch of 25 amino acids. In RADIO, the homologous region encodes a helix - 
loop -helix DNA binding motif. There is no homology in the N- terminal region (van 
Duin et al., 1986). RADIO and RAD1 associate in yeast to perform the 5' incision in 
NER, the role performed by ERCC1/XPF in mammalian NER. There is also a 
homologue of ERCC1 in S. pombe, SWI10 and this associates with the S. pombe 
homologue of XPF, spRAD 16. The RADIO and RAD 1 has a role in recombination 
in yeast (Tomkinson et al., 1993, Bardwell et al., 1994); ERCC1/XPF seems to be 
involved in recombination in mammals (Chipchase et al., 2003). Deletion of 5 
residues from the C- terminus of the mammalian ERCC1 results in complete 
inactivation of the protein (Sijbers et al., 1996). A putative nuclear localisation 
signal has been assigned to amino acids 17 to 23 of the N- terminus and the 
mammalian ERCC1 protein has 83 N- terminal amino acids (not found in yeast) 
which has 38% homology to the C- terminus of the E. coli NER protein UvrC (van 
Duin et al., 1988; Hoeijmakers et al., 1986). However, deletion of 91 N- terminal 
amino acids of ERCC1 has no effect upon the activity of the protein. 
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1.11.2 Interaction between ERCC1 and XPF. 
The first indication that ERCC1 and XPF act as a complex in NER came from the 
inability of cell -free extracts from ERCCI and ERCC4 deficient rodent cell lines 
(and human XPF cells) to complement repair deficiency in vitro. At this stage, XPF 
and ERCC4 were suspected to be equivalent and this was later proven (Sijbers et al., 
1996). The free ERCC1 protein is unstable (Yagi et al., 1997); in cell -free extracts 
from XPF deficient cells there is no available ERCC1 to bind to XPF and 
complement the ERCC1 deficient cells, since the lack of XPF in the XPF deficient 
cells means the ERCC1 is unstable. The association between the proteins was again 
suggested by an experiment in which ERCC1 antibodies were added to cell -free 
extracts from wild type (wt) cells to deplete the ERCC1 levels. This could not 
complement ERCC4 or XPF deficient cells, indicating that removal of ERCC1 
resulted in removal of XPF (ERCC4) (van Vauren, 1993). The correcting activities 
for ERCC1, ERCC4 and XPF co- purified as a high molecular weight species - 100 - 
120kDa and this complex was able to co- correct the three complementation groups in 
vitro). The complex was found to contain the ERCC1 protein (33kD) and a 112kDa 
protein (ERCC4 or XPF) with endonuclease activity (Biggerstaff et al., 1993). 
ERCC1 and XPF (ERCC4), therefore, formed a heterodimer capable of endonuclease 
activity in NER. The domains responsible for stable binding in the complex were 
located using C- and N- terminal truncated recombinant ERCC1 and XPF proteins. 
The binding domains of the ERCC1 and XPF proteins were localised to residues 
224- 297 and 814 -905 respectively (de Laat et al., 1998). The XPF binding region of 
ERCC1 is in the region of homology to the E. coli UvrC protein mentioned earlier, 
so the interaction domain between ERCC1 and XPF does not correspond to 
RAD 1 /RAD 10 in S. cerevisiae as this region is not present in the yeast ERCC1 yeast 
homologue. There is also an interaction domain that enables ERCC 1 to bind to 
XPA, one of the damage recognition proteins of NER and therefore required for 
recruitment and positioning at the damage site. The ERCC1/XPF complex was 
shown to bind to an XPA affinity column (Park and Sancar, 1994) and truncated 
recombinant proteins (as with the XPF and ERCC 1 experiment) localised the ERCC 1 
and XPA interaction domains to residues 92 -119 and 75 -114 respectively (Li et al., 
1994). This explains the NER deficiency of the Chinese hamster cell line (43.3B), 
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complemented by ERCC1, as the mutation in this cell line (the 98th residue) lies 
within the XPA interaction domain; the mutation prevents interaction between 
ERCC1 and XPA during NER. 
1.12 Animal models of NER disorders 
A number of mice with inactivating mutations in DNA repair pathway genes have 
been produced with the intention of gaining insight into the DNA repair mechanisms. 
The rarity of human DNA repair disorders such as XP, CS and TTD mean that in 
vivo mouse models are of great importance to furthering understanding of the role of 
DNA repair genes. Mice with deficient DNA repair pathways (such as NER and 
MMR) are useful for the study of carcinogenesis and mutagenesis, as well as therapy 
development, in terms of the disorder they are developed to model. They are also 
useful for general studies of potentially carcinogenic and mutagenic substances 
(Wijnhoven and van Steeg, 2003). A database of mouse strains carrying targeting 
mutations in genes affecting biological responses to DNA damage initiated in 1997 is 
now at version 5 and this indicates the high rate of mouse knockout production and 
the interest in this approach for modelling human DNA repair disorders (Friedberg 
and Meira, 2003). Mice produced with mutations in DNA repair genes often exhibit 
a number of phenotypic abnormalities found in the associated human disease, serving 
as good models. However, this is not always the case as the consequences of the 
gene inactivation in the mouse often have unexpected results. These differences can 
often be attributed to differences between the physiology /developmental processes of 
the mouse and human due to divergent evolution. For example, deficiency in the 
enzyme hypoxanthine phosphoribosyltransferase (HPRT) in humans results in a 
disease called Lesch -Nyhan syndrome, a severe neurological disorder resulting in 
mental retardation and self mutilation (Lesch and Nyhan, 1964). In contrast, mice 
lacking in the gene are phenotypically normal (Hooper et al., 1987) because mice are 
more reliant upon adenine phosphoribosyltransferase (APRT) than HPRT in their 
purine salvage pathway than humans (Wu and Melton, 1993). Mouse models are a 
useful tool for study of NER disorders but care is required when results of gene 
inactivation in the mouse are extrapolated to humans. The Erccl null mouse was the 
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first in vivo model for defective NER. Since this mouse was developed a number of 
other NER mutant mice have been developed. 
1.12.1 Csa null mice 
Csa null mice are viable (van der Horst et al., 2002). The null mice have phenotypic 
features in common with human CS patients. The mice are UV hypersensitive as 
demonstrated by the UV hypersensitivity of embryonic fibroblast cell lines derived 
from the mice. The mice have defective TCR but normal GGR. The mice also 
exhibit pronounced age- dependent loss of retinal photoreceptor cells. However, the 
mice do not develop the severe developmental and neurological abnormalities 
associated with human CS patients. In addition, the null mice develop skin tumours 
and this is not a feature of CS in humans. The increased risk of skin cancer 
development in the mice may reflect less efficient global genome repair than in 
humans in the absence of TCR. 
1.12.2 Csb null mice 
Csb null mice are viable (van der Horst et al., 1997). Mice were produced with a 
mutation similar to one discovered in a human CS patient; a premature stop codon 
was inserted into the fifth exon of the Csb gene. The mice do produce a mRNA 
fusion transcript but this is not translated into protein. The null mice share a number 
of phenotypic features with CSB patients; the mice had reduced growth compared to 
wild type animals and behavioural analysis suggested the mice have a mild 
neurological abnormality. The mice were UV hypersensitive and fibroblast cell lines 
derived from the mice had defective TCR but GGR levels were normal. All these 
symptoms are features of mild CS in humans and in this respect the mice are good 
models for the disorder. However, the mice had some features that are not found in 
human CSB patients; the mice have a predisposition to developing skin cancer, do 
not exhibit impaired sexual development and do not exhibit neurological 
dysmyelination. 
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1.12.3 Xpa null mouse 
Human XPA patients present the most severe phenotype of the seven XP 
complementation groups. Generation of Xpa null mice has been reported twice (de 
Vries et al., 1995; Nakane et al., 1995). Two different methods were used to 
generate the mice; in one group's mouse a neo cassette was inserted into exon 4 and 
the other group deleted exons 3 and 4. Both mice were shown to be complete 
`knockouts' by northern or western blot analysis. The mice were viable and fertile, 
with a normal appearance up to 13 and 18 months and did not exhibit the progressive 
neurodegeneration associated with XPA group patients. The mice were NER 
deficient and this was demonstrated by the hypersensitivity of null mouse -derived 
fibroblast cell lines to UV and genotoxic compounds. The residual repair of DNA 
damage was extremely low ( <5% in the mouse) and this is comparable to the level of 
repair detected in XPA patients ( <2 %). Both groups reported that their mice had a 
markedly increased rate of UVB induced skin and eye cancer when compared to wild 
type littermates. 21% of mice aged over 1 year were later reported to have increased 
rates of spontaneous liver tumour development (de Vries et al., 1997). The Xpa null 
mice are a good model for study of skin, eye and liver cancer development observed 
in human XPA patients but cannot be used as a model for research of the 
neurodegeneration observed in 20% of human patients. 
1.12.4 Xpc null mice 
Xpc null mice are viable and have no phenotypic abnormalities. However, cell lines 
derived from the mice are hypersensitive to UV. Mice have an increased risk of 
developing skin cancer as well as UV- induced pathological skin and eye changes. 
These symptoms are consistent with XPC patients (Sands et al., 1995). 
1.12.5 Xpd mutant mice 
Complete deletion of Xpd results in a pre -implantation embryonic lethal phenotype 
(de Boer et al., 1998). This is thought to be due to the inability of cells lacking XPD 
to perform basal transcription due to inactivation of the TFIIH transcription factor. 
Because complete `knockouts' were not viable, mice containing a point mutation in 
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the Xpd gene were generated. The location of the point mutation was chosen to 
simulate a mutation discovered in a patient with the photosensitive form of TTD. 
The mutation was introduced via `gene -cDNA fusion targeting' in which human 
cDNA containing the mutation replaced the homologous sequence at the 3' end of 
the mouse gene. Mice generated using this modified gene share a number of 
phenotypic features with human TTD patients; the mice have brittle hair, reduced 
growth, skin abnormalities, reduced fertility and reduced lifespan. Human TTD 
patients generally develop neurological abnormalities over time and the occasional 
tremors reported in the mice suggest that they may also have neurological 
abnormalities. The increased hypersensitivity to UVB measured in fibroblasts 
derived from the mice (1.5 fold higher than wt) matched the level measured in 
human fibroblasts derived from TTD patients. Although the mice are good models 
for most of the symptoms of TTD, the predisposition towards UVB and chemically 
induced skin cancer development observed in the mice does not conform to the 
human TTD phenotype. As in the case of CSB mice, it was suggested that this could 
be due to less efficient GGR in mice than humans. 
1.12.6 Xpf mutant mice 
Because the proteins encoded by XPF and ERCC1 form a heterodimer it was 
assumed that Xpf null mice would exhibit the severe phenotype of Erccl mutants. A 
group attempting to create a mouse with only partial inactivation of the Xpf gene, for 
a long term study of UV carcinogenesis and to investigate the role of ERCCI /XPF in 
immunoglobulin class switch recombination (CSR), accidentally generated a 
complete Xpf knockout (Tian, 2004). A mutation was introduced into the gene that 
resulted in the formation of a premature stop codon. However, this mutation resulted 
in complete inhibition of Xpf expression. The mice had exactly the same phenotype 
as Erccl deficient mice, the severe postnatal growth defect, abnormalities in the 
nuclear size of liver cells and early death at 3 weeks after birth. Embryonic 
fibroblasts cell lines derived from the mice were hypersensitive to UV and 
mitomycin C (cross -linking agent). Human XPF patients show mild symptoms of 
photosensitivity and occasional neurological abnormalities but do have low levels of 
XPF protein. 
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1.12.7 Xpg mutant mice 
Xpg null mice were produced as a model for human XPG /CS. The mice were 
produced by insertion of a neo cassette into exon 3 of the Xpg gene. The mice had 
growth retardation that became increasing severe with time, premature death by day 
23 after birth, progressive emaciation and weakness, developmental retardation of 
the brain leading to progressive ataxia and decreased activity levels. The mice share 
a number of phenotypic features with human CS and XPG patients (the small brain 
size, developmental retardation and progressive neurological dysfunction). Because 
XPG and early onset CS patients are usually have truncated XPG protein rather than 
complete lack of protein a second type of mutant mouse was generated by the same 
group to more closely mimic this situation. These mice had a truncation of the 
protein C- terminus due to genomic Xpg DNA being replaced with a mutated cDNA 
fragment. These mice had growth retardation and short life span, matching the 
symptoms of human XPG /CS patients (Sun et al., 2003; Shiomi et al., 2004 
1.12.8 Erccl null mice 
Because no human disorder is associated with mutation of the ERCC1 gene it had 
been suggested that ERCCI- deficiency resulted in an embryonic lethal phenotype. 
Erccl- deficient mice were successfully developed in the Melton laboratory and these 
were the first mouse in vivo model for defective NER (McWhir et al., 1993). The 
Erccl gene was inactivated by insertion of a neo cassette into exon 5 and the mice 
were produced using the embryonic stem cell method. The Erccl null pups have a 
range of severe phenotypic abnormalities including severe runting (weighing 20% 
less than wild type littermates) and death within three weeks of birth (prior to 
weaning) due to liver failure. The liver cells of the mice had nuclear abnormalities. 
These abnormalities grew progressively worse with time and the appearance of 
polyploid liver cells (accompanied by elevated p21 levels) was highly unusual as 
such high levels of polyploidy are normally only found in 1- to 2- year -old wild -type 
mouse livers. The slightly elevated p53 levels in the liver, brain and kidneys of the 
Erccl null mice indicated that DNA damage was accumulating in these tissues rather 
than being repaired, yet increased apoptosis was not detected in these tissues. This 
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appearance of polyploidy in response to accumulating DNA damage may reflect an 
additional non -NER- related function for the Ercc 1 protein and it is interesting that 
the elevated p21 associated with this premature polyploidy development is not a 
feature of polyploidy in wild type adult livers (Chipchase et al., 2003, Nunez et al., 
2000). The general appearance of the mice mimicked that of premature ageing. The 
NER deficient status of the Erccl null mice was demonstrated by the UV 
hypersensitivity of embryonic fibroblast cell lines derived from the mice. The cells 
were also mildly sensitive to the cross -linking agent mitomycin C and this result 
indicated that recombination mediated repair of interstrand cross -links is either not 
entirely dependent upon Erccl in the mouse or that this function was not affected by 
the targeting. The ability of the cells to perform homologous recombination was 
normal. Northern blot analysis of the null mouse tissues detected an Erccl/neo fusion 
transcript that had the potential to encode more than the N- terminus of the protein. 
The targeting did inactivate the NER capability of Erccl in the mice but they are not 
a model for the human NER disorder XP (Melton et al., 1998). 
Two Erccl null lines were subsequently independently developed by a group in 
Holland (Weeda et al., 1997). In one `knockout' line the Erccl gene was disrupted 
by insertion of a neo cassette into exon 7 and in the second line a seven amino -acid 
carboxy -terminal truncation was engineered by insertion of a premature stop codon 
at residue 292. The mice shared the runting and premature death phenotype of the 
original Erccl null mouse produced in the Melton Lab., but the line with the 
truncation had less severe symptoms. The Dutch mice had a longer life span than the 
original Erccl knockout, 78 days in the null mice and up to 6 months in the mice 
with the truncation. This may be due to the fact that these mice were of a different 
genetic background to the original null mice or it may be due to some low levels of 
Erccl activity. A number of extra phenotypic abnormalities were reported in the 
Dutch mice; nuclear abnormalities of the kidney, kidney malfunction, absence of 
subcutaneous fat and early onset of ferritin deposition in the spleen (which can result 
from increased turnover of erythrocytes). It is likely that the enhanced life span of 
the Dutch mice relative to the original Erccl null line gave these symptoms time to 
develop and subsequent examination of the original Erccl null line detected some of 
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the features reported in the Dutch mice. Embryonic fibroblast cell lines derived from 
the two Dutch mutants were UV hypersensitive and mitomycin C sensitive and this 
confirmed the NER deficient status of the mice. As with the original Erccl null 
mouse, the Dutch mice could also potentially give rise to a transcript encoding more 
than the N- terminal half of Erccl. 
The short lifespan of the original Erccl knockout limited the type of in vivo analysis 
that could be performed. In order to investigate the effect of the Erccl deficiency in 
tissues other than the liver a second mouse line was developed in the Melton Lab. 
with a liver specific Erccl transgene. This line has a longer lifespan than the original 
knockout (up to 10 weeks) and the liver is normal, indicating that the cause of 
premature death in original mice was due to liver failure. The liver transgene mice 
developed kidney damage by 10 weeks. 
1.13 Erccl expression in vitro and in vivo 
1.13.1 Erccl expression in mouse tissues and discovery of novel transcript 
In mice and humans the ERCC1 gene is expressed constitutively at low levels. This 
is in keeping with the expression pattern of the other NER genes. Earlier work in 
this laboratory by Dr. Selfridge revealed that the 1.1kb transcript was expressed in 
skin, brain, heart, lungs, liver, spleen, kidney, testes and muscle. There was some 
heterogeneity in the size of the Erccl transcript detected in the brain and heart but a 
discrete, novel transcript of 1.5kb was discovered in the skin and this transcript was 
outwith the range of the heterogenous transcripts in brain and testes (see figure 1.1). 
The upstream transcript was also detected in human skin. The 1.5kb transcript is the 
major Erccl transcript in the skin and no evidence of this transcript was found in the 
other tissues studied. The novel transcript is also the major transcript in human skin 
(Dr. Winter, Melton Lab., unpublished data). It is the novel transcript that forms the 
main focus of the work presented in this thesis. The 1.5kb transcript originates 
400bp upstream of the normal mouse 1.1kb transcript and both the 1.1kb and 1.5kb 
transcripts encode the same protein. The skin -specific transcript initiates upstream of 
the normal transcript's promoter, indicating the presence of a second, skin -specific, 
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promoter. What makes the 1.5kb, skin -specific, transcript particularly interesting is 
that it is only present in mouse skin and it is the primary transcript in this tissue. 
ERCC 1 is required for removal of UV- induced DNA lesions and the skin is the main 
tissue exposed to UV in the body. Our hypothesis is that the novel transcript confers 
an advantage to skin in helping to meet the higher biological demand for ERCC 1 
activity in this tissue. The elevated expression of Erccl observed in the testes may 
be related to the high demand for recombination in this tissue. The Erccl expression 
patterns of a number of cell lines were then characterised by Dr. Selfridge in order to 
facilitate investigation of the novel transcript's induction, promoter region and 
function. Skin- derived cells, keratinocytes and dermal fibroblasts both express the 
novel transcript; in keratinocytes the major transcript is the 1.5kb, skin -specific 
transcript. In fibroblasts the level of 1.1kb and 1.5kb transcripts is equal. Mouse 
embryonic stem cells and a CHO cell line express only the 1.1kb transcript. Erccl- 
deficient derivatives of the keratinocyte, embryonic fibroblast and CHO cell lines 
were also available. The use of these cell lines is discussed in detail in chapter 3. 
Because of the higher biological demand of the skin for UV induced DNA damage 
repair, it may seem obvious that increased Erccl transcription (and protein levels) 
would confer a survival advantage in the avoidance of UV- induced carcinogenesis. 
However, it is not clear why this requirement is not met by increased expression of 
the normal transcript. It is, therefore, of interest to investigate expression of the skin 
transcript in more detail. 
1.13.2 Erccl protein levels in the skin relative to other tissues 
The level of mRNA in different mouse tissues has been studied and Fig. 1.1. 
demonstrates typical expression patterns for a panel of mouse tissues. Both the 1.1kb 
and 1.5kb Erccl transcripts encode a fully -functional Erccl protein, so both these 
transcripts contribute to the total protein level in the skin. Although no published 
data is available, unpublished data from the Melton Lab. demonstrated that the level 
of protein expressed in the skin is proportional to the total level of 1.1kb and 1.5kb 
transcript in the tissue. Because the 1.1kb transcript is expressed constitutively at 
low levels, it is the level of 1.5kb transcript that mainly contributes to the protein 
level in the skin; mouse strains expressing high levels of 1.5kb transcript have 
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corresponding high protein while mice with low levels of 1.5kb transcript have low 
levels of protein (see figure 7.1). The possible implications of the high 1.5kb 
transcript expression in the skin in relationship to Erccl protein level is discussed in 
detail in chapter 7. One reason for the paucity of published data regarding the 
relationship between transcript expression and corresponding protein levels in the 
mouse is that the original antibodies for western analysis were raised against human 
ERCC 1 and did not recognise the mouse protein. The level of transcript in human 
skin is proportional to the level of protein. Without further analysis, no firm 
conclusions can be made regarding the relationship between Erccl transcript 
expression and resultant protein level. 
In Fig. 1.1, there is variation in the level of Erccl transcript expression in the panel 
of mouse tissues examined. Assuming that the level of protein in these tissues is 
proportional to transcript level, as it appears to be in skin, the protein level is likely 
to be lower than skin in tissues such as the liver, spleen and muscle. The 1.1kb 
transcript is expressed at high levels in the heart, brain, lungs and testes; the protein 
level in the lungs is likely to be equal to the level in skin, while the high level of 
1.1kb transcript in the brain, heart and testes is likely to lead to a higher 
Ercc 1 protein in these tissue in comparison to skin. It is not known whether the 
heterogeneity in transcript size in the brain, heart and testes reflects expression of 
transcripts capable of encoding a functional Erccl protein. If these transcripts do 
encode a functional protein then the level of protein in these tissues is likely to be 
higher than in the skin. It is possible that the high level of transcript observed in 
internal tissues reflects a high biological demand for ERCC1 protein, which may 
relate to non -DNA damage repair roles such as recombination. 
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Figure 1.1 Identification of a novel Erccl transcript in mouse skin 
This work was performed by Dr. Selfridge, Melton Lab. 
Northern blot analysis of a panel of tissue RNA from a wild type male mouse. Panel 
shows tissues probed with an 800óp BamHI fragment of Erccl cDNA, 
corresponding to exons 1 to 8. The RNA loads were equal (ethidium bromide 
staining image could not be clearly reproduced from original). 











1.14 Project Aims 
The role of the recently discovered skin -specific Erccl transcript is unknown. The 
normal transcript is expressed constitutively at low levels in the body while the novel 
transcript is expressed at high levels only in the skin. Because the skin has a high 
biological demand for repair of UV- induced DNA damage and non -repair of UV- 
induced lesions can eventually lead to development of serious cancers such as 
malignant melanoma, it may be that evolutionary selection has resulted in high 
expression of the novel transcript in this tissue. The role of the skin -specific 
transcript required investigation. The skin -specific Erccl transcript initiates 
upstream of the normal transcript's promoter, indicating the likely presence of a 
second promoter. No classical promoter elements are present in the region flanking 
the Erccl gene but an intriguing CT repeat region had been identified. Identification 
of regions required for expression of the skin -specific transcript was necessary. The 
aims of the work presented in this thesis were; 
(A) To investigate the promoter region of the skin- specific Erccl transcript. 
(B) To investigate the role of the skin -specific Erccl transcript in the skin. 
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Chapter 2 
Materials and Methods 
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2.1 Materials 
2.1.1 Laboratory reagents and suppliers: 
Amersham Bioscience UK Ltd.: NICKTM Column 
BDH Ltd.: Grams crystal violet solution, hydrochloric acid 
Biogenesis: RNA -BeeTM 
BIOLINE: HYPERLADDER ITM 
BIO -RAD: CHELEX® 100 Resin (200 -400 mesh) 
Boehringer Mannheim UK Ltd.: deoxyribonucleotides 
Difco Laboratories: agar, bacto -tryptone, bacto -yeast extract 
Fisher: boric acid, chloroform, EDTA, ethanol, glacial acetic acid, isopropanol, 
methanol, potassium acetate, sodium acetate, sodium chloride, sodium citrate, 
sodium hydroxide, trichloroacetic acid 
InvitrogenTM life technologies: agarose, ultraPURE agarose electrophoresis grade, 
foetal bovine serum, formamide, phenol, Tris 
Kimberley Clark Ltd.: paper towels 
New England BioLabs Inc.: 100X purified BSA 
NEN® Life Science Products: Genescreen Plus® 
Promega: RNasin® Ribonuclease Inhibitor 
Qiagen Ltd.: tip 500 columns, 
Roche: Deoxynucleoside triphosphate set (dNTPs), random hexamers 
Scientific Laboratory Supplies: Semperguard gloves 
Sigma Chemical Co. Ltd.: f3- mercaptoethanol, bromophenol blue, dextran sulphate, 
DTT, epidermal growth factor (EGF), ethidium bromide, ficoll, formaldehyde, 
glycerol, herring sperm DNA, mineral oil, MOPS, phenol, plastic cuvettes, Triton X- 
100, Tween 20 
2.1.2 DNA/RNA modifying enzymes 
InvitrogenTM life technologies: Taq DNA Polymerase, Hind III 
New England BioLabs Inc.: restriction endonucleases 
Roche: Klenow polymerase, M -MuLV reverse transcriptase 
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2.1.3 Radioactive reagents 
Amersham Biosciences: Redivue [a -32P] -dCTP ( -'3000Ci/mmole, 10mCi/ml.) 
2.1.4 Antibiotics 
Sigma Chemical Co. Ltd.: ampicillin, penicillin G, streptomycin 
2.1.5 Mammalian cell culture reagents 
Difco Laboratories: trypsin 
Greiner bio -one: plasticware 
InvitrogenTM life technologies: Dulbecco's modified Eagle Medium (DMEM), foetal 
calf serum, Glasgow Modified Eagle Medium (GMEM), L- glutamine, non -essential 
amino acids, sodium pyruvate 
Sigma Chemical Co. Ltd.: epidermal growth factor (EGF) 
2.1.6 Bacterial culture reagents 
Fisher: bacto -tryptone 
ICN Biomedicals /pharmaceuticals: bacto -yeast extract 
InvitrogenTM life technologies: terrific broth 
2.1.7 Oligonucleotides 
Oligonucleotides were synthesised by the Oswel DNA service. The sequences of the 
primers used are provided in Table 2.1. 
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Table 2.1 Oligonucleotides 
Table shows primer name, reference code, sequence and description. Positional 
numbering as in figure 3.1. 
Primer 
name 




Erccl cDNA 5' end 




Erccl cDNA 3' end 




Erccl flanking region 




Erccl flanking region 
( -208 to -181 ) 
2.2 Media 
2.2.1 Bacterial culture media 
Luria Broth (LB): 1% (w /v) bacto- tryptone, 0.5% (w /v) bacto -yeast extract and 0.5% 
(w/v) NaCl. 
Luria Agar: 1.5% agar, 1% (w /v) bacto -tryptone, 0.5% (w /v) bacto -yeast extract and 
0.5% (w /v) NaC1. 
Terrific Broth (TB): 1.2% (w /v) bacto -tryptone, 2.4% (w /v) bacto -yeast extract, 0.4% 
(v /v) glycerol, 170mM potassium dihydrogen orthophosphate, and 72mM 
dipotassium hydrogen orthophosphate. 
When required, ampicillin was added immediately prior to pouring of dishes, to a 
final concentration of 100µg/ml. 
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2.2.2 Mammalian tissue culture media 
Dulbecco's modified Eagle Medium (DMEM) was used as the base culture medium 
for murine keratinocyte cell lines. 
Glasgow Modified Eagle's Medium (GMEM) (McPherson, 1962, with modifications 
by W. House, Medical Research Council Institute of Virology, University of 
Glasgow, 1964) was used as the base culture medium for murine fibroblast and 
Chinese hamster ovary (CHO) cell lines. 
Freezing medium for long term storage of cells consisted of the appropriate 
supplemented culture medium with additional DMSO and FCS to final 
concentrations of 10% (v /v) and 12% (v /v) respectively. 
Chinese hamster ovary cell culture medium: 6% (v /v) FCS, iX non -essential amino 
acids, 1mM sodium pyruvate, 25U /ml penicillin, 251.1g/ml streptomycin, in GMEM. 
Fibroblast culture medium: 10% (v /v) FCS, 1X non -essential amino acids, 1mM 
sodium pyruvate, 25U /ml penicillin, 2511g/ml streptomycin, in GMEM 
Keratinocyte culture medium: 8% (v /v) chelex- treated FCS, 25U /ml penicillin, 
25µg /m1 streptomycin, 2mM L- glutamine, lOng/ml EGF. 
Fibroblast serum starvation medium: 0.5% (v /v) FCS, 1X non -essential amino acids, 
1mM sodium pyruvate, 25U /ml penicillin, 251.tg/ml streptomycin, in GMEM 
2.3 Solutions and buffers 
Carnoy fixative: 3 parts methanol, 1 part glacial acetic acid 
Grams crystal violet: 10% (v /v) Grams crystal violet solution 
Formalin: 4% (v /v) formaldehyde in phosphate buffered saline. 
Formamide sample buffer (FSB): 2.4X MOPS, 48% de- ionised formamide, and 29% 
formaldehyde 
l0X MOPS - 1 litre: 200mM 4- morpholinepropanesulfonic acid (MOPS), 50mM 
sodium acetate, 10mM EDTA, pH 7.0 
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Oligo labelling buffer: 50µ1 solution A, l25111 solution B, 751.il solution C 
Solution A: 1.25M Tris -HC1 pH 8.0, 0.125M MgC12, 25mM ß- mercaptoethanol, 
0.5mM each of dGTP, dATP and dTTP. 
Solution B: 2M HEPES buffer adjusted to pH 6.6 with NaOH. 
Solution C: Random hexadeoxyribonucleotides, OD26onm= 90 units /ml, in TE 
Phenol/trisodium citrate EDTA (STE): STE: 50% (v /v) STE, 50% (v /v) phenol 
Pre -hybridisation buffer: 6X SSC, 1% SDS, 10% (w /v) dextran sulphate, 100mg /m1 
denatured herring sperm DNA. 
PI: 50mM Tris -HC1 pH 8.0, 10mM EDTA, 100µg /ml Rnase A 
PH: 20mM NaOH, 1% (w /v) SDS 
PM: 2.5M potassium acetate pH 4.8 
l0X PCR buffer: 500mM KC1, 1.5mM MgC12, 10mM Tris -HC1 pH 8.3, 0.01% (w /v) 
gelatin, 0.45% (v /v) Triton X -100, 0.45% (v /v) Tween 20 
QBT: 750mM NaC1 pH 7.0, 50mM MOPS, 15% (v /v) ethanol, 0.15% (v /v) Triton X- 
100 
QC: 1M NaC1 pH 7.0, 50mM MOPS, 15% (v /v) ethanol 
QF: 1.25M NaCl pH 8.2, 50mM MOPS, 15% (v /v) ethanol 
10X RT buffer: 500mM Tris -HC1 pH 8.3, 60mM MgC12, 400mM KC1, 10mM DTT 
5X sample buffer: 20% (v /v) glycerol, 100mM EDTA, 0.1% (w /v) bromophenol blue 
20X SSC: 3M NaC1, 0.3M tri -sodium citrate pH 7.0 
STE: 10mM NaC1, 10mM tri -sodium citrate, 1mM EDTA. 
10X TBE: 0.9M Tris -HC1, 0.9M boric acid, 20mM EDTA. 
TE buffer: 10mM Tris -HC1, 1mM EDTA pH 8.0 
2.4 Bacterial strains 
The E. coli strain DH5a was used for propagation of plasmids. The genotype of 
DH5a is supE44, lacU169 (0 80lacZM15), hsdR17, RecAl , endAl, gyrA96, thi -1, 
and was first described by Hanahan (1983). 
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2.5 Mammalian cell culture lines 
Table 2.2 Mammalian cell culture lines 
CELL LINE DESCRIPTION REFERENCE 
PF20 Immortalised wild type 
mouse embryonic 
fibroblast cell line 
Melton et al., 1998 
PF24 + #2D -4 Immortalised Erccl and 
HPRT deficient murine 
embryonic fibroblast cell 
line 
Melton et al, 1998 
CHO9 Immortalised wild type 
Chinese hamster ovary 
cell line, subclone of the 
CHO -KK cell line 
Wood and Burki, 1982 
CH043.3B (TG #1) Immortalised Erccl and 
HPRT -deficient Chinese 
hamster ovary cell line 
derived from the parental 
CHO9 cell line. 
Wood and Burki, 1982 
Keratinocyte ( +1 +) Mouse wild type 
keratinocytes 
Melton, unpublished data 
Keratinocyte ( -I -) Erccl and HPRT- 
deficient mouse 
keratinocytes 
Melton, unpublished data 
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2.6 Methods 
2.6.1 Growth of E. coli 
Cells were grown at 37 °C either in suspension in LB or TB with shaking, or on the 
surface of Luria agar plates. Cells grown on Luria agar plates supplemented with 
ampicillin were incubated at 30° to prevent growth of satellite colonies. 
2.6.2 Preparation of competent cells for transformation 
Bacteria were transformed with plasmid DNA by the method of Mandel and Higa 
(1970) with the modifications by Dagert and Ehrlich (1974). An inoculating loop 
was used to scrape bacterial growth from a fresh Luria agar plate of E. coli. and this 
was added to 50m1 of LB supplemented with MgC12 to a final concentration of 
20mM. Cells were grown with vigorous shaking at 37 °C until the OD600nm of the 
suspension equalled 0.2 (approximately 1.5 -2 hours) and the cells were in the log 
growth phase. The cells were chilled on ice for 5 minutes, and then spun down at 
2,000rpm at 4 °C for 15 minutes. The pellet was gently resuspended in 20m1 ice -cold 
freshly prepared transformation buffer. The suspension of competent cells was then 
incubated on ice for 30 minutes with occasional agitation and then spun for a further 
15 minutes at 4 °C. The supernatant was then poured off and the pellet was 
resuspended in 2m1 ice -cold transformation buffer. The resuspended cells were then 
transferred to a 15ml centrifuge tube and stored on ice for 2 hours prior to 
transformation. 
Approximately lOng of plasmid DNA in a volume of 111l was added to 100µ1 of 
competent cells, which were then incubated on ice for 20 minutes. Following heat 
shock at 37 °C for 5 minutes, 400µ1 of warm LB was added, mixed gently, and the 
mixture was incubated at 37 °C for -45 minutes to allow expression of antibiotic 
resistance. Aliquots of 1O0µ1 and 150111 of the mixture were then spread to dryness 
on selective ampicillin plates (which had been dried and warmed in the incubator) 
and incubated overnight at 37 °C. A no -DNA control was also routinely cultured. 
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2.6.3 Growth of mammalian CHO cells 
Mammalian CHO cells were maintained in supplemented GMEM at 37 °C in a 5% 
CO2 atmosphere in a humidified tissue culture incubator (Sanyo CO2 incubator). To 
passage cells the medium was aspirated, the bottom of the flask or dish rinsed with 1- 
2m1 of trypsin (0.05% w /v) to remove remaining medium, then a further 1 -2ml of 
trypsin added and incubated at 37 °C until the cells had become detached. The cells 
were then suspended in 5 volumes of medium and transferred to a sterile 50m1 tube, 
and then pelleted by 5 minutes centrifugation at 1,300rpm. The supernatant was 
discarded and the cells resuspended in an appropriate volume of medium, and an 
aliquot transferred to a tissue culture flask. 
For long term storage, cells were kept in liquid nitrogen. Cultures to be frozen were 
trypsinised, spun down, the supernatant removed, and cells resuspended in ice cold 
freezing medium. 1ml aliquots were placed at -20 °C for 2 hours then transferred to - 
70°C overnight before removal to liquid nitrogen. Frozen aliquots were thawed 
rapidly at 37 °C and diluted in 9m1 of medium before being pelleted by centrifugation 
at 1,300rpm for 5 minutes. The supernatant was discarded, the cells resuspended in 
an appropriate volume of medium and transferred into a flask. 
2.6.4 Growth of mammalian fibroblasts 
Mammalian fibroblasts were maintained in supplemented GMEM at 37 °C in a 5% 
CO2 atmosphere in a humidified tissue culture incubator (Sanyo CO2 incubator). 
Passage and storage was performed in the same manner as in the CHO cells. 
2.6.5 Growth of mammalian keratinocytes 
Mammalian keratinocytes were maintained in supplemented DMEM at 37 °C in a 5% 
CO2 atmosphere in a humidified tissue culture incubator (Sanyo CO2 incubator). To 
passage cells the medium was aspirated, the bottom of the flask or dish rinsed with 1- 
2m1 of trypsin (0.05% w /v) to remove remaining medium, then a further 1 -2ml of 
trypsin added and incubated at 37 °C until the cells had become detached. This 
process takes 20 -30 minutes for keratinocytes and very gentle scraping was 
performed if the cells did not start to detach after 20 minutes to avoid damage to cells 
from longer exposure to the trypsin. To remove calcium from the FCS, 0.05g of 
chelex was added per ml FCS and mixed for 1 hour. The solution was then filtered 
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through Whatman no. 1 filter paper to remove the particulate matter and then filtered 
through a 0.2 millipore nalgene filter to sterilise. 
2.6.6 Electroporation 
In order to achieve transient expression of cloned DNA sequences in cultured 
mammalian cells, a linearised Erccl minigene vector was introduced by 
electroporation with a selectable HPRT minigene construct under the control of the 
mouse phosphoglycerate kinase (PGK -1) gene promoter. Cells to be electroporated 
were trypsinised, pelleted by centrifugation, and resuspended in 10m1 of medium. 
The cells were counted using a 1:100 dilution in isoton and 5.0X106 cells were then 
resuspended in 0.8ml of electroporation buffer (HPS) containing 120µg of plasmid 
DNA in 100111 sterile distilled water and then transferred to an electroporation 
cuvette (0.4cm, Bio -Rad). The cuvette was slotted into a Gene Pulser (Bio -Rad), and 
the cells pulsed at 300V, 50011F capacitance. After 10 minutes of incubation at room 
temperature the electroporated cells were resuspended in the appropriate volume of 
medium before being transferred to petri- dishes. Following overnight culture the 
medium was changed to selective medium containing HAT. In cases where UV 
selection was also required, the non -selective medium was aspirated and 0.2ml of 
sterile PBS was applied. Fibroblasts and CHO cells then received a dose of 7.5 Jm 2 
of UV (254nm), the PBS was aspirated and HAT selective medium applied. The UV 
selection regime in keratinocytes was different because fewer cells survive to form 
colonies, meaning that to impose both HAT selection and UV selection can result in 
too few cells surviving. Therefore, HAT selection was the same as in the other cell 
types but a dose of 3 Jm 2 of UV was applied instead of 7.5 Jm 2. 
2.6.7 Clonal selection 
Following electroporation, clones were selected and isolated using cloning rings 
(5mm and 10mm in diameter). Following aspiration of media the petri dish 
containing the clone(s) was rinsed with 1XPBS. Depending upon the size of the 
clone, the appropriate cloning ring was selected using sterile tweezers, dipped lightly 
in Vaseline to coat the underside of the ring and applied to the surface of the dish. 
The clone had to be completely encompassed by the ring and the clone also had to be 
discrete from other clones. Trypsin (0.05% w /v) was applied (1 -2 drops depending 
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upon the ring selected). If the non -selected cells were required then 1XPBS was 
applied to the dish during trypsinisation to prevent drying. Once trypsinisation was 
complete the cells were removed from inside the ring and placed in a 5m1 flask 
containing the appropriate growth media. 
2.6.8 UV survival assays 
To measure UV survival of cultured fibroblasts, 104 PF20 cells were plated per 
30mm dish and 2X104 PF24 cells were plated (the wild type cells grow more quickly 
so a lower plating density was used). With CHO cells, 1.5X104 cells were plated per 
30mm petri dish. The keratinocyte plating density was 4X104 cells per 30mm dish. 
The following day the medium was aspirated from the dishes and replaced with 
0.2m1 of sterile PBS and the dishes were UV -C irradiated (254nm) at a fluence of 
0.15 Jm 2s -1. Because the wild type keratinocytes are very resistant to UV, the UV 
lamp was lowered to a height where the fluence was 0.625 Jm 2s -I, to prevent the 
cells from drying out during irradiation. The UV survival assay of the transformed 
keratinocytes was performed with the lamp at the height that delivers a fluence of 
0.15 Jm 2s -I. Following irradiation, the medium was replaced and the dishes were 
incubated for a further five days (or until the no -UV controls became confluent).. 
The cells were then fixed in Carnoy fixative and stained with Crystal Violet then 
gently rinsed in water prior to drying overnight. Dead cells detach from the surface 
of the plate during incubation and are removed during medium changes and rinsing. 
The degree of cell growth was then determined by extracting the dye from the 
stained cells using 70% ethanol and measuring the optical density (OD) at 575nm on 
a Thermospectronic Bioplate 3 spectrophotometer using plastic disposable cuvettes. 
Each UV dosage was performed in duplicate and survival was determined relative to 
unirradiated control dishes (representing 100% on survival index). The survival 
index was defined as the ratio of the mean OD of irradiated cells /mean OD of cells in 
unirradiated dishes. The survival index percentage was then plotted on a logro scale 
against UV dose. 
2.6.9 Preparation of plasmid DNA (Qiagen prep). 
For preparation of up to 500µg of plasmid DNA, a column purification method was 
employed. Bacteria were grown for 24 hours at 37 °C in 50m1 of TB supplemented 
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with ampicillin to a final concentration of 100µg /ml. Cells were pelleted by spinning 
at 3,900rpm for 20 minutes at 4 °C. The pellet was resuspended in 10m1 of solution 
P1 supplemented with Rnase to a final concentration of 0.5µg /ml, and the cells lysed 
by addition of 10m1 of solution P2, with 5 minutes incubation at room temperature. 
10m1 of cold solution P3 was added, with gentle mixing, and the tube incubated on 
ice for a further 20 minutes. Precipitated chromosomal DNA, SDS and protein were 
sedimented by centrifugation at 17,000rpm for 30 minutes at 4 °C. The supernatant 
was removed promptly, filtered and applied to a Qiagen -tip 500 column, previously 
equilibrated with 10m1 of QBT buffer. After washing twice with 30m1 QC buffer, 
the plasmid DNA was eluted from the column with 15ml QF buffer. 12ml of 
isopropanol was added to precipitate the DNA, which was then spun down at 
4,000rpm for 20 minutes at 4 °C. The DNA pellet was resuspended in 500m1 of 
sterile distilled water, prior to transfer into a microfuge tube, whereupon DNA was 
reprecipitated with 50111 of P3 and 1ml of cold absolute ethanol. Following 10 
minutes centrifugation, the nucleic acid pellet was washed twice with 70% (v /v) 
ethanol, air dried, resuspended in 2O0111 sterile distilled water and stored at -20 °C. 
2.6.10 Purification of plasmid DNA by phenol extraction 
DNA (usually diluted in 4001.11) was added to an equal volume of phenol/STE in an 
Eppendorf tube, vortexed and centrifuged in a microfuge until the mixture separated 
into two layers. The top layer was transferred to a fresh tube and half of this volume 
of butanol was added. This mixture was vortexed and centrifuged in a microfuge 
(Hettich MIKRO 20) at 13,000rpm for 1 minute or until the mixture separated into 
two layers. The top layer was then discarded and one tenth of the volume of 3M 
sodium acetate (pH 5) was then added. The mixture was vortexed and 2.5X the 
volume of chilled absolute alcohol (EtOH) was added to precipitate the DNA. The 
mixture was vortexed and centrifuged for 7 minutes or until the DNA pellet formed. 
The supernatant was then carefully poured off and the pellet was rinsed with a small 
volume of 70% EtOH. The EtOH was gently poured off and the pellet was air -dried 
then resuspended in the desired volume of distilled H2O prior to OD measurement. 
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2.6.11 Preparation of mammalian RNA (RNA -BeeTM method). 
A modification of the method described by Chomczynski and Sacchi (1987) was 
used for the isolation of total RNA from all cultured cells and tissues. The method 
used the commercially available reagent RNA -BeeTM (Biogenesis) and followed the 
protocol supplied by the manufacturers. Briefly, tissue was homogenised with 1 ml 
RNA- BeeTM /50mg tissue using an Ultra -Turrax T25 homogeniser (IKA- 
Laboratechnik). Cultured cells were lysed directly in the culture dish by the addition 
of RNA -BeeTM (1m1 per 3.5ml petri dish) and the RNA was solubilised by pipetting 
the lysate a few times. The RNA was extracted by the addition of 0.2m1 chloroform 
per 1ml of RNA -BeeTM used, followed by vigorous shaking of the mixture for 15 -30 
seconds prior to placing on ice for 5 minutes. The suspension was then centrifuged 
at 12,000g for 15 minutes at 4 °C. The aqueous phase was transferred to a fresh tube 
and the RNA precipitated by the addition of an equal volume of isopropanol. The 
RNA was left to precipitate at 4 °C for 5 -10 minutes and then pelleted by 
centrifugation at 12,000g for 5 minutes at 4 °C then washed in 75% ethanol (using at 
least 1 ml of ethanol per 11-n1 of RNA -BeeTM used for the initial homogenisation) 
2.6.12 Estimation of DNA concentrations via OD measurement 
DNA samples were diluted in 1ml of distilled water and the OD at 260nm and 
280nm measured in a spectrophotometer (Thermospectronic Bioplate3) using 
matched quartz cuvettes. 1 A260 Unit of dsDNA = 50µg/ml. The ratio of A260/A280 
gives an estimate of nucleic acid purity. A value ? 1.8 indicates that the sample is 
pure DNA. A value below 1.8 indicates that the preparation is contaminated with 
proteins and aromatic substances while a value above 2 indicates possible 
contamination with RNA. 
2.6.13 Estimation of RNA concentrations via OD measurement 
RNA samples were diluted in lml of distilled water and the OD at 260nm and 280nm 
measured in a spectrophotometer (Thermospectronic Bioplate3) using matched 
quartz cuvettes. 1 A260 Unit of ssRNA = 40gg/ml H2O. The ratio of A2 60/A28.0 gives 
an estimate of nucleic acid purity. A value ? 2.0 indicates that the sample is pure 
RNA. A value below 2.0 indicates that the preparation is contaminated with proteins 
and aromatic substances. 
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2.6.14 Restriction of DNA with endonucleases 
See figures 3.1, 3.2, 3.3 and 3.4. DNA digests were performed to ensure the identity 
of minigene DNA following Qiagen preps using a single EcoRI digest and a double 
kpnl /EcoRI digest. Reactions were carried out in accordance with temperature and 
buffer conditions recommended by the manufacturer. The double digest was 
performed in two stages; the kpnl digestion was performed in React 1 buffer for 1.5- 
2 hours prior to addition of EcoRI and React 3 buffer for further digestion. The Kpnl 
and EcoRI /kpnl digests were terminated by the addition of 5X sample buffer for 
agarose gel electrophoresis. Once the kpnl /EcoRI and EcoRI digestion had verified 
the minigene identity, the minigenes could be linearised with Notl. 1% agarose gel 
electrophoresis was performed to ensure minigenes were fully digested by Notl prior 
to electroporation. A second round of EcoRI and kpnl /EcoRI restriction was 
performed to double -check the identity of the minigenes following Notl 
linearisation. 
2.6.15 Electrophoresis of DNA in agarose gels 
DNA fragments were separated on 1 -2% (w /v) electrophoresis grade agarose gels 
containing 0.5µg /ml ethidium bromide and 1X TBE. DNA samples were mixed with 
one -fifth volume of 5X sample buffer prior to loading. Electrophoresis was carried 
out horizontally at 100 -140V in a 1X TBE buffer system. 
Hyperladder ITM was used as a size marker. This ladder contains 14 regularly spaced 
bands ranging from 200bp to 10Kb, the 1Kb and 10Kb bands have the highest 
intensity. Following electrophoresis, DNA/RNA was visualised in a High 
Resolution UV Gel Documentation system and digitally photographed where 
necessary. Where necessary, gel photographs were analysed using the public domain 
NIH Image program, ImageJ software (version 1.3), developed at the U.S. National 
Institutes of Health and available on the Internet at http: / /rsb.info.nih.gov /nih- image /. 
2.6.16 Northern blot - electrophoresis of RNA in agarose gels 
RNA samples were electrophoresed on denaturing 1.4% (w /v) ultraPURETM agarose 
containing 0.51.tg /ml ethidium bromide, 1X MOPS and 0.66M de- ionised 
formaldehyde. Formaldehyde and ethidium bromide were added to the melted 
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agarose mixture following cooling to 75 °C and then gels were poured and set in a 
fume -hood. 
Samples were prepared by the addition of 30µg of total RNA (in 20µ1 dH2O) to an 
equal volume of FSB. This mixture was heated for 5 minutes at 65 °C, snap -cooled 
on ice and one quarter volume of 5X sample buffer was added. The samples were 
then loaded directly. Gel resolution was improved by performing electrophoresis at 
4 °C (in a refrigerated room). Electrophoresis was performed at 100V for 3 -6 hours 
in a 1X MOPS buffer system. 
2.6.17 Northern blot - transfer of RNA from agarose gels to membranes 
Following electrophoresis the gel was soaked for two 20 minute periods in l0X SSC 
(a dilution of 20X SSC buffer), with gentle agitation to remove ethidium bromide 
and formaldehyde. The Genescreen Plus®nylon membrane was soaked for 5 minutes 
in 10XSSC at room temperature. RNA was transferred to the Genescreen membrane 
by capillary action using 10XSSC as the transfer medium. When transfer was 
complete (12 to 24 hours) the Genescreen membrane was marked with pencil to 
indicate the side that was in contact with the gel and rinsed in 2XSSC for 10 minutes 
with gentle agitation, air dried and then baked for 2 hours at 80° C under a vacuum 
(Yallenkamp vacuum oven). 
2.6.18 Northern blot - randomly primed labelling method 
An 870bp restriction fragment from the ERCCI cDNA clone pTZME (kindly 
provided by M. van Duin (described in van Dunn et. al., 1988) was used detect 
ERCCI mRNA. This fragment extends from the 5' end to a BamHI site in exon 8. 
Radioactive labelling of DNA to high specific activity was performed by the 
randomly primed labelling method (Feinberg and Vogelstein, 1983). DNA probes 
were denatured, annealed to random hexamer primers, part of the oligolabellíng 
buffer (OLB) solution, and the complementary strand was synthesised from the 3 "OH 
termini of the hexanucleotide primers using Klenow polymerase (the large fragment 
of DNA polymerase I) in the presence of [a32P]dCTP (3000Cn/mmol) The 
radiolabelled dCTP is incorporated into the newly synthesised DNA strand. These 
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radiolabelled DNA fragments serve as efficient probes in filter hybridisation. 25ng 
of DNA, dissolved in 32p1 of distilled, de-ionised 10. wa.s denatured h y boiling for 
5 minutes and snap chilled on ice_ I OA of °LB, 200g of BSA. 50uei of [ct.321:1dCTP 
and 7.5 units of Klenow polymerase were &ii 14,31 and the mixture wasP incubated for 3 
hours (or overnight) at room ternmartire [final volume of mixture =50u1].. 24.11. of 
this mixture was spotted onto Wharman glass microfibre filters (2.1cm 
diameter) for measurement of IltellndCTP incorporation. Prior to hybridisation, 
2.25mg of sonicated herring sperm DNA was added to the probe, which was then 
denatured by boiling for 5 min.. 
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flit from. each pair was; 
transferred (using forceps) to 50m1 capped tubes containing 45m1 of ice -cold 
5 %(w /v) TCA. The filters were gently agitated for 2 minutes and then transferred to 
fresh tubes containing the same volume of ice -cold TCA. The washing was repeated 
two more times. The washed filters were then transferred to fresh tubes containing 
70% ethanol, left briefly, then dried at room temperature. The four filters (two 
washed and two unwashed) were inserted into individual scintillation vials. 
Following addition of scintillation fluid, the 32P radioactive decay was measured in 
the 32P channel of the liquid scintillation counter. These values were used to calculate 
the proportion of radionucleotide incorporated, the total amount of product and the 
specific activity. 
2.6.21 Northern blot - pre- hybridisation and hybridisation 
Pre -hybridisation of the genescreen membrane was performed in a temperature - 
controlled rotisserie in 30m1 of prehybridisation buffer at 60 °C for a minimum of 2 
hours. 15m1 of pre -hybridisation buffer was removed prior to addition of the probe. 
The probe was denatured by boiling for 5 minutes in a screw -cap tube with 225µg of 
10mg /m1 sonicated herring sperm DNA (2.25mg) and promptly added to the pre - 
hybridisation solution with the glass vial in a vertical position to avoid dripping 
concentrated probe on the genescreen membrane. Hybridisation was performed 
overnight at 60 °C. After hybridisation, the solution was discarded and the blot was 
rinsed for 2X5 minutes in 2XSSC at room temperature, 2X30 minutes in 2XSSC, 1% 
(w /v) SDS at 65 °C and 2X30 minutes in 0.1XSSC at room temperature. The blot 
was then sealed in cling -film and the activity was measured with a Geiger counter to 
estimate the optimal exposure time. 
2.6.22 Autoradiography 
Blots were autoradiographed using Kodak X -ray film in a cassette with intensifying 
screens (Cronex Lightning Plus, Du Pont) and stored at -70 °C to slow reversion of 
activated bromide crystals in the film to their stable form. The resulting signals were 
analysed using the public domain NIH Image program, ImageJ software (version 
1.3), developed at the U.S. National Institutes of Health and available on the Internet 
at http: / /rsb.info.nih.gov /nih- image /. 
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2.6.23 RT -PCR - reverse transcription 
Reverse transcription was carried out on 20µg of total RNA. To denature the RNA, 
samples were heated to 70 °C for 2 minutes and then snap cooled on ice. Reverse 
transcription was carried out at 43 °C for 1 hour in 1X RT -PCR buffer with 0.5111 
Rnasin, dNTPs to a final concentration of 1.25mM, 0.1µg of random hexamers, 25µg 
of oligo -dT, and 30 units of reverse transcriptase. The reaction was then heated at 
75 °C for 1 minute and then snap cooled on ice. A second round of reverse 
transcription was carried out by the addition of a further O.5111 Rnasin and 30 units of 
reverse transcriptase. After incubation at 43 °C for 1 hour the reaction was diluted in 
2000 of TE and stored at 4 °C. For subsequent procedures 1Oµ1 of the total cDNA 
pool was used. 
2.6.24 RT -PCR - amplification of DNA by the polymerase chain reaction. 
PCR was carried out in 501.11 volumes in 1XPCR buffer supplemented with EDTA 
and dNTPs to final concentrations of 0.4mM and 0.1mM respectively. 2.5 units of 
Taq DNA polymerase, 10111 of the total cDNA pool from the RT reaction plus 300ng 
of each primer were used per PCR. Cycle conditions were 94 °C for 1 minute to 
denature, 68 °C for 1 minute to anneal and 1.5 min synthesis with 28 cycles for the 
A/5 and 2/5 primer pairs and 30 cycles for the B/5 primer pair. Reactions were 
performed on a Techne PHC -2 PCR machine. 
2.6.25 Animal husbandry 
Mice were maintained in accordance with established animal care guidelines (Poole, 
1989), and all procedures were licensed by the Home Office under the Animals 
(Scientific Procedures) Act 1986. The mice were kept under a 12 hour light and 12 
hour dark cycle, with standard mouse diet and tap water. The mouse strain was 
C57BL/6. 
2.6.26 Animal procedures - isolation of primary fibroblasts 
The method of primary fibroblast isolation varied depending upon the age of the 
embryo or pup. Sacrifice of the pregnant mice (to obtain embryos) and pups, for 
analysis of ERCC1 transcript expression, was performed by trained members of staff 
in our laboratory. Fibroblast isolation was performed using sterile instruments in a 
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primary culture hood. In experiments where light exposure had to be controlled, the 
stages following decapitation were performed in low light levels and the cells were 
shielded from light during incubation. Every effort was made to minimise light 
exposure. Sacrificed embryos /pups were shielded from light, all fluorescent lights of 
the hood and work area were turned off and window blinds were adjusted so that the 
ambient light level was very low (only enough visibility to work by). Tissue not 
being manipulated was kept covered with aluminium foil. The only stage that 
needed more illumination was the separation of dermis from epidermis and this was 
performed as quickly as possible to minimise light exposure. In light/dark 
experiments, a dish was designated the `viewing dish' and this dish was 
synchronously passaged with the `dark' dishes to track density during the cell 
expansion stage, reducing exposure of the `dark' dishes to microscope light. 
2.6.27 Isolation of primary embryonic fibroblasts from 13.5- day -old embryos 
The murine uterus was transferred to 50m1 tube containing 37 °C fibroblast medium. 
The tube was transferred to the cell culture suite in a vacuum flask containing water 
warmed to 37 °C. The tube was wrapped in aluminium foil for the light/dark 
experiments. 
The embryos were decapitated using a scalpel and dipped in ethanol (100 %) to 
sterilise, then rinsed in sterile PBS. 
Because the skin was too delicate to be removed manually at this age, each embryo 
was placed into a 50m1 tube containing 0.5ml of trypsin (0.05% w /v) and incubated 
at 37 °C for 20 -30 minutes. 
The trypsin was then aspirated and the embryo was rinsed in sterile PBS, which was 
then aspirated. 15m1 of fibroblast medium was then added to each tube. Each 
embryo was pipetted -10X to break up the embryo prior to plating. 
Cells were plated in the appropriate volume of fibroblast medium in 90mm petri 
dishes and incubated in the normal conditions for fibroblast culture (see fibroblast 
culture method). During the primary culture experiments the cells were not 
permitted to reach confluence prior to RNA sampling. 
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2.6.28 Isolation of primary embryonic fibroblasts from 16.5- day -old embryos 
The method of fibroblast isolation from 16.5- day -old embryos is the same as with 
13.5- day -old embryos up to the trypsin incubation stage. 
Following sterilisation and rinsing in sterile PBS, each embryo was placed in a 50m1 
tube containing 1.5ml of trypsin (0.05% w /v) and incubated at 37 °C for 1 hour. 
The trypsin was then aspirated and the embryo was rinsed with sterile PBS, which 
was then aspirated. The skin was then removed (as described for 18.5- day -old 
embryo section) and chopped up using scalpels before being placed in a 50m1 tube 
containing 5ml of fibroblast medium. The skin was then pipetted and the tube was 
shaken vigorously to separate the cells. 
The cells were then plated in 60mm petri dishes with the appropriate volume of 
fibroblast medium (with the equivalent of no more than 3 skins per dish to avoid 
peeling). 
2.6.29 Isolation of primary fibroblasts from 18.5- day -old embryos and pups. 
Embryos older than 16.5 days and pups were sacrificed and rinsed in sterile PBS. 
The limbs and tail were removed from the embryos /pups and a slit was made down 
the spine that extended through the epidermis and dermis but not into the underlying 
tissue. The edge of the skin at the slit was then teased from underlying tissue using 
tweezers and, gripping the underlying tissue with blunt -ended tweezers, the skin was 
gently detached from the underlying tissue by pulling and rolling around the second 
pair of tweezers, taking care not to tear the skin. 
The skin was then rinsed in ethanol (100 %) and then sterile PBS before being floated 
dermis side down in a petri dish containing trypsin (0.05% w /v). The skin was left 
for 12 hours at 4 °C (must not be left for longer or it becomes difficult to separate the 
skin layers without tearing). 
Following trypsinisation, the dermis and epidermis were teased apart using tweezers. 
The epidermal layer is extremely delicate and must be slowly and gently pulled away 
from the dermal layer. 
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Once the two layers had been separated, the dermal layer was sliced using tweezers 
and added to a 50m1 tube containing 5m1 of fibroblast medium. The dermis was then 
shaken vigorously /pipetted to separate the cells. The mixture was passed through a 
fine sieve and suspended in the appropriate volume of medium prior to plating out in 
60mm petri dishes. No more than the equivalent of 3 skins was plated per 60mm 
petri dish, as this is sufficient to create a monolayer of cells. If the cells are plated 
too thickly the cells adhere to the bottom of the dish and then peel away. Incubation 
conditions are described in the fibroblast culture method. 
2.6.30 UV- irradiation of primary cultures 
Dermal fibroblasts from a pool of seven E18.5 skins were isolated and cultured in 
near darkness. Following expansion in culture for 7 days, two 90mm petri dishes of 
cells approaching confluence were pooled and split between eight 90mm petri dishes 
(passage 1). 24 hours later medium was aspirated from the dishes and sterile PBS 
was applied to prevent the cells from drying out during irradiation. The UV -C dishes 
were irradiated at a fluence of 0.15 Jm 2s -1. The dose delivered was 6 Jm 2 and the 
UV lamp was at the same height as for the UV survival assays. The UV -B 
irradiation was performed with the UV lamp at the same height as for the UV -C 
irradiations and cells were irradiated for 5 minutes. Control dishes were not UV 
irradiated. The `light control' dishes were not shielded from light during the medium 
change. Dark control dishes were shielded from light during the medium changes. 
2.6.31 Serum starvation experiment. 
Dermal fibroblasts from a pool of seven E18.5 skins were isolated and cultured in 
near darkness. Following expansion in culture for 10 days, four 90mm petri dishes 
of cells approaching confluence were pooled and split between eight 90mm petri 
dishes (passage 2). 24 hours later, 5 dishes were aspirated and serum starvation 
fibroblast medium was applied. The medium on the remaining dishes was changed 
for fresh medium. The cultures were released from serum starvation 48 hours later 
and RNA was extracted post -release at Oh, 3h, 6h, 20h and 48h. RNA was extracted 
from the control dishes at Oh and 48 hours. 
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Chapter 3 
Use of Erccl minigenes to complement DNA repair deficiency 
in Erccl- deficient cultured mouse embryonic fibroblasts. 
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3.1 Control of gene expression in eukaryotes. 
Before discussing the promoter of the Erccl gene, which is atypical of higher 
eukaryotic genes, it is necessary to present a summary of how eukaryotic promoters 
are usually arranged. Expression of eukaryotic genes is controlled via the interaction 
of a set of proteins, trans -acting transcription factors, with a region of the gene called 
the promoter and sequences known as promoter -proximal elements and enhancers. 
Transcription factors recognise and bind such motifs in the genetic sequence and are, 
therefore, specific to particular genes. RNA polymerase II, responsible for synthesis 
of mRNA, is recruited by transcription factors for transcription of genes. By this 
process, transcription factors initiate transcription, enabling expression of genes to be 
controlled and modified in response to external or internal environmental stimuli. 
Promoters, promoter -proximal elements and enhancers are all types of cis -acting 
regulatory sequences to which the trans- acting transcription factors interact. 
Interaction with promoters initiates transcription while the rate of transcription is 
increased by the presence of the promoter -proximal elements and enhancers; as the 
name suggests, enhancers enhance the rate of transcription. Promoters are usually 
located upstream of the transcriptional start site (TSS), also known as the 
transcriptional initiation site (TIS). Promoter -proximal elements are obviously close 
to the promoter (and TSS) while the enhancer elements are often quite distal to the 
TSS. 
Three conserved sequence elements usually located near the TSS in promoters of 
higher eukaryotes are the TATA, CAAT and GC boxes and these classical promoter 
elements are usually located approximately 30, 100 and 200 bp upstream of the TSS 
respectively. The consensus sequence of the TATA box is TATA (T /A)A(T /A), that 
of the CAAT box is GGCCAATCT and the GC box sequence is GGGCGG. The 
TATA box recruits the components of the RNA polymerase II initiation complex and 
RNA polymerase II then initiates transcription approximately 30 bp or less 
downstream of the TATA box (in mammalian systems), so the TATA box 
determines where transcription of the gene begins. TFIID forms part of the RNA 
polymerase initiation complex and this is composed of a number of sub -units. One 
of these sub -units is the TATA -box binding sub -unit (TBP) and it is this molecule 
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that initially recognises the TATA box. This is followed by recruitment of the 
remaining RNA polymerase II initiation complex sub -units. The CAAT and GC 
boxes enhance the efficiency of the TATA box. The CAAT box enhances the 
frequency of transcriptional initiation while the GC box (often present in multiple 
copies) binds with a transcription factor called Sp 1. Although these boxes are found 
in most eukaryotic promoters there are exceptions. Some genes expressed at very 
low levels contain none of these three boxes but do have a CG -rich sequence 
upstream from the TSS, which is located nearby. Aside from the CAT and GT 
boxes, other upstream elements include the sequences GCCACACCC and 
ATGCAAAT. 
The enhancers of a gene can influence the efficiency of the promoter from as great a 
distance as 50kb. Unlike the promoter elements, which are usually located upstream 
of the TSS, enhancers can be located upstream or downsteam of the promoter and 
still influence transcription efficiency. As mentioned earlier, there is specificity in 
the interaction of transcription factors with their target genes. There are transcription 
factors that bind to promoter regions and others that bind to enhancer regions. This 
is possible because enhancers contain sequence motifs that are recognised by 
particular transcription factors. Enhancers are important in higher eukaryotes for 
differential control of gene expression. Some enhancers can respond to changes in 
external environmental conditions such as temperature fluctuations or internal 
environmental changes such as the production of steroid hormones. This is very 
important because different gene products may be required at different times or 
different locations in the body depending upon the prevailing environmental 
conditions. A second property of enhancers is that some are capable of directing 
tissue -specific gene expression. 
The ERCC1 gene is unusual because it does not have the genetic motifs that are 
normally associated with eukaryotic gene expression. The human ERCC1 promoter 
was characterised (van Duin et al., 1987) and does not contain any of the classical 
promoter elements associated with eukaryotic genes. The promoter was found to 
reside within 170bp of the transcriptional start site. When this 170bp region was 
joined 5' to a complete human ERCC1 cDNA, the DNA damage repair deficiency of 
Erccl deficient CHO43 -3B cells was corrected. As the novel skin -specific Erccl 
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transcript initiates 5' to the 170bp region that contains the promoter of the normal 
Erccl transcript a second, skin -specific promoter must be present. A 1.05kb 5' 
flanking sequence of the Erccl gene was cloned and sequenced by Kan -Tai Hsia 
(Figure 3.1) and utilised in construction of the minigenes used for the transfections 
illustrated later. This sequence contains the 170bp region that contains the normal 
promoter and should also contain the skin -specific promoter because of the likely 
proximity to the skin TSS. Sequencing this region revealed the presence of a number 
of interesting sequence motifs. A TATA box (consensus sequence TATATAA) was 
found at nt position -823 to -829 and a GC box (consensus sequence GGGCGG) was 
located at nt position -975 to -980. However, the TATA box is approximately 322óp 
upstream of the putative TSS of the skin transcript and since TATA boxes are 
usually within 30óp of the TSS this TATA box is probably either non -functional or 
coincidental. GC boxes are usually located within 200óp of the TSS so the GC box 
is also a little distal to be acting as a promoter -proximal element. Two interesting 
sequence motifs in the fragment are a stretch of CA repeats at the 5' end and stretch 
of CT repeats. One of the polypyrimidine /polypurine CT regions repeats 34 times 
(CT)34 while a second repeats 4 times (CT)4. Counting from the A of the normal 
transcript TSS being designated as nt +1, the (CT)34 repeat begins at nt -428 while 
the (CT)4 begins at nt -358. Since the region responsible for transcription of the skin - 
specific transcript is only used in skin it is possible that tissue specificity is achieved 
by regulatory enhancer regions. 
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Figure 3.1 Nucleotide sequence of the murine Erccl 5' flanking region 
The nucleotide sequence of the murine Erccl 5' flanking region (pRK1.05) is shown. 
The stretch of CA repeats is highlighted in red. Consensus sequences for GC and 
TATA boxes are highlighted in yellow and green respectively. The nt position for 
initiation of transcription in skin is shown in pink. The normal transcriptional start 
site is highlighted in dark green. BseRI, BcUI and kpnl restriction sites are in red, 
underlined and have italic tags. The CT repeat tract is highlighted in blue. Data 
kindly provided by Kan-Tai Hsia. Figure adapted from original by Jim Selfridge. 
Nucleotide numbers are numbered with the `A' of the normal transcript's 
translational start site as nt +1. 
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-1284 GAATTCACAG CGTAGGCATG TGCTTGTA. 
-1224 
-1225 
CC TCACAACTAG GAAAACATTA AAAAAGATAT AGAGGGATTA -1165 
-1164 CATATGATGA CCTTTGGGCG TGCCCTCTCT CAATACACGA AGACCAAAAG AAAATGGAGA -1105 
-1104 ATACGTTGGT AAATGCATGC AAAATTTTAA ATGGAGAATT TTTAAAAGTA TGAACTCGAA -1045 
-1044 GGAAAGATTT GCAGCCTAAT GAAGTGACTA ACAGCATCAG CCCTTAAGCA TCACTCCAAC -985 
- 984 AAATGGGCGG TAATCAAAAG ATGCTCATCT CCTTTTCCTC CCCCTTTTTA ATTTAAAAAA -925 
- 924 ACCGTTGAAT TGCTCATTTC GAAAAAATGG GCAAAGGATA TGAGCCAATC TTTGTTAAAA -865 
-864 GGAATAGGCA AAGGAAATGA GCAAGAACAA AAAAAMM IIGACCATTA AACTATTTCC -805 
-804 TTAGCAATCA CAGAACTACA AGTTGGAACG GGGTGAAACT GTCCTTCCAG GAAATGAGTC -745 
-744 ATACTAAGTC ATTCATGGGG CCCAGGTCTC GGAACACAGG TGTCCCTTCC TTCAGGAAGC -685 
- 684 TCGTCCTCAC ACCCCAGCTG GGTCAGGTGC TCCCCCTAAC ACGGGCTCAA TGTCCTCTGG -625 
-624 GCTCTCCCTT CCCGACCCTG CCCGCTCTGG GTTGTCCCTG TCTGACTGTC CCACTGGACT -565 
-564 TTAAGCCACA GCTGTCGGTA TCAGTCCCTG CTTGGGATGC AAGTGGGGAA TGGCTTAGAA -505 
I / 
-504 TTA,TGAGTC AATGTCTGTG GGCTGAGTCC ACCCACGCTT ACAGGGAAGG GCGTCCTCTG -445 
BseR1 
-444 AAATCTCACC TCCCT -385 
-384 - - -GT- MI CCTTTC CCTCTTTCCC TCCCCCACCT -325 
Bc lI 
-324 CCTTTGATCA TCACTGAGCC 
-264 ACAACTACTT GAAGTCAAAG 
GGATCTGGAG TCTGGGAAGC GCTCAAGAGG GCCTTGGAAC -265 
kpnl 
TCTCCCAGGT ACCAAGATGC ACAAGCTTCC ATCCGCCCCA -205 
-204 AACCACAGCG GTCCTCCAGG ACCATAGAGA GCAGCGCGAA TAGAGTTCCC CGCTCTAACT -145 
- 144 CCTCCGGGGA GCAGCGAGAC GAGCGAAGGG CCIGAGGGCC GGAAGTGAGT CTAGCAGGAG - 85 
- 84 TTGTGCTGGC TGTGCTGGCG TTGTGTCGCC TCTGTTTCCC CCCGTGGTAT TTCCTTCTAG - 25 
- 24 GCATCGGGAA AGACCAGGCC CCAGATG +3 
Promoters can be identified by the use of reporter genes. However, this method was 
not suitable for identification of the skin -specific transcript promoter because of the 
presence of the normal promoter in the 5' flanking region of the Erccl gene. 
Attaching the 5' flanking region of the murine Erccl gene to a reporter gene would 
result in expression of the reporter gene product. However, this expression would 
result from interaction with both the normal promoter, 170bp upstream of the TSS, 
and any elements functioning as a skin -specific transcript's promoter. Even if the 
skin -specific transcript's promoter could be rendered non -functional by deletion of a 
crucial region the reporter gene would still be expressed due to the presence of the 
normal promoter. To be certain that the reporter gene expression resulted from 
transcription due to the skin - specific transcript's promoter, the normal promoter 
would have to be deleted from the region flanking the reporter gene. However, 
deletion of the normal promoter could have unexpected results. It is a possibility that 
the normal promoter may be required for the skin -specific promoter elements to 
function correctly. The cell type in which the experiment was conducted would also 
be important since the skin -specific transcript is obviously not expressed in all 
tissues. 
3.1 .1 Selection of cells suitable for transfection with Erccl minigenes. 
Due to the high levels of nucleases associated with mouse skin it is technically 
problematic to isolate RNA from this tissue for study of Erccl transcripts. A panel 
of cultured cells available in the Melton laboratory was screened by northern blot and 
several cell lines were identified that had useful Erccl expression patterns for 
investigation of the novel Erccl transcript that had been identified in mouse skin. 
Six cell lines, three pairs, were selected for use in minigene transfections. A wild 
type mouse keratinocyte line, Ker. ( +1 +), expressed both Erccl transcripts with a 
high 1.5kb to 1.1kb transcript ratio and this is the pattern of expression observed in 
skin; an Erccl and Hprt null murine keratinocyte line, Ker. ( -/ -), was available for 
transfection with minigenes. Mouse embryonic fibroblasts express both the 1.5 and 
1.1kb Erccl transcripts at equal levels and a wild type cell line, PF20, was available; 
an Erccl and Hprt null mouse embryonic fibroblast line, PF24, was also available. 
Finally, Chinese hamster ovary cells express only the 1.1 kb transcript and a cell line 
was available, CHO43.3B (TG #1); an Erccl and Hprt null CHO line was also 
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available. The three Erccl and Hprt null cell lines are hypersensitive to UV and 
HAT while their wild type counterparts are resistant to UV and HAT. The mouse 
embryonic fibroblasts (PF20) are dermal in origin and, therefore, have an expression 
pattern that mimics that of the in vivo dermal Erccl expression pattern. The wild 
type keratinocyte line is epidermal in origin and this is why they have an expression 
pattern that mimics that of in vivo epidermis. When skin is processed as a whole 
tissue it includes the dermis and epidermis, so the Erccl pattern of expression 
observed in skin is like that of keratinocytes (with a high 1.5 to 1.1kb transcript 
ratio). The cell lines and the Erccl transcripts they produce are summarised in table 
3.1 and the expression pattern was shown in figure 1.2. 
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Table 3.1 Cells used for in vitro Erccl expression pattern 
investigations. 
Table shows the Erccl and Hprt null cell lines chosen for use in the Erccl minigene 
transfections and their wild type counterparts. Also detailed are the Erccl transcripts 
produced by the wild type cells. 
Wild type cell line Erccl expression pattern 
of wild type cell line 
Erccl and Hprt null 
counterpart 
Chinese Hamster Ovary 
cell line: 
CHO#9 
1.1kb transcript only CHO43.3B (TG #1) 
Mouse embryonic 
fibroblast cell line: 
PF20 
Equal ratio of 1.5kb to 1.1 
kb transcript 
Mouse embryonic 
fibroblast cell line: 
PF24 
Mouse keratinocytes: 
Ker. ( +/ +) 
High ratio of 1.5kb to 
1.1kb transcript 
Mouse keratinocytes: 
Ker. ( -/ -) 
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3.2 Structure of Erccl minigenes 
Three Erccl minigenes were available in the Melton laboratory. These had been 
constructed in order to identify regions of the 5' flanking sequence of the Erccl gene 
required for production of the skin -specific transcript. One of the minigenes, Erccl 
MG #13, had been used to transform Erccl -null fibroblasts, Chinese hamster ovary 
cells and keratinocytes. Subsequent UV survival analysis had demonstrated that this 
minigene was capable of correcting the UV hypersensitivity of these cell lines. The 
minigene was, therefore, functional and transfection resulted in production of 
ERCC 1 protein. Deletion of regions in the flanking sequence led to production of 
two further minigenes for use in transfections. This could enable identification of 
regions required for production of the skin -specific transcript. Deletion of essential 
regions could result in changes in the UV hypersensitivity of the transfected cells. 
Loss of the skin -specific transcript following deletion of crucial regions would be 
identified by RT -PCR analysis of RNA extracted from transfected cells. To this end, 
Ercc1MG #11 and #20 had been constructed. 
The use of minigenes is subject to a number of limitations. Because minigenes 
randomly integrate into the genome, total expression levels can be influenced by the 
number of minigenes incorporated, the copy number, and by random associations 
with chromosomal elements such as enhancers and silencers situated near the 
integration site of the minigene. It is possible for multiple copies of a minigene to 
successfully integrate into the genome of a particular cell and higher copy numbers 
may result in higher levels of transgene product being expressed than would be the 
case with the endogenous gene. Because of the variability in the location of 
minigene integration in the genome, it is possible that the resultant expression level 
may be enhanced or reduced depending upon the proximity to expression control 
elements such as enhancers or silencers (such elements are discussed in greater detail 
in the introduction to chapter 3). Assuming the correct minigene copy number, 
transgene expression could still be abnormal compared to endogenous gene 
expression due to interaction between the minigene and expression control elements 
leading to either higher or lower expression depending upon the element involved. 
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Stable integration of minigenes results in stable expression while failure to integrate 
leads to transient expression. 
3.2.1 Construction of Erccl MG #13 
Erccl MG #13 was assembled using the cloning strategy shown schematically in 
Figure 3.2. The minigene was constructed by linking a 1.05kb stretch of the 5' 
flanking sequence of the murine Erccl gene (mentioned earlier with regard to the 
presence of the interesting (CT) repeat region) to an Erccl gene fragment containing 
exons 1 -10 and the 3' end of the Erccl cDNA which contains the polyadenylation 
signal. Construction of Erccl MG #13 was performed by Jim Selfridge using three 
parental plasmids available in the Melton laboratory. The 5' flanking region was 
isolated from the genomic subclone, pRK1.05, as a 1.05kb SstI /Kpnl fragment. The 
Erccl gene fragment which contained exons 1 -10 was constructed by joining a 9.3kb 
genomic subclone pKpnl 9.3, containing exons 1 -7, to a 300óp KpnI /EcoRI fragment 
of the 3' end of the Erccl cDNA containing exons 7 -10, the polyadenylation signal 
and a short 3' UTR. The KpnI site in exon 7 was utilised in the joining of these two 
components. The assemblage was cloned into SstI /EcoRI cut pBluescriptII SK +. 
Following identification of recombinants by blue /white colour selection and 
characterisation by restriction analysis a positive clone was identified and sequencing 
confirmed the integrity of the cloning sites. Notl restriction of the BluescriptII SK+ 
polylinker released the linearised 10.4kb Erccl MG #13. This linearised minigene 
could be used directly to transfect cells. As the exact location of the promoter of the 
skin -specific transcript was unknown, it was possible that the 1.05kb region used in 
construction of the minigene did not contain all the elements required for correct 
expression of the skin -transcript. However, the 1.05kb region did contain the 
interesting (CA) and (CT) repeat regions and this was worthy of further investigation. 
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Figure 3.2 Construction of Erccl minigene #13 
a, The 5' flanking sequence clone pRK 1.05 was cut with Sstl and KpnI to liberate 
the insert. Drawn to scale: 1cm= 100bp. b, The exon 7 to 10 region of the cDNA 
subclone pBluescriptll SK+ EX4 -10 (RI), was isolated as a 300bp KpnI /EcoRI 
fragment. Drawn to scale lcm= 100bp. c, The 9.3kb KpnI genomic fragment 
carrying exons 1 to 7 was isolated from pKpnl 9.3. Drawn to scale: lcm =lkb. 
d, Each of the isolated fragments were cloned into SstI /EcoRI cut pBluescriptll SK +. 
Drawn to scale lcm =lkb. 
Plasmid backbone shown as a thin line. 5' flanking sequence shown in cyan, cDNA 
sequence shown in blue, exons shown as numbered red boxes & introns shown as 
thick line. Restriction sites used for cloning and subsequent analysis shown as 
follows: EcoRI, E; BamHI, B; BglIl, Bg; Kpnl, K; PstI, P; Sstl, S; Notl, N. 
Restriction sites cut for cloning or later linearising are indicated by scissors icon. 
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3.2.2 Construction of Erccl MG #11 
Everything upstream of a KpnI site in the 1.05kb flanking region was deleted in 
minigene #11. This deletion included the region thought to contain the skin -specific 
promoter and the TSS of the skin -transcript. 
The following fragments were ligated to form Erccl MG #11 (Figure 3.3); the 
fragment containing exons 1 -7 (Kpnl) came from pKpnI9.3. This was ligated to a 
fragment containing exons 7 -10 (Kpnl /EcoRI) which came from PBlueScript SK + 
Ex4- 10(RI) in Bluescriptll SK +. Ms. Carolanne McEwan (Melton Lab.) constructed 
Ercc1 MG #11. 
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Figure 3.3 Construction of Erccl minigene #11 
Plasmid backbone is shown as thin line. cDNA sequence shown in blue. Exons 
shown as numbered red boxes. Introns shown as thick line. Restriction sites used for 
cloning and subsequent analysis shown as follows: EcoRI, E; BamHI, B; Bglll, Bg; 
KpnI, K; Pstl, P; Sstl, S; Notl, N. 
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3.2.3 Construction of Erccl MG #20 
The following fragments were ligated in BluescriptII SK+ (SstI/EcoRI) to form 
Erccl MG #20 (Figure 3.4); the 9.3kb genomic subclone pKpnl 9.3 containing exons 
1 -7 (Kpnl); the 300óp fragment of the 3' end of the Erccl cDNA (KpnI/EcoR1) 
containing exons 7 -10, the polyadenylation signal and a short 3' UTR were ligated to 
the modified 1.05kb fragment. The (CT) repeat region of the 1.05kb fragment 
(SstI /KpnI) in Bluescriptil SK+ was removed by restriction with BseRI and BcMI. 
The intriguing (CT) repeat region was deleted in Erccl MG #20. Ms.Carolanne 
McEwan (Melton Lab.) constructed Erccl minigene #20. 
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Figure 3.4 Construction of Erccl minigene #20 
Plasmid backbone is shown as thin line. 5' flanking sequence shown in cyan, cDNA 
sequence shown in blue. Exons shown as numbered red boxes. Introns shown as 
thick line. Deletion indicated by triangle. Restriction sites used for cloning and 
subsequent analysis shown as follows: EcoRl, E; BamHI, B; Bglll, Bg; KpnI, K; PstI, 
P; Sstl, S; Nod, N. 
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3.2.4 Summary of differences between minigenes 
Erccl MG #13 contains the 1.05kb flanking region that contains the normal 
transcript's promoter and is likely to contain the skin -specific transcript promoter. 
Erccl MG #11 contains the normal transcript promoter but lacks the region upstream 
of the Kpnl site that is thought to contain the skin specific transcript promoter. 
Erccl MG #20 is very similar to Erccl MG #13 apart from the (CT) repeat deletion. 
The (CT) repeat deletion may result in loss of skin- transcript expression if this region 
forms part of the skin specific transcript's promoter. Any differences between the 
expression of Erccl MG #13 and Erccl MG #20 will be due to the absence of the 
(CT) repeat region in Erccl MG #20. See figure 3.5 for comparison of the three 
minigenes. 
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Figure 3.5 Comparison of Erccl minigenes 13, 20 and 11 
The three Erccl minigenes, 13, 11 and 20 are shown. The plasmid backbone is 
shown as a thin line. 5' flanking sequence shown in cyan, cDNA sequence shown in 
blue. Exons shown as numbered red boxes. Introns shown as thick line. Deletion in 
Erccl MG #20 indicated by triangle in 5' flanking region. 
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3.3 Correction of UV hypersensitivity in murine embryonic fibroblasts 
transformed with Erccl MG #13, #20 and #11 
Cells were electroporated as explained in method section. The 3:1 ratio of MG DNA 
to pBT /PGK- Hprt used for the electroporation ensured a high likelihood that Hprt 
DNA entering cells would be accompanied by MG DNA. The experimental control 
was electroporation of cells with pBT /PGK- Hprt DNA only. Subsequent co- 
selection was by means of HAT selection (selecting cells containing pBT /PGK- 
Hprt) and UV (selecting cells with correction of UV hypersensitivity due to the 
presence of MG DNA). The co- selection selects cells transformed with both the 
pBT /PGK- Hprt and Erccl MG DNA. The UV -C dose chosen for post - 
electroporation selection was 7.5.1/m-2. At this dose non -transfected cells die while 
cells with functional minigene survive. The UV selection dose was set to allow cells 
with partial function of the minigene to survive, expression merely had to be 
sufficient to correct the UV hypersensitive phenotype of the PF24 cells. 
Table 3.2 shows the number of colonies /dish for plating density of 5X105. Colony 
counts following transfection demonstrated that the control (Hprt only cells) had 
few, if any, colonies following UV/HAT co- selection. In contrast, cells transformed 
with Hprt DNA + Erccl minigene #13, #11 or #20 survive selection and give rise to 
numerous colonies. The ratio of colonies in the HAT + UV dishes to colonies in the 
HAT dishes is much lower in the Hprt only transfection (ratio 0.002) in comparison 
to the minigene #13, #11 and #20 transfections (ratios of 0.208, 0.165 and 0.253 
respectively. Clones for subsequent UV survival studies were selected from the 
5X105 dishes as this plating density resulted in discrete colonies. The fact that 
colonies survived UV selection following transfection with Erccl MG #13, #11 or 
#20 and the similarity in ratio of HAT +UV selected colonies to HAT selected 
colonies for each minigene demonstrates that all three minigenes are functional in 
PF24 and, at this level of analysis, are capable of correcting the UV hypersensitive 
phenotype of the PF24 cells equally effectively. 
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Table 3.2 Colony counts following Erccl- minigene -transfection and HAT /UV 
selection in Erccl- deficient mouse embryonic fibroblasts 
Number of colonies /petri dish for plating density of 5X105. Colonies were counted 
following selection with HAT or co- selection with HAT + UV. UV colony numbers 
are an average of 3 dishes. The ratio of HAT +UV selected colonies to HAT only 
selected colonies is shown to indicate the ratio of cells surviving co- selection to those 





selection (n =1) 
No. colonies 
following HAT +UV 
selection (average 




to HAT selected 
colonies 
Erccl MG #13 + 
pBT /PGK- Hprt 
475 99 RANGE 48 -197 
SD ± 69.5 
SE 40.2 
0.208 
Erccl MG #11 + 
pBT /PGK- Hprt 
615 102 RANGE 50 -84 
SD ± 58.8 
SE 34 
0.165 
Erccl MG #20 + 
pBT /PGK- Hprt 
423 107 RANGE 61 -84 
SD ± 54.8 
SE 31.6 
0.253 
pBT /PGK - Hprt 1ß8 0.3 RANGE 0 -1 
SD ± 0.5 
SE 0.3 
0.002 
Note: Without repeating the experiment with a greater number of dishes plated with cells for each 
transfection, it is not possible to comment upon the statistical significance of the differences in the 
ratio of HAT +UV to HAT selected colonies. It is possible that although the ratio of HAT + UV 
selected to HAT selected colonies in cells transformed with MG #11 is lower than that of the cells 
transformed with MG #13 and MG #20 this may not be statistically significant. The colony count for 
pBT /PGK - Hprt transfected cells following HAT selection is lower than expected when compared to 
the other transfections and a possible explanation is low transformation efficiency. 
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3.3.1 Correction of UV hypersensitivity in murine embryonic fibroblasts 
transformed with Erccl MG #13 
Before performing UV survival assays with Erccl minigene #13 -derived minigenes, 
it was necessary to examine the ability of the Erccl MG #13 to correct the UV 
hypersensitivity of the Erccl deficient murine embryonic fibroblasts, PF24. 
Correction of the hypersensitivity of the fibroblasts would indicate that 
transformation with Erccl MG #13 results in the production of functional ERCC1 
protein. If this minigene was not able to correct the UV hypersensitivity of the PF24 
cells then continuing analysis by transforming cells with the minigenes derived from 
MG #13 would be pointless. Lack of functionality with the derived minigenes would 
provide no insights if they were produced from a non -functional minigene. 
The UV survival assays were performed as follows; 16 30mm diameter petri dishes 
were plated with 2X104 cells per dish and cultured overnight to allow the cells to 
settle and adhere to the surface of the dish in a uniform layer. 24 hours after plating, 
the dishes were irradiated with various doses of UV -C. The UV -C doses used in the 
survival assays cover a range which is normally not lethal to cells with wild type 
Erccl expression while Erccl null cells are killed by the higher UV doses of the 
survival assay. In this way, correction of UV hypersensitivity by Erccl minigene 
expression can be ascertained by comparison of the UV survival curve of 
transformed cells with those of non -transformed and wild type cells. 
For each UV dose, two dishes were irradiated. The experiment was performed in 
duplicate to provide an average survival value for each dose. In addition to the 
irradiated dishes, a number of control dishes were also cultured but not irradiated. 
All the dishes were cultured until the control dishes became confluent; at this time all 
the dishes were fixed and stained. The UV survival curves for the PF24 cells 
transformed with Ercc1 MG #13 are shown in figure 3.6. The staining of the cells 
enabled quantification of survival with the stain value of the control dishes 
representing 100% on the survival index and percentage staining in the irradiated 
dishes with comparison to the controls equating to the percentage score on the 
survival index for each dose of UV. Cell properties that contribute to the survival 
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index score are the resistance of the cells to the UV dose (the percentage of cells 
initially surviving UV irradiation), the ability of the cells to repair damaged DNA 
(which leads to either apoptosis or release from cell cycle arrest), rate of DNA 
damage repair following irradiation and the growth rate of the surviving cells. 
The plots demonstrate that the PF24 cells transfected with Erccl MG #13 are not 
hypersensitive to UV. The survival curve of the PF24 cells which were not 
transfected with Erccl MG #13 were hypersensitive to UV with 99.5% of cells 
surviving a UV dose of 0.625 Jm 2, 73.4% surviving the 1.25 Jm 2 dose, 26.7% 
surviving the 2.5 Jm 2 dose, 9.1% surviving the 3.75 Jm 2 dose and 0.7% surviving 
the highest dose of 10 Jm 2. In comparison, 84.2% of the wild type PF20 cells 
survived the 3.75 Jm 2 dose, 74.2% survived the 5 Jm 2 dose and 16% survived the 
highest dose of 10 Jill-2. When the survival curves of the PF24 clones transfected 
with Erccl MG #13 are compared to the PF20 wild type cells then the similarity is 
clear, indicating correction of UV hypersensitivity of the PF24 cells by transfection 
with Ercc1 MG #13. MG #13 clones 1 and 2 have higher survival than the wt PF20 at 
the high UV doses and MG #13 clone 6's survival matches that of the wt PF20 line 
while MG #13 clone 8 is lower that that of PF20 and the other Erccl MG #13 clones 
at the highest UV dose. 
The survival profile of PF24 MG #13 clone 2 showed resistance to UV at both 3.75 
Jm 2 and 5 Jm 2, dropping to 48% and 25% survival at 7.5 Jm 2 and 10 Jm 2. PF24 
MG #13 clone 1 had slightly higher UV survival than clone 2 at the lower UV doses, 
91.5% and 84.7% at 3.75 and 5 Jin-2 and slightly lower survival than clone 2 at the 
higher UV doses with 46% and 18% survival at 7.5 Jm 2 and 10 Jm 2. The survival 
curve of PF24 MG #13 clone 6 was slightly lower than that of PF24 MG #13 clones 1 
and 2, but almost identical to that of the wt PF20 with 60% and 57% survival at UV 
doses of 3.75 Jm 2 and 5 Jm 2 and survival of 39% and 16% at the higher UV doses 
of 7.5 Jm 2 and 10 Jm 2. The survival curve of PF24 MG #13 clone 8 was lower than 
the other 3 clones and the PF20 cells but higher than the non -transfected cells. At 
3.75 and 5 J /m2, 72 and 65% of cells survived while at 7.5 and 10Jm2 32 and 7.1% 
of the cells survived. 
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In figure 3.6, although the error bars do not quite overlap, the difference between 
clone 8 and the mean of clones 1,2 and 6 (mean = 24.4) is considered to be not quite 
statistically significant when tested using a two -tailed t -test (P= 0.056) at UV dose 
10.1m-2. When clone 8 is compared to individual clones, there is no statistically 
significant difference between clone 8 and clone 1 (P= 0.3232). However, there is a 
statistically significant difference between clone 8 and clone 2 (P= 0.0125) and 
between clone 8 and clone 6 (P= 0.0154). The error bar on clone 1 is large and 
almost overlaps with clone 8, while the error bars on clones 8, 2 and 6 are small and 
do not overlap. At the lower UV doses the error bars of all the clones overlap, 
indicating that the difference between the clones only manifested at the highest UV 
dose. 
From the survival curves and magnitude of the error bars on those curves it was clear 
that transfection of Erccl -null murine fibroblasts, PF24, resulted in correction of UV 
hypersensitivity to a level near or equal to wt PF20 levels in all the clones. This 
indicates that minigene #13 transfection resulted in translation of a functional ERCC1 
protein. Subsequent RT -PCR analysis (figure 3.10) enabled identification of the 
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Figure 3.6 Correction of UV hypersensitivity of Erccl deficient 
fibroblasts (PF24) following transfection with Erccl minigene #13 
The UV survival curves for wild type (PF20) and Erccl deficient (PF24) murine 
fibroblasts and four minigene- positive PF24 clones are shown. The experiment was 
performed in duplicate and the mean value is shown for each point. Circle, PF24; 
inverted triangle, PF20; square, clone #1; diamond, clone #2; triangle, clone #6; 
hexagon, clone #8. 
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3.3.2 Expression of Erccl minigene #11 in Ercc1- deficient murine fibroblasts, 
(PF24). 
Erccl minigene#11 was produced by deletion of the region upstream of the Kpnl 
restriction site in MG #13. This means that minigene#11 does not contain the region 
in which the skin promoter is thought to lie, nor the transcriptional start site of the 
skin transcript, meaning expression of the minigene should only result in production 
of the normal 1.1kb transcript. Hypothetically, this could result in reduced UV 
survival in comparison to the cells transformed with Erccl MG #13 if the skin - 
specific transcript contributes to UV resistance. It is also possible that deletion of this 
region could result in loss of functionality of the minigene. The inability to express 
the 1.5kb transcript due to the deletion in Ercc1MG #11 is more likely to have an 
effect upon the UV survival of transformed keratinocytes than mouse embryonic 
fibroblasts. This is because the fibroblasts normally produce the 1.5kb and 1.1kb 
transcripts at an equal ratio whereas keratinocytes produce primarily the 1.5kb 
transcript. This is why three different cell lines were used for investigation of the 
minigenes, each cell line has a different wild type Erccl expression pattern and 
transformation with the minigenes provides different insights into the importance of 
the deleted regions to expression of the novel transcript. 
The survival curves of the clones transfected with Ercc1MG #11 are shown in figure 
3.7. The plot demonstrated that transfection with MG #11 corrects the UV 
hypersensitivity of the PF24 murine fibroblasts to wild type levels. Comparison of 
the mean survival of the set of clones transfected with MG #11 to the mean survival 
of the set of clones transfected with MG #13 indicates that the two minigenes correct 
UV hypersensitivity to a similar extent. The wt and null controls on the plot are the 
same as in the minigene#13 plot and the experiment was performed as before with 
only the minigene used for transfection differing. 
For ease of comparison, the survival values for the controls were as follows; PF20 
survival at 3.75, 5, 7.5 and 10 Jm 2 were 88, 84, 74 and 16% respectively while 
survival of the non -transfected PF24 for those UV doses were 27, 9, 6 and 0.7% 
respectively. The survival curves of two of the clones transfected with 
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Ercc1 MG #11, clones 9 and 14, were slightly higher than the wt PF20 while the 
survival curves of the other two clones, clones 6 and 10, were slightly lower than the 
wt curve. PF24 Ercc1MG #11 clone 14 had the highest survival curve with 82, 54, 36 
and 24% surviving UV doses of 3.75, 5, 7.5 and 10 Jm 2 respectively. PF24 
Ercc1MG #11 clone 9 had the second highest survival curve with 70, 56, 43 and 20% 
of cells surviving those UV doses. PF24 Erccl MG #11 clone 10 had very slightly 
lower survival than the wild type PF20 with 94, 83, 41 and 15% of cells surviving 
UV doses of 3.75, 5, 7.5 and 10 Jm2 PF24 Ercc1MG #11 clone 6 had a slightly 
lower survival curve than clone 10 with 81, 46, 25 and 12% survival for the same 
UV doses. 
Because the UV survival curves of the clones transformed with Ercc1MG #11 have a 
similar mean survival to the mean survival of the clones transformed with Erccl 
MG #13, deletion of the region upstream of the Kpnlsite (containing the skin 
transcript's TSS and likely promoter region) did not result in reduced ability to repair 
UV- induced DNA damage. RT -PCR analysis was performed to ensure that only the 
normal Erccl transcript was being produced by the transfected cells. 
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Figure 3.7 Correction of UV hypersensitivity of Erccl deficient 
fibroblasts (PF24) following transfection with Erccl minigene #11 
The UV survival curves for wild type (PF20) and Erccl deficient (PF24) murine 
fibroblasts and four minigene- positive PF24 clones are shown. The experiment was 
performed in duplicate and the mean value is shown for each point. Circle, PF24; 
inverted triangle, PF20; square, clone #6; diamond, clone#9; triangle, clone #10; 
hexagon, clone #14. 
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3.3.3 Expression of Erccl minigene #20 in Erccl- deficient murine fibroblasts, 
(PF24). 
In Erccl MG #20 there is a deletion of the (CT) repeat region between restriction sites 
(BseRI /BclI) of the 1.05kb fragment. This region could be required for expression of 
the skin transcript as it could be a promoter element. Deletion of a region that 
formed part of the skin specific promoter could lead to loss or reduction in 
expression of the skin transcript. The deletion in Erccl MG #11 includes the CT 
repeat region. Lack of skin transcript production following transfection with 
Ercc1MG #11 does not allow conclusions about the importance of particular 
sequences contained in the deleted region to be made. The deletion in Erccl MG #20 
is more specific and changes in expression of the skin transcript following 
transfection with this minigene when compared to the expression seen with Erccl 
MG #13 could indicate that the CT repeat region is part of the skin specific promoter. 
The UV survival curves of PF24 cells transformed with Erccl MG #20 are shown in 
figure 3.8. The plots demonstrate that PF24 cells transformed with Erccl MG #20 are 
not hypersensitive to UV. The experiments were performed in the same way as with 
Erccl MG #13 and Erccl MG #11 and the controls on the plot are the same as with 
the earlier transformations. Again, for ease of comparison, the survival values of the 
Erccl wild type PF20 cells at 3.75, 5, 7.5 and 10 Jm 2 were 88, 84, 74 and 16% 
respectively. Survival index percentages of the non -transformed PF24 for the same 
UV doses were 27, 9, 6 and 0.7% respectively. 
There is greater variability in the level of correction of UV hypersensitivity in clones 
resulting from transfection with MG #20 than with minigenes #13 and #11. PF24 
Erccl MG #20 clone 12 has higher survival that the wild type PF20 and the clones 
transformed with Erccl MG #13. In contrast, PF24 Erccl MG #20 clones 6 and 9 
have lower survival at the highest value than the wild type PF20 and clones 
transformed with Erccl MG #11 and Erccl MG #13, while PF24 Erccl MG #20 clone 
10 has slightly higher survival than the Erccl MG #13 clone 8. The mean survival of 
the set of clones transfected with MG #20 is lower than that of the sets transfected 
with MG #13 and #11. 
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The highest survival curve was that of PF24 Erccl MG #20 clone 12 with survival 
index percentages of 85, 76, 50 and 33% for UV doses of 3.75, 5, 7.5 and 10,1m-2 
respectively. In contrast, the survival curves of PF24 Erccl MG #20 clone 10 is 
lower than that of wild type PF20 with survival index percentages of 98, 61 and 9% 
survival for UV doses of 3.75, 5 and 10Jm 2 respectively. PF24 Erccl MG #20 clone 
9's survival curve is very low. Clone 9 survival index percentages for UV doses of 
3.75, 5 and 10Jm 2 were 69, 51 and 5.75 %. 
Deletion of the CT repeat region in Erccl MG #20 did result in reduced ability to 
repair UV induced DNA damage in transformed cells when compared with cells 
transfected with Erccl MG #13 and this is indicated by the lower mean survival of 
the set of clones transformed with MG #20 when compared to that of the set of clones 
transformed with Erccl MG #13. 
Transfection of PF24 with minigene #13 corrects the UV hypersensitivity of PF24 to 
wild type (PF20) level. Loss of the region upstream of the Kpnl restriction site in 
Ercc1MG #11 did not impair the functionality of the minigene when compared to 
Erccl MG #13. The discrete deletion of the CT repeat region in Erccl MG #20 
appears to lead to less correction of UV hypersensitivity in transformed cells when 
compared to Erccl MG #13 and #11. 
95 
Figure 3.8 Correction of UV hypersensitivity of Ercc1- deficient 
fibroblasts (PF24) following transfection with Erccl minigene #20 
The UV survival curves for wild type (PF20) and Erccl deficient (PF24) murine 
fibroblasts and four minigene- positive PF24 clones are shown. The experiment was 
performed in duplicate and the mean value is shown for each point. Circle, PF24; 
inverted triangle, PF20; square, clone #6; diamond, clone#9; triangle, clone #10; 
hexagon, clone #12. 
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3.4 Expression of minigenes in Erccl null murine fibroblasts (PF24) - 
RT-PCR analysis 
RT -PCR analysis was required to show which transcripts were being expressed by 
the transformed cells and this would indicate if the minigenes were being expressed 
appropriately for the cell type. Earlier work by Dr. Selfridge in the Melton lab. had 
shown that northern blots could not be used to discriminate between Erccl 
transcripts in transformed cells because of differential polyadenylation at the 3' end 
of the transcript. This differential polyadenylation between transcripts meant that 
differences in size at the 3' end of transcripts obscured differences in transcript size 
due to differential initiation. For this reason, a method that did not rely upon 
transcript size separation (by electrophoresis) for transcript identification was 
required and RT -PCR was the most suitable choice. 
Murine embryonic fibroblasts normally express both the normal transcript and the 
skin specific transcript. The fibroblast cell line is dermal in origin and this explains 
why the ratio of 1.5kb to 1.1kb transcripts is equal, the cell line mimics the in vivo 
dermal pattern. The expected expression pattern for a correctly expressed Erccl 
minigene in PF24 would be both transcripts in equal amounts. The deletion in Erccl 
MG #11 should not allow production of the skin transcript. The deletion of the (CT) 
repeat region in Erccl MG #20 could result in loss of the skin transcript, if the region 
is crucial for the skin promoter to function, or reduced expression of skin transcript if 
the region is not crucial but is required to enhance the promoter activity. As UV 
sensitivity was corrected by transformation with Erccl MG #20, the deletion in this 
minigene obviously does not result in complete loss of both transcripts. The deletion 
could be causing a reduction in transcription of both transcripts or expression of only 
the normal transcript if the deleted region merely enhances production of the skin 
specific transcript. The RT -PCR technique used in the following experiments in not 
quantitative, so all comments regarding the level' of transcript detected by RT -PCR 
are presented for interest only and should be interpreted with caution. 
Because the RT -PCR performed in these studies is not a quantitative method, caution 
must be applied when interpreting the results of transcript 'levels". This is because 
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RT -PCR is highly sensitive to minute differences in initial RNA quantity because of 
the amplification process and due to the availability of substrate as the reaction 
progresses. In this thesis the expression patterns are discussed in terms of both the 
absence or presence of a band and in terms of the 'brightness' or level of product 
band for each transcript detected. Because the pattern observed between clones was 
reproducible, both in the case of using the same cDNA and from between batches of 
cDNA using the same RNA, the results regarding levels are reported for interest and 
should not be over -interpreted. 
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3.4.1 How Erccl transcripts can be differentiated by RT -PCR 
All three of the Erccl minigenes were capable of correcting the UV hypersensitivity 
of the PF24 cells, indicating that functional Erccl transcripts were being produced by 
the transfected cells and that the transcripts were being translated into functional 
protein. In order to find out whether the transformed cells were transcribing the 
normal Erccl transcript, the skin- specific transcript or both transcripts RT -PCR was 
performed upon whole RNA extracted from the cells. 
Four primers were used to differentiate between the two Erccl transcripts. The 
primers with numerical prefixes are named after the number of the exon in which 
their hybridisation site is located. The three 5' primers were referred to as `A', `B' 
and `2' while the 3' primer was referred to as `5'. There are, therefore, three primer 
pairs A/5, B/5 and 2/5. Primer A hybridised to a region in the 1.05 flanking 
sequence upstream of the Kpnl site; Primer B hybridised to a region between the 
Kpnl site and exon 1; Primer 2 hybridised to a region in exon 2 and primer 5 
hybridised to a region in exon 5. The PCR products for the primer pairs A/5, B/5 and 
2/5 are 779, 667 and 459 base pairs in length respectively. The skin transcript 
contains the hybridisation sites of all the primers whereas the normal transcript only 
contains the hybridisation sites of the 2/5 primer pair. This means that when RT- 
PCR was performed, the skin transcript was detected by the presence of all three 
PCR products while the normal transcript only gave rise to the 2/5 PCR. Therefore, 
the A/5 & B/5 PCR products indicate the presence of the skin transcript while the 2/5 
PCR product indicates the presence of normal transcript and/or skin specific 
transcript. A product for the 2/5 reaction without product from the A/5 reaction 
indicated the presence of the normal transcript in the absence of the skin specific 
transcript. Wild type keratinocytes produce both Erccl transcripts (although almost 
exclusively the skin specific transcript) while embryonic cells (HM -1) produce only 
the normal transcript. RNA from these cells was used as the controls for the RT- 
PCR; in figure 3.9a all three PCR products are present in the keratinocyte sample but 
only the 2/5 reaction results in a product with RNA from HM -1. 
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Figure 3.9 Discrimination between Erccl transcripts and primer 
hybridisation sites in Erccl minigenes #11, #13 and #20 
Figure 3.9 shows the three minigenes with the possible PCR products aligned to the 
hybridisation regions. Transfection with Erccl MG #13 and #20 could hypothetically 
result in expression of both Erccl transcripts. These would be detected by products 
from all three PCR reactions - see a., b. and c. Ercc1MG #11 does not contain the 
skin TSS so it is not possible for transfection with this minigene to result in 
expression of the skin specific transcript but production of the normal transcript is 
possible. This would be detected by PCR products from the 2/5 reaction while any 
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Erccl MG #13 contains all the sequence required for hybridisation of the primers so 
transfection of a cell type which normally expresses both Erccl transcripts with this 
minigene and subsequent correct expression of the minigene should, hypothetically, 
result in detection of two transcripts with RT -PCR (see figure 3.9b for minigene 13 
and primer hybridisation). Transfection with Erccl MG #13 corrected the UV 
hypersensitivity of the PF24, indicating that transcription and translation were taking 
place following transfection and that the minigene was giving rise to functional 
ERCC 1 protein. RT -PCR would enable identification of the transcripts produced 
and this would indicate whether the minigene was being expressed appropriately for 
the cell type. 
The deletion in Erccl MG #20 does not interfere with the primer hybridisation 
sequence but it could affect transcript production if the deleted sequence is necessary 
for skin transcript production (see figure 3.9c). Therefore, transfection of fibroblasts, 
which in the wild type express both transcripts, with Erccl MG #20 could have a 
number of possible outcomes. Transfection of PF24 with Erccl MG #20 corrected 
the UV hypersensitivity of the fibroblasts, indicating that the minigene was being 
expressed and that it was functional. However, it was possible that the deletion in 
the minigene could result in abnormal Erccl expression for the cell type. RT -PCR 
would indicate which transcript(s) were being produced in response to transfection 
with Erccl MG #20 and this would indicate whether the deleted region was required 
for skin transcript production. 
The deletion in Ercc1 MG #11 removes the hybridisation site of primer A. The 
primer B hybridisation site is very close to the 5' end of the minigene and the 
hybridisation site of primers 2 and 5 are unaffected (see figure 3.9d). Transfection of 
PF24 with this minigene could not result in production of the skin transcript as the 
TSS of this transcript was deleted from the minigene. Transfection of PF24 with this 
minigene should only result in production of the normal transcript, regardless of the 
fact that the wild type fibroblasts express both transcripts. The expected RT -PCR 
results for PF24 transfected with Ercc1MG #11 would be for the 2/5 reaction to 
produce a product and any other transcripts initiating upstream of the normal 
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transcript would be detected by the B/5 reaction. It would not be possible to get a 
product from the A/5 reaction. 
See figure 3.9 (a). In wild type fibroblasts both the normal and the skin specific 
transcripts are produced at equal levels. In contrast, wild type keratinocytes express 
the skin specific transcript at a much higher level than fibroblasts do. When RT -PCR 
is performed on these cell types the resulting A/5 and 2/5 product bands in 
fibroblasts are approximately equal in intensity while in keratinocytes the A/5 band 
is brighter than the 2/5 band. The B/5 reaction is not as efficient as the A/5 and 2/5 
reactions so this band is less intense than the A/5 band although both reactions detect 
the skin specific transcript. Only the 2/5 reaction results in a band when RNA from 
embryonic HM -1 cells is tested and this is because these cells only express the 
normal transcript. Untransformed PF24 cells do not result in any signal when RT- 
PCR is performed. Keratinocytes and HM -1 cells act as controls for the RT -PCR 
reactions. 
3.4.2 Expression of Erccl MG #13 in Erccl- deficient murine fibroblasts 
(PF24) - RT -PCR analysis 
The hypothetical result for PF24 fibroblasts transformed with Erccl MG #13 would 
be that both transcripts would be produced if the minigene contained all the 
sequences necessary for their expression. 
When the RT -PCR results were examined (figure 3.10) the expression of the 
minigene was appropriate for the cell type in 3 of the four clones. Clones #2, #6 and 
#8 each had positive signals in all three PCR reactions, indicating production of both 
transcripts. The keratinocyte and embryonic cell controls gave the correct expression 
pattern. One of the clones, clone #1, had an abnormal expression pattern as there 
was only one positive signal in the 2/5 reaction and this was extremely weak (it can 
only be seen in the higher exposure panel below the main figure). Although the 
experiments were repeated to ensure that the RNA levels were equal in all cases the 
low band intensity from this clone proved to be reproducible. Surprisingly the low 
expression in this clone did not correlate with lower UV survival so the Erccl was 
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expressed at a level capable of repairing the DNA damage following UV irradiation. 
The three remaining clones, #2, 6 and 8 all expressed both transcripts and RT -PCR 
resulted in strong bands for all three reactions. The bands in clone #2 were strong in 
all three reactions. Clones #6 and 8 had strong A/5 and 2/5 bands while the B/5 band 
was a less intense. In later experiments the B/5 reaction conditions were changed 
from 30 cycles to 32 cycles. 
RT -PCR is not considered to be a quantitative technique so caution must be applied 
when interpreting any difference in the strength of the signal resulting from the PCR 
reactions. However, as every effort was made to ensure that the conditions were 
equal in all the tests, it is worth investigating whether there was any correlation 
between signal intensity (hypothetically representing level of Erccl transcript) and 
UV survival. If intensity of the 2/5 band directly indicates total transcript level in the 
clone, this would mean that the transcript level is highest in clone 2 followed by 
clones 8, 6 and 1. The clones with the highest percentage UV survival at the highest 
UV dose (figure 3.6) are clone 2 followed by clone 1, 6 and 8. Therefore, there was 
no correlation between the actual intensity of the bands and the UV survival of the 
clones. All four clones expressed the transcripts in sufficient quantity to correct the 
UV hypersensitivity of the fibroblasts. 
In summary, 3 clones were producing both transcripts and in each clone the 
transcripts were produced at roughly equal levels while one clone had an abnormal 
expression pattern. The expression pattern of 3 clones is correct for the cell type and 
indicates that Erccl MG #13 is functional and contains all the elements necessary for 
expression of both transcripts. 
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Figure 3.10 Expression of Erccl MG #13 in PF24 - RT -PCR 
RT -PCR analysis of RNA extracted from Erccl-null PF24 clones transformed with 
Ercc1MG #13. Total RNA was prepared and reverse transcribed using oligo -dT 
primers. The Erccl cDNA was then PCR amplified from the cDNA pool of each 
clone. Three PCR reactions were performed on cDNA from each clone using the 
following forward primers respectively; primer `A' is specific a region upstream of 
the normal transcriptional start site, primer `B' is specific to a region upstream of the 
Kpnl restriction site and primer `2' is specific to exon 2. Primer `5' is specific to a 
region in exon 5 and is the reverse primer for each of the three reactions. 201.1g of 
cDNA was used in each PCR reaction. The primers used were Sigma primers. The 
PCR was set to 30 cycles for all three PCR reactions. The PCR products were 
electrophoresed at 100V on an ethidium bromide /1% agarose gel for 1.5 hours. 
The lower panel is a higher exposure of the gel shown in the upper panel to 
























































































































































3.4.3 Expression of Erccl MG #11 in Erccl- deficient murine fibroblasts 
(PF24) - RT -PCR analysis 
The hypothetical result for PF24 fibroblasts transformed with Erccl MG #11 would 
be that only the normal transcript would be expressed. The RT -PCR results for 
fibroblasts transformed with Ercc1 MG #11 are shown in figure 3.11. All four of the 
clones only had positive signals in the 2/5 reactions, indicating that only the normal 
transcript was expressed in the fibroblasts transformed with Ercc1MG #11. There is 
no PCR product from the B/5 reaction, indicating no aberrant upstream transcripts 
are being produced (this relevance of this observation will become apparent when 
these results are compared to keratinocytes transformed with this minigene). When it 
is considered that fibroblasts normally express both transcripts it is surprising that 
lack of the skin specific transcript did not reduce the viability of the transformed 
cells in the UV survival assay (figure 3.7). The UV hypersensitivity of the clones 
transformed with Ercc1MG #11 was just as effectively corrected as the clones 
containing Erccl MG #13 (figures 3.6 and 3.7). 
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Figure 3.11 Expression of Erccl MG #11 in PF24 - RT -PCR 
RT -PCR analysis of RNA extracted from Erccl -null PF24 clones transformed with 
Ercc1MG #11. Total RNA was prepared and reverse transcribed using oligo -dT 
primers. The Erccl cDNA was then PCR amplified from the cDNA pool of each 
clone. Three PCR reactions were performed on cDNA from each clone using the 
following forward primers respectively; primer `A' is specific to a region upstream 
of the normal transcriptional start site, primer `B' is specific to a region upstream of 
the Kpnl restriction site and primer `2' is specific to exon 2. Primer `5' is specific to 
a region in exon 5 and is the reverse primer for each of the three reactions. 
20µg of cDNA was used in each PCR reaction. The primers used were Sigma 
primers. The PCR was set to 30 cycles for all PCRs. The PCR products were 
electrophoresed at 100V on an ethidium bromide /1% agarose gel for 1.5 hours. 
The PCR product in the A/5 lane of clone #14 is likely to be an over -spill from the 











































































































































3.4.4 Expression of Erccl MG #20 in Ercc1- deficient murine fibroblasts 
(PF24) - RT -PCR analysis 
The hypothetical result for PF24 fibroblasts transformed with Erccl MG #20 depends 
upon the importance of the deleted (CT) repeat region to skin transcript expression. 
Assuming that this region is required for correct expression of the skin transcript, 
transformation with this minigene that lacks the region could result in no expression 
of the skin transcript but expression of the normal transcript or reduced expression of 
the skin transcripts with expression of the normal transcript. If this region were not 
required for correct expression of the skin transcript then deletion of the region 
would not impair the ability of transformed cells to express both transcripts. 
RT -PCR results for the clones transformed with Erccl MG #20 are shown in figure 
3.12. The results for the keratinocyte and embryonic cells demonstrate that the 
primers were all functioning correctly in the RT -PCR. Transfection with MG #20 
resulted in mixed expression of the skin specific transcript between clones, indicating 
that the deleted region may be important for correct expression of the skin specific 
transcript. Three clones had product bands for all three reactions while one only had 
a 2/5 signal. In terms of band intensity, only clone #6 had strong bands for all three 
PCR reactions. Two of the clones ( #10 and 12) had weak A/5 bands with strong 2/5 
bands while clone#9 only resulted in a positive signal in the 2/5 reaction. In three of 
the four clones both the skin and normal transcripts were being expressed, as 
indicated by the positive signals for the A/5 and 2/5 reactions. One of the clones, 
clone#9, was only expressing the normal transcript and this pattern was abnormal for 
the cell type. The B/5 reaction was quite variable between clones. The lower levels 
of A/5 reaction product were intriguing, yet when the actual intensity of the bands 
was correlated with UV survival no pattern emerged. In order of decreasing A/5 
band intensity, clone 6 had the highest band intensity and this was followed by 
clones 12 and 10 (equal intensity) and finally clone 9. When the clones are arranged 
in decreasing order for the highest survival at the highest UV dose (figure 3.7) then 
the highest UV survival index percentages were in clone 12 followed by clones 10, 6 
and 9. Although clone 9 did have the lowest band intensity for A/5 and the lowest 
UV survival the UV survival of the other clones did not correlate with the intensity 
107 
of their A/5 bands. As the RT -PCR used was not quantitative, the level of product 
band cannot be equated to the level of transcript. 
Expression of Erccl MG #20 resulted in no skin specific transcript production in one 
of the clones but this did not result in reduced repair of UV hypersensitivity in 
transformed cells. The skin -specific transcript was present in the remaining three 
transformed clones and although the product bands were weak, the UV 
hypersensitivity of these clones was corrected. It appeared that removal of the (CT) 
repeat region may result in reduced expression of the skin transcript, especially in 
clone #9. However, the presence of the (CT) repeat region could not be an absolute 
requirement for skin transcript production as transformed clones #6, 10 and 12 still 
gave positive signals for the A/5 reactions. 
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Figure 3.12 Expression of Erccl MG #20 in PF24 - RT -PCR 
RT -PCR analysis of RNA extracted from Erccl-null PF24 clones transformed with 
Ercc1 MG #20. Total RNA was prepared and reverse transcribed using oligo -dT 
primers. The Erccl cDNA was then PCR amplified from the cDNA pool of each 
clone. Three PCR reactions were performed on cDNA from each clone using the 
following forward primers respectively; primer `A' is specific to a region upstream 
of the normal transcriptional start site, primer `B' is specific to a region upstream of 
the Kpnl restriction site and primer `2' is specific to exon 2. Primer `5' is specific to 
a region in exon 5 and is the reverse primer for each of the three reactions. 
20µg of cDNA was used in each PCR reaction. The primers used were Sigma 
primers. The PCR was set to 30 cycles for all PCR reactions. The PCR products 
were electrophoresed at 100V on an ethidium bromide /1% agarose gel for 1.5 hours. 
The lower panel is a higher exposure of the gel shown in the upper panel to more 
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The three Erccl minigenes are functional in PF24. This is demonstrated by the 
survival of colonies following UV selection post electroporation, as well as by the 
results of the UV survival assays. 
The deletion in Erccl MG #11 did not reduced UV survival in comparison to 
transformation with Erccl MG #13 Similar numbers of colonies survived UV + HAT 
selection post electroporation for the two minigenes. Both corrected UV 
hypersensitivity to a similar extent in the UV survival assays. 
The deletion of the CT repeat region in Erccl MG#20 reduced UV survival in 
comparison to cells transformed with Erccl MG#13. The number of colonies 
surviving UV selection post electroporation was similar between the two minigenes. 
However, the scores for percentage survival index of UV survival curves at the 
higher UV doses of the survival assay was lower in cells transfected with Erccl 
MG#20 than Erccl MG #13, indicating less effective correction of the PF24 UV 
hypersensitivity phenotype by Erccl MG#20 expression. 
The Erccl expression pattern observed in PF24 transformed with the minigenes was 
appropriate for the cell type in 3 of the 4 clones transformed with Erccl MG#13 and 
3 of 4 clones transfected with Erccl MG#20. This result suggested that the CT repeat 
region deleted from MG#20 may be required for correct expression of the skin 
specific transcript as band intensity for the skin-specific transcript product was 
reduced in the RT -PCR but no conclusions may be drawn in the absence of 
quantitative RT -PCR data. The deletion in Ercc1MG#11 meant that it was not 
possible for expression of the 1.5kb transcript to take place so, taking the deletion 
into account, the expression pattern of the 4 clones transfected with Erccl MG#11 




Use of Erccl minigenes to correct UV hypersensitivity 
of Ercc1- deficient Chinese hamster ovary cells 
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4.1 Expression of minigenes in cells which express only the normal 
Erccl transcript 
The main purpose of transfecting cells with the Erccl minigenes was the 
identification of sequences responsible for production of the skin transcript. For 
those experiments cells which would normally express both the normal 1.1kb and the 
skin specific 1.5kb transcripts were utilised. However, it was also important to 
determine if the minigenes would be expressed appropriately in other cell lines, such 
as those that did not normally express the skin transcript. Northern blot analysis by 
Dr. Selfridge (Melton lab.) had identified two cell types that expressed only the 
normal 1.1kb transcript; murine ES cells and Chinese hamster ovary (CHO) cells. 
(Figure 4.1) Since the minigenes were constructed using a murine sequence, an 
Erccl-null murine ES cell line would have been useful for these tests. However, no 
such cell line was available in the Melton lab. 
The human ERCC1 gene was the first mammalian DNA repair gene to be 
discovered. This was by virtue of its ability to complement the UV hypersensitivity 
of the CHO cell line CH043.3B. Using such a cell line would enable to cell type - 
specificity of the minigene expression patterns to be examined. Results would 
indicate whether the minigenes were expressed appropriately in a cell type that does 
not produce the skin specific transcript. Furthermore, the results would demonstrate 
the ability of the minigenes to be expressed in cells from a different species and 
correct the UV sensitivity of the non -murine cells. 
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Figure 4.1 Northern blot analysis of Erccl transcript present in cultured 
cell lines. 
Northern blot analysis of RNA samples from a range of cultured cell lines 
(performed by Dr. Selfridge, Melton Lab.). Total RNA was prepared from a mouse 
embryonic stem cell line (HM -1), a wild -type mouse fibroblast cell line (PF20), an 
Erccl null fibroblast cell line (PF24), a wild -type Chinese hamster ovary cell line 
(CHO9), an Erccl null Chinese hamster ovary cell line (CHO43.3B), a wild -type 
mouse keratinocyte cell line (Ker. ( +/ +)) and an Erccl null mouse keratinocyte cell 
line, Ker. ( -/ -). 
RNA was electrophoresed through a 1.4% agarose -formaldehyde gel, transferred 
onto a nylon membrane and probed with an 800bp BamHI fragment of the Erccl 

































































4.2 Basis of Ercc1- deficiency in CH043.3B (TG #1) 
Fortuitously, a spontaneously occurring CH043.3B derived cell line was available, 
CH043.3B (TG #1). This cell line was both Erccl and Hprt deficient, enabling the 
same selection regime to be adopted following minigene transfection as in the 
fibroblast experiments. CH043.3B cells have a non -conservative point mutation that 
results in an amino acid substitution at the 98th Erccl residue. The cells are deficient 
in Erccl protein but do produce normal levels of the 1.1kb transcript (see figure 4.1) 
(Hayashi et al, 1998). This transcript was detectable on northern blots. The Erccl 
transcript produced by the Erccl knockout cells has aberrant splicing because a neo 
cassette disrupts exon 5. The RT -PCR assay used to detect Erccl transcripts was 
designed specifically to distinguish between transcripts produced from minigene 
expression/normal expression and the endogenous transcript found in the Erccl 
knockout CH043.3B cells. The transcript in the CH043.3B cells does not contain 
the sequence homology to primer 5 of the RT -PCR reaction. 
4.3 Correction of UV hypersensitivity of Ercc1- deficient CH043.3B 
(TG #1) transformed with Ercc1 MG #13, 20 and 11 
As the wild type CHO cell line, CHO9, normally expresses the 1.1kb Erccl 
transcript and very low levels of the 1.5kb transcript, transfection of CH043.3B 
(TG #1) with Erccl MG #13 should primarily result in production of the 1.1kb 
transcript if the minigene is expressed appropriately for the cell type. 
Colony counts following transfection would demonstrate that the control (Hprt only 
cells) would have few, if any, colonies following UV/HAT co- selection whereas 
cells transformed with MG and Hprt DNA would survive and give rise to numerous 
colonies. Clones for subsequent UV survival studies were selected from the 1X105 
dishes as this plating density resulted in discrete colonies. 
Table 4.1 shows the number of colonies /dish for a plating density of 1X105. 
Colonies were counted following selection with HAT or co- selection with HAT and 
UV. The ratio of HAT +UV selected colonies to HAT only selected colonies is shown 
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to indicate the ratio of cells surviving co- selection to those surviving HAT only 
selection. The ratio of HAT +UV selected colonies to HAT selected colonies was 
similar between the three minigenes, as were the colony numbers. 
Table 4.1 Colony counts following Ercc1- minigene -transfection and 
HAT /UV selection in Ercc1- deficient CHO43.3B (TG #1) cells 
Number of colonies /petri dish for plating density of 1X105. Colonies were counted 
following selection with HAT or co- selection with HAT + UV. UV colony numbers 
are an average of 2 dishes. The ratio of HAT + UV selected colonies to HAT only 
selected colonies is shown to indicate the ratio of cells surviving co- selection to those 







following HAT +UV 
selection 
Ratio of HAT +UV 
selected colonies to 
HAT selected 
colonies 
Erccl MG #13 + 
pBT /PGK -Hprt 
13 (n =3) 
Range 7 -24 
SD ± 7.6 
SE 4.4 
0.433 
Erccl MG #11 + 
pBT /PGK -Hprt 
57 23 (n =3) 
Range 16-27 
SD ± 4.8 
SE 2.8 
0.404 
Erccl MG #20 + 
pBT /PGK -Hprt 
36 22 (n =3) 
Range 16-27 
SD ± 4.6 
SE 2.7 
0.611 
pBT /PGK -Hprt 59 (n =2) 
Range 54 -64 
SD ± 5 
SE 3.5 
0.5 (n =2) 
Range 0 -1 




Note: Without repeating the experiment with a greater number of dishes plated with 
cells for each transfection, it is not possible to comment upon the statistical 
significance of the differences in the ratio of HAT +UV to HAT selected colonies. It 
is possible that although the ratio of HAT + UV selected to HAT selected colonies in 
cells transformed with MG #11 and MG #20 is lower than that of the cells transformed 
with MG #13 this may not be statistically significant. 
4.3.1 Correction of UV hypersensitivity in CHO43.3B (TG #1) transformed 
with Erccl MG #13 
As in the fibroblast experiments, cells were co- transfected with a 3:1 ratio of Notl 
linearised Erccl MG #13 and the PGK driven Hprt minigene, pBT /PGK -Hprt. Post 
transfection, cells were left overnight to settle in a non -selective medium. The 
growth media was changed 24 hours post electroporation to HAT medium to kill 
non-pBT/PGK- Hprt transfected cells and a subset of dishes were additionally 
exposed to a UV dose of 7.5Jm 2. Due to the ratio of DNA used in the transfection, 
cells that survived this selection were likely to also contain the Erccl MG #13. 
Colonies were picked following this selection regime. Four of the colonies were 
expanded for use in UV survival studies. The UV survival studies were performed as 
with the fibroblasts but the plating density was lower in this experiment because of 
the rapid growth rate of the CHO cells; 2X104 cells were plated/30mm petri dish and 
allowed to settle overnight to adhere to the dishes in a uniform layer. The following 
morning the cells were irradiated with various UV doses. The dishes were then 
cultured until the control dishes, which had not been UV irradiated, became 
confluent. The dishes were then fixed and stained for quantification of UV survival. 
The UV survival curves are shown in Figure 4.2. 
When the controls are examined the UV hypersensitivity of the non- transfected 
CHO43.3B (TG #1) control is apparent when the survival curve is compared to that 
of the wt CHO9. The percentage of cells surviving rapidly decreases with increasing 
UV dose in the non -transformed CHO43.3B (TG #1) sample, with survival index 
percentages of 63 and 47% for the low UV doses of 1.25 and 2.5Jm 
2 dropping to 27, 
15.2 and 2% for the higher doses of 3.75, 5, 7.5 and IOJm 2. The D50 value for the 
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non -transformed CH043.3B (TG #1), the dose at which only 50% of the cells 
survive, is merely 2.2Jm 2 while neither the wt CHO9 nor all bar one of the 
transfected clones drop as low as 50% survival for even the highest UV dose of 
10J/m-2. The survival curve of the wt CHO9 shows high resistance to UV with 95, 
93, 81 and 70% survival for the highest UV doses of 3.75, 5, 7.5 and 10Jm 2. Three 
of the Erccl MG #13 transformed clones had survival curves which were very similar 
to that of the wt CHO9. For those respective UV doses, clone 10 had survival values 
of 88, 89, 81 and 70 %; clone #4 had survival values of 103, 93, 95 and 89% and clone 
#9 had survival values of 96, 93, 90 and 90 %. One clone, clone #3, had an unusual 
curve that lay between that of the wt and null controls. Survival values for the higher 
doses of 3.75, 5, 7.5 and 10Jm 2 were 44, 27, 15 and 9 %, much lower than the other 
clones. There was partial correction of UV sensitivity by Erccl MG #13 transfection 
with clone #3 but the other clones showed complete correction of UV 
hypersensitivity. However, transfection with Erccl MG #13 generally rescued the UV 
hypersensitivity of the CH043.3B (TG #1) cells to wild type levels and, therefore, 
resulted in production of functional protein in a cell line from a non -murine species. 
The RT -PCR results would reveal whether the unusual UV survival curve of clone 
#3 was due to unusual Erccl expression. 
In figure 4.2, the error bars of clone 3 do not overlap with the other clones. When 
tested using a two -tailed t -test, the difference between clone 3 and clone 4 at a UV 
dose of 10 Jm 2 is extremely significant (P= 0.005). At the same UV dose, there is 
also an extremely significant difference between clone 3 and clone 9 (P= 0.0001) and 
a very statistically significant difference between clone 3 and clone 10 (P= 0.0038). 
The error bars of clone 3 and the other clones do not overlap even at lower UV 
doses, indicating that clone 3 is atypical of the clones transfected with MG #13. 
When clone 3 is compared to untransfected cells at the UV dose of 7.5 Jm 2 there is a 
very statistically significant difference (P= 0.0096), indicating that the clone has a 
greater resistance to UV than the untransfected cells at this dose, but the error bars 
almost overlap at the lower doses. Clone 3 was more like the untransfected cells 
that the transfected clones and this suggests that the minigene may not have 
integrated properly into this clone or was not being correctly expressed. 
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Figure 4.2 Correction of UV hypersensitivity of Ercci- deficient 
CH043.3B (TG #1) following transfection with Erccl minigene #13 
The UV survival curves for wild type (CHO9) and Erccl- deficient CH043.3B 
(TG# 1) and four minigene- positive CH043.3B (TG# 1) clones are shown. The 
experiment was performed in duplicate and the mean value is shown for each point. 
Circle, non -transformed CH043.3B (TG #1); inverted triangle, CHO9; diamond, 
clone #3; hexagon, clone #10; triangle, clone#9; square, clone #4. 
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4.3.2 Correction of UV hypersensitivity in CH043.3B (TG #1) transformed 
with Erccl MG #11 
Ercc1 MG #11 does not contain any of the sequence upstream of the Kpnl restriction 
site, meaning that is does not contain the area likely to contain the skin specific 
transcript's promoter. Since wt CHO cells normally make only the normal, 1.1kb, 
transcript this deletion should not adversely affect production of the normal 
transcript. 
The transfection and UV survival assays were performed as with the Erccl MG #13 
transfection. The controls shown in Figure 4.3 are the same as in Figure 4.2 For ease 
of comparison the survival values of the CHO9 control at UV doses of 3.75, 5, 7.5 
and 10Jm 2 were 95, 93, 81 and 70% respectively while the survival values of the 
CH043.3B (TG #1) control for those UV doses were 27, 5, 2 and 2 %. The survival 
curves of the CH043.3B (TG #1) clones transfected with Ercc1MG #11 are very 
similar to that of the wt CHO9 curve. The lowest survival recorded in a transfected 
clone was 66% for the highest UV dose of 10 Jm 2 for Ercc1MG #11 clone #6. 
The survival values of clone #2 for the higher UV doses of 3.75, 5, 7.5 and 10.1m-2 
were 96, 87, 85 and 79% respectively; the survival index percentages of clone #6 for 
those values were 80, 85, 67 and 66 %; for clone #5 the survival index percentages 
were 99, 90, 87 and 76% while for clone#9 the survival index percentages were 88, 
76, 93 and 89% respectively. Transfection with Ercc1MG #11 was, therefore, 
resulting in production of a functional Erccl protein that corrected the UV 
hypersensitivity of the CH043.3B (TG #1) cells. This demonstrated that the 
minigene was being expressed in cells from a non -murine species. RT -PCR analysis 
would reveal whether transcript production was appropriate for the cell type. 
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Figure 4.3 Correction of UV hypersensitivity of Erccl- deficient 
CH043.3B (TG #1) following transfection with Erccl minigene #11 
The UV survival curves for wild type (CHO9) and Erccl deficient CH043.3B 
(TG #1) and four minigene- positive CH043.3B (TG #1) clones are shown. The 
experiment was performed in duplicate and the mean value is shown for each point. 
Circle, CH043.3B (TG #1); inverted triangle, CHO9; diamond, clone #5; hexagon, 
clone#9; triangle, clone #6; square, clone #2. 
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4.3.3 Correction of UV hypersensitivity in CH043.3B (TG #1) transformed 
with Erccl MG #20 
Erccl MG #20 does not contain the (CT) repeat region that may be involved in 
initiating production of the 1.5kb skin specific Erccl transcript. As the wt CHO cells 
only produce the 1.1kb transcript the same considerations apply as when the cells 
were transfected with Ercc1 MG #11. Lack of sequences required for production of 
the skin specific transcript should not adversely effect the transformed cells since 
only the sequence for production of the normal transcript is required in this cell type. 
The normal transcript should be sufficient to correct the hypersensitivity of the cell 
line. 
As before, the controls had the following UV survival index percentages for UV 
doses of 3.75, 5, 7.5 and 10Jm 2. CHO9 had survival index percentages of 95, 93, 81 
and 70% respectively. The CH043.3B (TG #1) control had survival values of 27, 15, 
2 and 2 %. The survival values of the clones did not drop below 50 %, even at the 
highest UV dose of 10 Jm 2. For UV doses of 3.75, 5, 7.5 and 10Jm 2, clone #1 had 
survival values of 103, 97, 96 and 87 %, clone #1 had survival values of 104, 98, 84 
and 70 %, clone #17 had values of 100, 94, 104 and 53% while clone #18 had values 
of 99, 92, 88 and 83 %. The survival curves of the clones were very similar to that of 
the wt CHO9 curve, demonstrating correction of UV hypersensitivity by transfection 
with Erccl MG #20. Functional Ercc 1 protein was, therefore, being produced 
following transfection. RT -PCR analysis would enable identification of the 
transcripts being produced to investigate if the minigene was being expressed 
appropriately for the cell type. 
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Figure 4.4 Correction of UV hypersensitivity of Erccl deficient 
CH043.3B (TG #1) following transfection with Erccl minigene #20 
The UV survival curves for wild type (CHO9) and Erccl- deficient CH043.3B 
(TG #1) and four minigene- positive CH043.3B (TG #1) clones are shown. The 
experiment was performed in duplicate and the mean value is shown for each point. 
Circle, CH043.3B (TG #1); inverted triangle, CHO9; diamond, clone #13; hexagon, 
clone #18; triangle, clone #14; square, clone #1. 
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4.4 Expression of minigenes in Ercc1 deficient CH043.3B (TG #1) - RT- 
PCR analysis 
RT -PCR analysis was required to show which transcripts were being expressed by 
the transformed cells and the resulting transcript detection using RT -PCR would 
indicate if the minigenes were being expressed appropriately for the cell type. 
4.4.1 Expression of Erccl MG #13 in Erccl deficient CH043.3B (TG #1) - RT- 
PCR analysis 
Identification of the transcripts produced following transfection with Erccl MG #13 
is of particular interest in this cell type as it would show whether the transcripts 
produced were appropriate for the cell type. As wild type CHO cells normally only 
produce the 1.1kb transcript from their endogenous gene the hypothetical result 
would be a product from only the 2/5 primer pair. 
When RT -PCR was performed upon RNA extracted from CH043.3B (TG #l) cells 
transfected with Erccl MG #13 the expression pattern was not as expected for the cell 
type (see fig. 4.5). All four of the clones are expressing the minigene as all have a 
product from the 2/5 reaction. However, very pale A/5 bands are apparent in clones 
4, 9 and 10 and there is a strong A/5 band in clone 3. The A/5 reaction product 
indicated the presence of the skin -specific Erccl transcript. CHO cells should not 
produce the 1.5kb transcript. Therefore, this expression pattern detected in the 
transformed clones is abnormal for this cell type. Because the expression patterns of 
the controls, Ker. ( + / +) and HM -1 are correct, the abnormal pattern in the 
transformed clones is not an artefact of the reaction. Very pale B/5 product bands 
are apparent in clones 3 and 9 and these can be seen in the brighter image. It is likely 
that the skin -specific transcript is being expressed at low levels because of the very 
pale A/5 bands and the lack of a B/5 product in two of the clones. The B/5 reaction 
is not as efficient as the A/5 reaction and this means that if there is a low level of 
transcript then it is more likely to be detected by the A/5 reaction. The UV 
hypersensitivity was corrected back to wild type levels in clones, 4, 9 and 10 and was 
partially corrected in clones #3. 
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Figure 4.5 Expression of Erccl MG #13 in CH043.3B (TG #1) - RT -PCR 
RT -PCR analysis of RNA extracted from Erccl- deficient CH043.3B (TG #1) clones 
transformed with Ercc1 MG #13. Total RNA was prepared and reverse transcribed 
using oligo -dT primers. The Erccl cDNA was then PCR amplified from the cDNA 
pool of each clone. Three PCR reactions were performed on cDNA from each clone 
using the following forward primers respectively; primer `A' is specific a region 
upstream of the normal transcriptional start site, primer `B' is specific to a region 
upstream of the Kpnl restriction site and primer `2' is specific to exon 2. Primer `5' 
is specific to a region in exon 5 and is the reverse primer for each of the three 
reactions. 
201.ig of cDNA was used in each PCR reaction. The PCR was set to 30 cycles for all 
three primer pairs. The PCR products were electrophoresed at 100V on an ethidium 
bromide /1% agarose gel for 1.5 hours. 
The lower panel is a higher exposure of the gel shown in the upper panel and more 
clearly shows the presence of a PCR product in the A/5 reactions of clones 4, 9 and 






















































































































































































4.4.2 Expression of Erccl MG#1 1 in Erccl- deficient CH043.3B (TG #1) - RT- 
PCR analysis 
Because of the deletion in Ercc1MG #11 it is not possible for transfection to result in 
production of the 1.5kb transcript. As CHO cells normally only produce the 1.1kb 
transcript, expression of the minigene in this cell type should result in a situation 
which matches the wild type pattern. It is possible that the region deleted may be 
required for correct expression of the normal transcript as it could have a controlling 
function. Therefore, deletion of the region upstream of the Kpnl site could also lead 
to abnormal Erccl expression in transformed cells. If the minigene is functional then 
the hypothetical result for the RT -PCR is product from only the 2/5 reaction. 
When RT -PCR was performed upon RNA extracted from CH043.3B (TG #1) cells 
transfected with Erccl MG #11 the expression pattern was as expected for the cell 
type (see fig. 4.6). All four of the clones are expressing the minigene as all have a 
product from the 2/5 reaction. The expression patterns of the controls, Ker. +/+ and 
HM -1, are correct. The level of Erccl expression following transfection with 
Ercc1MG #11 and detected by RT -PCR was sufficient to correct the UV 
hypersensitivity of the cells to wild type levels (see fig. 4.3). 
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Figure 4.6 Expression of Erccl MG #11 in CH043.3B (TG #1) - RT -PCR 
RT -PCR analysis of RNA extracted from Erccl- deficient CH043.3B (TG#1) clones 
transformed with Ercc1MG #11. Total RNA was prepared and reverse transcribed 
using oligo -dT primers. The Erccl cDNA was then PCR amplified from the cDNA 
pool of each clone. Three PCR reactions were performed on cDNA from each clone 
using the following forward primers respectively; primer `A' is specific a region 
upstream of the normal transcriptional start site, primer `B' is specific to a region 
upstream of the Kpnl restriction site and primer `2' is specific to exon 2. Primer `5' 
is specific to a region in exon 5 and is the reverse primer for each of the three 
reactions. 
201.1g of cDNA was used in each PCR reaction. The PCR was set to 30 cycles for all 
three primer pairs. The PCR products were electrophoresed at 100V on an ethidium 





































































































































































4.4.3 Expression of Erccl MG #20 in Ercc1- deficient CH043.3B (TG #1) - RT- 
PCR analysis 
Identification of the transcripts produced following transfection with Erccl MG #20 
is interesting because the deleted CT repeat region may be important for correct 
expression of Erccl. As CHO cells normally only produce the 1.1kb transcript the 
hypothetical result would be a product from only the 2/5 primer pair. However, if 
the (CT) repeat region is required for control of 1.5kb transcript production then it is 
possible that abnormal production of transcripts may be detected following 
transfection with this minigene. 
When RT -PCR was performed upon RNA extracted from CH043.3B (TG #1) cells 
transfected with Erccl MG #20 the expression pattern was not as expected for the cell 
type in 3 of the 4 clones (see fig. 4.7). All four of the clones are expressing the 
minigene as all have a product from the 2/5 reaction. However, pale A/5 bands are 
apparent in clones #1, #13 and #14. The A/5 reaction product indicated the presence 
of the skin -specific Erccl transcript. Therefore, this expression pattern detected in 
clones #1, #13 and #14 of the cells is abnormal for this cell type. This aberrant 
expression pattern was also observed in the clones transfected with Erccl MG #13. 
CHO cells should not produce the 1.5kb transcript. Because the expression patterns 
of the controls, Ker. +/+ and HM -1, are correct the abnormal pattern in the 
transformed clones is not an artefact of the reaction. There are no B/5 product bands. 
It is likely that the skin -specific transcript is being expressed at low levels because of 
the pale A/5 bands and the lack of a B/5 product for those clones which have A/5 
bands. The B/5 reaction is not as efficient as the A/5 reaction and this means that if 
there is a low level of transcript then it is more likely to be detected by the A/5 
reaction. 
The clones with A/5 bands, clone #1, #13 and #14 had UV survival curves which 
clustered around the wild type pattern and the hypersensitivity of clone #18, which 
had the correct pattern of expression for the cell type, was as effectively corrected by 
the MG expression as the three clones which had abnormal 1.5kb transcript 
production. This suggests that the expression of the 1.5k transcript did not confer a 
survival advantage upon the clones in comparison to the clone with only the 1.1kb 
transcript. 
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Figure 4.7 Expression of Erccl MG #20 in CH043.3B (TG #1) - RT -PCR 
RT -PCR analysis of RNA extracted from Erccl- deficient CH043.3B (TG #1) clones 
transformed with Ercc1 MG #20. Total RNA was prepared and reverse transcribed 
using oligo -dT primers. The Erccl cDNA was then PCR amplified from the cDNA 
pool of each clone. Three PCR reactions were performed on cDNA from each clone 
using the following forward primers respectively; primer `A' is specific a region 
upstream of the normal transcriptional start site, primer `B' is specific to a region 
upstream of the Kpnl restriction site and primer `2' is specific to exon 2. Primer `5' 
is specific to a region in exon 5 and is the reverse primer for each of the three 
reactions. 
20µg of cDNA was used in each PCR reaction. The PCR was set to 30 cycles for all 
three primer pairs. The PCR products were electrophoresed at 100V on an ethidium 





























































































































































Transfection with Erccl minigenes #13, #11 and #20 resulted in correction of the UV 
hypersensitivity of the CHO43.3B (TG #1) cell line and, by definition, in production 
of functional Ercc 1 protein in cells from a non -murine species. However, RT -PCR 
analysis revealed that the expression patterns of the minigenes were variable. 
In the case of Ercc1MG #11 it was not possible to produce skin transcripts as the skin 
TSS is missing in this minigene. As expected, only the 1.1kb transcript was present 
in cells transfected with Ercc1MG #11. Correct expression of Erccl MG #13 and #20 
would have resulted in production of only the 1.1kb transcript. However, the clones 
transfected with Erccl MG #13 had abnormal Erccl transcript production for the cell 
type (fig. 4.5). In the case of transfection with MG #13 expression of the skin 
specific transcript was variable. Erccl MG #13 was correctly expressed in clone #9 
However, in clones #3 and #4 and #9, cells that should only express the 1.1kb 
transcript were expressing both the normal and skin transcripts, the band intensity 
was very low in comparison to the control Ker. (+1+). There is, therefore, some 
semblance of the transfected cells retaining specificity of Erccl expression 
appropriate for the cell type since in the clones expressing skin = specific transcript in 
most cases product was absent in the B/5 reaction, indicating likely low levels of 
skin -specific transcript expression. 
These results could be interpreted in a number of ways. Firstly, the minigenes did 
result in production of functional Erccl as the UV hypersensitivity of the CHO43.3B 
(TG #1) cells was corrected. This was a promising result as it indicated that the 
minigenes were functional in cells from a non -murine species. However, 1.5kb 
transcripts were produced at low levels in all four of the clones transformed with 
Erccl MG #13 and 3 of the 4 clones transformed with Erccl MG #20. It was a 
possibility that the UV selection regime following transformation could be resulting 
in a bias towards clones with abnormal Erccl expression. Perhaps abnormal Erccl 
expression, the presence of 1.5kb transcripts, was required to survive the UV 
selection regime. It was a possibility that had to be explored so alterations were 
made to the experimental technique in the following keratinocyte transformations. 
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Clones were selected having been co- selected with HAT and UV as in previous 
experiments but in these experiments only HAT selection was applied to some dishes 
following electroporation to discover if there was any difference between those 
selected by either method at the UV survival and RT -PCR analysis. 
In addition, it was possible that the clones being selected were not representative of 
the entire population of transformed cells. To address this possibility, cells were 
plated following electroporation and the transformed cells were treated as pools as 
well as selecting individual colonies for study. 
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Chapter 5 
Use of Erccl minigenes to correct UV hypersensitivity of 
Ercc1- deficient keratinocytes 
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5.1 Expression of minigenes in cells which normally have a high skin - 
specific to normal transcript ratio 
Transformation of the Erccl- deficient fibroblasts demonstrated that the minigenes 
were functional in a murine cell line that normally expressed both transcripts. 
However, the fibroblast pattern of Erccl expression, although similar to that of skin, 
is not identical. The murine skin Erccl expression pattern has a high skin specific 
(1.5kb) to normal (1.1kb) Erccl transcript ratio. Fortunately a suitable cell line was 
available for further investigation of the importance of various sequences to the 
control of the skin specific expression pattern. Dr. Selfridge (Melton Lab.) had 
demonstrated by northern blot that cultured wild type murine keratinocytes have an 
identical Erccl expression pattern to that of skin (fig. 4.1). Erccl- deficient murine 
keratinocytes had previously been isolated and were also Hprt -deficient. This made 
them ideal candidates for use in the minigene transfection experiments as the Hprt 
status of the cells meant that the same co- transfection method could be performed as 
in the fibroblast and CHO experiments. 
Keratinocytes are technically more demanding to culture than the other cell types 
studied. This meant that some changes were required at the stage where transformed 
clones were selected because these cells do not grow well at low densities. The cells 
also require specially treated growth media and trypsinisation conditions. The slow 
growth rate of the cells increases the time spent expanding cell numbers and this 
increase the risk of fungal contamination. Keratinocytes originate from the 
epidermal layer and are more resistant to UV than fibroblasts and CHO cells. This 
meant that higher UV doses were required in the UV survival experiments before any 
lethal effects were apparent. 
To further investigate the possibility that the UV selection regime following 
transfection could be favouring clones with abnormal minigene expression a second 
component was added to the UV survival experiments. As well as subjecting 
transformed clones to selection by HAT and UV prior to the UV survival 
experiments, a subset of clones had HAT selection only. In tandem with this, for 
each of the two selection conditions mentioned, pools of cells were subjected to the 
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same treatment. These pools were to be representative of entire transformed cell 
populations. Differences between the results for the UV survival and RT -PCR with 
HAT versus HAT + UV selection and for pools versus clones would assist in 
determining if the UV selection following transformation was causing clones 
expressing the minigenes abnormally to be favoured. 
Following the UV survival experiments with the clones and pools, pools which had 
undergone HAT only selection following transfection were compared to pools which 
had undergone HAT + UV selection by means of RT -PCR. The Erccl MG #20 pool 
which had been subjected to HAT only selection was then repeatedly irradiated with 
UV to find if this would induce a change towards the Erccl expression pattern of the 
pools which had undergone UV and HAT selection following transfection. 
5.2 Number of colonies comprising keratinocyte pools 
The number of colonies in each pool of transformed cells in shown in table 5.1. For 
each minigene there were two pools that had either undergone selection by HAT only 
following electroporation, or HAT and UV selection. The number of colonies was 
counted before the cells were trypsinised from the original plating dishes to be 
expanded in flasks for UV survival assays and RT -PCR. For each minigene the co- 
selection results in fewer colonies surviving than the HAT selection alone. There 
was a large difference between the ratio of HAT +UV selected colonies to HAT 
selected colonies between pools transformed with Erccl MG #13 and #20 when 
compared to the ratio seen in cells transformed with Ercc1MG #11. The ratio of 
HAT + UV selected colonies to HAT selected colonies in the MG #11 pool was only 
0.483, demonstrating that transfection with Ercc1MG #11 did not correct the UV 
hypersensitivity of the cells as well as transfection with Erccl MG #13 and #20. 
For minigene 13 there were 163 fewer colonies in the HAT +UV pool (total of 501 
colonies) than the HAT only pool (664 colonies). In the cells transformed with 
Ercc1 MG #11 there were 513 fewer colonies in the HAT +UV pool (554 colonies) 
than the HAT only pool (1057 colonies). In the cells transformed with Ercc1 MG #20 
there were 222 fewer colonies in the HAT +UV pool (976 colonies) than the HAT 
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only pool (1198 colonies). The difference between the two selection regimes is an 
indication of how often the pBT /PGK -Hprt minigene alone transforms a cell during 
electroporation in comparison to how often both the pBT/PGK -Hprt minigene and an 
Erccl minigene are actually incorporated. This is because selection with HAT 
removes cells that do not contain the pBT /PGK -Hprt minigene while co- selection 
with HAT and UV removes cells which do not contain both pBT /PGK -Hprt and an 
Erccl minigene. 
Table 5.1 Colony counts following Erccl- minigene -transfection and 
HAT /UV or HAT only selection in Erccl- deficient keratinocyte pools. 
For each minigene there are two pools - one that underwent HAT selection and one 
that was HAT +UV. The plating density was 3.75x105 cells per dish. In each row of 
the table, details of the Erccl MG, selection regime and the total number of colonies 
comprising the pool is shown. 
Electroporation 
DNA 








Ratio of HAT + 
UV selected 
colonies to HAT 
selected colonies 
Erccl MG #13 + 
pBT/PGK -Hprt 
664 501 0.755 
Erccl MG#11 + 
pBT/PGK -Hprt 
1057 511 0.483 
Erccl MG#20 + 
pBT/PGK -Hprt 
1198 976 0.815 
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5.3 Correction of UV hypersensitivity of Erccl- deficient murine 
keratinocytes with Erccl minigenes 
As mentioned earlier, the pattern of Erccl expression that is observed in wild type 
murine keratinocytes is identical to that of skin, as keratinocytes have a high skin 
specific to normal transcript ratio. Hypothetically, transfection of Erccl- deficient 
murine keratinocytes with Erccl MG #13 should result in the wild type pattern of 
expression if the minigene is fully functional in the cultured keratinocytes. As in the 
previous experiments, the Erccl -deficient keratinocytes were co- transfected with 
Erccl MG #13 and pBT /PGK -Hprt at a 3:1 DNA ratio. The vector DNA had been 
linearised with Notl prior to transfection. Following transfection the cells were left 
to settle and adhere to the surface of the petri dishes overnight. 24 hours post 
electroporation the medium was replaced with selective HAT medium to prevent 
growth of cells that had not been transfected with the pBT /PGK -Hprt minigene. Due 
to the 3:1 ratio of Erccl to pBT /PGK -Hprt DNA the cells that survived this selection 
were likely to also contain the Erccl MG #13. At this stage half of the dishes also 
underwent UV selection. Clones were picked from dishes that had had HAT only or 
HAT +UV selection and entire pools of transformed cells were also cultured from 
dishes that had had either treatment. These pools and clones (following expansion) 
were then used in UV survival assays and the minigene expression patterns were 
investigated using RT -PCR. 
5.3.1 Correction of UV hypersensitivity of Ercc1- deficient murine keratinocyte 
clones following transfection with Ercc1 MG #13 
Assuming that Erccl MG #13 has all the sequence elements for correct expression 
ofErccl, transformation of Erccl null keratinocytes should lead to correction of UV 
hypersensitivity and an expression pattern that matches that of wild type 
keratinocytes. 
Following electroporation, five colonies from two selection regimes were expanded 
for use in UV survival studies. 4X104 cells were plated/30mm petri dish and allowed 
to settle overnight, to adhere to the dishes in a uniform layer. The following morning 
the cells were irradiated with various UV doses. The dishes were then cultured until 
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the control dishes, which had not been irradiated, became confluent. The dishes 
were then fixed and stained for quantification of survival. The UV survival curves 
for wild type (Ker. + / +), Erccl- deficient (Ker. -/ -) murine keratinocytes, three clones 
which had HAT selection only following transfection (clones 1, 2, 3) and two clones 
which had HAT and UV selection (clones 5 and 7) are shown in figure 5.1. 
When the controls are examined the 11V hypersensitivity of the Erccl- deficient 
keratinocyte (Ker.( -/ -)) control is obvious when compared to that of the wild type 
keratinocytes (Ker.( + / +)) . The percentage of cells surviving rapidly decreases in the 
Ker.( -/ -) sample, with survival index percentages of 96 and 14% for the low UV 
doses of 5 and l OJm 2 dropping to I% for the higher dose of 20.1m-2 . The D50 value 
for the Ker.( -/ -), the dose at which only 50% of the cells survive, is 6.5 Jm-2. In 
contrast, the wild type keratinocytes show the expected resistance to UV irradiation, 
with 97 and 113% survival at the lower UV doses of 5 and 10Jm 2 and 106% survival 
at 20 Jm 2. The survival index score does not drop as low as 50% over the UV dose 
range of the experiment. All the clones transfected with Erccl MG #13 show 
corrected UV sensitivity with the survival curves shifted towards the wild type curve. 
The clones that underwent HAT selection only following transfection had the 
following survival index percentages for the UV doses of 6, 10, 15 and 20 Jm 2; 
Erccl MG #13 clone 1 had 100, 77, 48 and 37% respectively (D50 valuel3 Jm 2), 
Erccl MG #13 clone 2 survival index percentages for those doses were 99, 102, 76 
and 55% (D50 value 19 Jm 2) and Erccl MG #13 clone 3 had survival index 
percentages of 94, 96, 75 and 50% (D50 valuel8 Jm 2). The mean survival of the set 
of clones selected with HAT is similar to that of the set of clones selected with 
HAT +UV, indicating little difference in the UV resistance of the clones resulting 
from the two selection regimes. The survival index percentages of the HAT + UV 
selected Erccl MG #13 clone 7 for UV doses of 6, 10, 15 and 20 Jm 2 are 108, 93, 74 
and 45% respectively (D50 value 17.5 Jm 2), while those of Erccl MG #13 clone 5 are 
92, 72, 51 and 23% respectively (D50 value 13 Jm 2). The average D50 value for the 
clones which were HAT only selected following transfection is 16.7 Jm 2 while the 
average D50 value for the clones that underwent HAT and UV selection post 
transfection is 15.3 Jm 2. 
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These survival curves show that transfection with Erccl MG #13 corrected the UV 
hypersensitivity of the keratinocytes and that selection with HAT + UV following 
transfection did not lead to selection of clones with a greater ability to repair UV 
damage than clones which had not undergone UV selection post transfection. RT- 
PCR analysis was required to investigate which transcripts the transfected clones 
were producing. 
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Figure 5.1 Correction of UV sensitivity of clones of Erccl-null 
keratinocytes (Ker.( - / -) following transfection with Erccl MG #13 
The UV survival curves for wild type (Ker. + / +), Erccl- deficient (Ker. -/ -) murine 
keratinocytes, three clones which had HAT selection only following transfection 
(clones 1, 2, 3 - in red) and two clones which had HAT and UV selection (clones 5 
and 7 - in blue) are shown. Pink, Ker.( -/ -); green Ker.( + / +); red, clones from HAT 
only selection regime; blue, clones from HAT +UV selection regime. Each UV point 
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5.3.2 Correction of UV hypersensitivity of Ercc1- deficient murine keratinocyte 
pools following transfection with Erccl MG #13 
The survival curves of the pools of clones transfected with Erccl MG #13 that 
underwent either HAT or HAT and UV selection post transfection are shown in 
figure 5.2. The number of colonies from each selection regime that went into each 
pool are shown in Table 5.1. The survival curves of the two pools show correction 
of UV hypersensitivity by transfection with Erccl MG #13. The survival index 
percentages for the pool that underwent HAT only selection following minigene 
transfection (HAT pool) had the following survival index percentages of 93, 89, 83 
and 72% for UV doses of 6, 10, 15 and 20 Jm 2. The survival index percentages for 
the pool that underwent HAT and UV selection following transfection for the same 
UV doses are 134, 108, 77 and 88% respectively. As the survival of the two pools 
did not fall as low as 50% over the UV range of the experiment it is not possible to 
calculate D50 values. The survival curves of the two pools overlap in parts so both 
pools have very similar DNA repair ability. 
The UV survival curves of both the clones and pools are shown in figure 5.3. When 
the survival curves of the clones are compared to those of the pools, the survival 
curves of the pools transfected with Erccl MG #13 overlap with those of the clones at 
low doses. When the HAT selected pool is compared to the mean of the HAT 
selected clones at UV dose 20 Jm 2 via two -tailed t -test, there is a very statistically 
significant difference (P = 0.0085). At lower UV doses the error bars overlap and at 
UV dose 10 .1m-2 the difference is not statistically significant (P= 0.8090), indicating 
that the difference in survival only manifested at the highest UV dose. When the 
HAT + UV selected pool is compared to the mean of the HAT + UV selected clones 
at UV dose 20 Jm-2 via two -tailed t -test, there is a very statistically significant 
difference (P = 0.0042). At lower UV doses the error bars overlap and at UV dose 
10 Jm 2 the difference is not statistically significant (P= 0.1778), indicating that the 
difference in survival only manifested at the highest UV dose. It is possible that the 
mixed population of the pools had slightly greater resistance to UV than the uniform 
cells of the clones. 
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Figure 5.2 Correction of UV sensitivity of pools of Erccl -null 
keratinocytes Ker.( -/ -) following transfection with Erccl MG #13 
The UV survival curves for wild type (Ker. + / +), Erccl- deficient (Ker. -/ -) murine 
keratinocytes, one pool which had HAT selection only following transfection with 
MG #13 (pool HAT) and one pool which had HAT and UV selection (pool HAT + 
UV) are shown. Each UV point represents the mean of two separate experiments. 
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Figure 5.3 Correction of UV sensitivity of clones and pools of Ercc1 -null 
keratinocytes Ker.( - / -) following transfection with Erccl MG #13 
The UV survival curves for wild type (Ker. + / +), Erccl- deficient (Ker. -/ -) murine 
keratinocytes, one pool plus three clones (clones, 1, 2 and 3) which had HAT 
selection only following transfection with MG #13 are shown in red. One pool plus 2 
clones (clones 5 and 7) which had HAT and UV selection are shown in blue. Each 
UV point represents the mean of two separate experiments. Pink, Ker.( -/ -); green, 
Ker.( + / +); blue, HAT + UV selected pool and clones; red, HAT selected pool and 
clones. 
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5.3.3 Correction of UV hypersensitivity of Erccl- deficient murine keratinocyte 
clones following transfection with Erccl MG #11 
Because Ercc1MG #11 lacks the sequence which contains the skin specific 
transcriptional start site it should not be possible for this transcript to be expressed in 
keratinocytes transformed with the minigene. Because wild type keratinocytes have 
a high upper to lower transcript ratio, the expression of this minigene will not mimic 
the normal expression pattern for the cell type. The UV survival curves of 
keratinocytes transformed with this minigene are interesting because they show how 
well the cells survive in the absence of an upper transcript. 
The controls are the same as in the previous experiments. All the clones transfected 
with Erccl MG #11 show corrected UV sensitivity with the survival curves shifted 
towards the wild type curve (see fig. 5.4). The clones that underwent HAT selection 
only following transfection had the following survival index percentages for the UV 
doses of 6, 10, 15 and 20 Jm 2; Erccl MG #11 clone 2 had 106, 95, 84 and 56% 
respectively, Erccl MG #11 clone 3 survival index percentages for those doses were 
114, 103, 94 and 81% and Erccl MG #11 clone 7 had survival index percentages of 
133, 136, 104 and 98 %. One of the survival curves of the clones that underwent HAT 
and UV selection post transfection (Erccl MG #11 clone 5) lies with the survival 
curves of the clones that did not undergo UV selection. The survival index 
percentages of the HAT + UV selected Erccl MG #11 clone 4 for UV doses of 6, 10, 
15 and 20 Jm 2 are 97, 77, 60 and 29% respectively (D50 value 16 Jm 2), while those 
of Erccl MG #11 clone 5 are 99, 94, 95 and 79% respectively. 
When the mean of the HAT selected clones (78.25) is compared to the mean of the 
HAT + UV selected clones (53.83) at UV dose 20 Jm 2 via two -tailed t -test, there is a 
statistically significant difference (P = 0.0371). At the lower UV dose of 10 Jm 2 
there is still a statistically significant difference between the means of the HAT and 
HAT + UV selected clones (P = 0.312). At lower UV doses there is overlap between 
error bars. These results are odd because it makes no biological sense that the HAT 
only selection has resulted in clones with greater correction of UV hypersensitivity 
than the clones selected with HAT and UV. Perhaps there was variability in the 
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correction of UV hypersensitivity between clones in the two selection regime and 
these differences represent a sampling effect. Without testing a larger number of 
clones it is not possible to know how representative the clones investigated here 
were. 
These survival curves show that transfection with Erccl MG #11 corrected the UV 
hypersensitivity of the Erccl/Hprt null keratinocytes and that selection with HAT + 
UV following transfection did not lead to selection of clones with a greater ability to 
repair UV damage than clones which had not undergone UV selection post 
transfection. RT -PCR analysis was required to investigate which transcripts were 
being produced by the transfected clones. 
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Figure 5.4 Correction of UV sensitivity of clones of Erccl-null 
keratinocytes (Ker.( -/ -) following transfection with Erccl MG #11 
The UV survival curves for wild type (Ker. + / +), Erccl- deficient (Ker. -/ -) murine 
keratinocytes, three clones which had HAT selection only following transfection 
with MG# 11 are shown in red (clones 7, 3 and 2) and two clones which had HAT 
and UV selection are shown in blue (clones 5 and 4). Pink, Ker.( -/ -); green 
Ker.( + / +); red, clones from HAT only selection regime; blue, clones from HAT +UV 
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5.3.4 Correction of UV hypersensitivity of Erccl- deficient murine keratinocyte 
pools following transfection with Ercc1MG #11 
The survival curves of the pools of clones transfected with Erccl MG #11 that 
underwent HAT or HAT and UV selection post transfection are shown in figure 5.5. 
The number of colonies from each selection regime that went into each pool are 
shown in Table 5.1. The survival curves of the two pools show correction of UV 
hypersensitivity by transfection with Erccl MG #11. The survival index percentages 
for the pool that underwent HAT only selection following minigene transfection 
(HAT pool) had the following survival index percentages of 124, 119, 117 and 88% 
for UV doses of 6, 10, 15 and 20 Jm 2. The survival index percentages for the pool 
that underwent HAT and UV selection following transfection for the same UV doses 
are 89, 94, 78 and 45% (D50 value = 19.1m-2) respectively. The survival curve of the 
pool co- selected with HAT + UV post transfection with MG #11 is lower than the 
pool selected with HAT. The pool selected with HAT alone has a higher survival 
index score than the wild type keratinocytes over the middle part of the UV range. 
The error bars of the pool selected with UV + HAT and the pool selected with HAT 
overlap at the lower UV doses. At UV dose 10 Jm 2 there is not quite a statistically 
significant difference between the pools (P= 0.0515); at UV dose 15 Jm 2 there is a 
very statistically significant difference (P= 0.0012) and at UV dose 20 Jm 2 the 
difference between the pools is also very statistically significant. Again, these results 
are odd because it makes no biological sense that the HAT only selection has 
resulted in clones with greater correction of UV hypersensitivity than the clones 
selected with HAT and UV. In pools any sampling effect should be diluted as many 
clones comprise each pool. 
When the survival curves of the pools transfected with Ercc1MG #11 are compared 
to those of the clones (figure 5.6), the curves overlap, indicating very similar UV 
survival capabilities. When the clones and pool that underwent HAT only selection 
following transfection are compared the curve of the pool lies within those of the 
clones, indicating that the UV survival ability of the cells is very similar. The same 
result is seen when the UV survival curves of the clones and pool selected by HAT 
and UV post transfection are compared. The survival curve of the pool lies within 
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those of those clones. It is clear from these results that the clones selected following 
either selection regime did not have higher than average UV survival capability since 
the pools of clones have the same UV hypersensitivity correction as the clones 
themselves. It seems from the results that the presence of the Erccl minigene 
corrects UV hypersensitivity regardless of post transfection selection regime and that 
the use of UV selection did not result in clones or pools with greater UV resistance, 
in fact, the clones and pools selected with HAT only generally had greater correction 
of UV hypersensitivity. This result makes no biological sense and the possibility of a 
sampling effect could only be ruled out by repeating the experiment and testing more 
clones to see how much variation exists. The RT -PCR results would demonstrate 
which Erccl transcripts were being expressed by the clones and pools investigated. 
Due to the deletion in the minigene the hypothesis was that these cells would only be 
expressing the 1.1kb transcript, which made the UV results interesting as the lack of 
upper transcript in cells which normally have high levels of upper transcript had not 
impaired the correction of UV hypersensitivity. In fact, when the UV curves of the 
clones and pools transfected with Ercc1 MG #11 are compared to those of Erccl 
MG #13 there is no difference in the effectiveness of the minigenes at correcting UV 
hypersensitivity, no difference had previously been observed in PF24 or CH043.3B 
(TG# 1) either. 
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Figure 5.5 Correction of UV sensitivity of pools of Ercc1 -null 
keratinocytes (Ker.( - / -)) following transfection with Ercc1MG #11 
The UV survival curves for wild type (Ker. + / +), Erccl- deficient (Ker. -/ -) murine 
keratinocytes, one pool which had HAT selection only following transfection with 
MG #11 (pool HAT) and one pool which had HAT and UV selection (pool HAT + 
UV) are shown. Each UV point represents the mean of two separate experiments. 
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Figure 5.6 Correction of UV sensitivity of clones and pools of Erccl -null 
keratinocytes (Ker.( -/ -)) following transfection with Erccl MG #11 
The UV survival curves for wild type (Ker. + / +), Erccl- deficient (Ker. ( -/ -)) murine 
keratinocytes, one pool plus three clones (clones, 2, 3 and 7) which had HAT 
selection only following transfection with MG #13 are shown in red. One pool plus 2 
clones (clones 4 and 5) which had HAT and UV selection are shown in blue. Each 
UV point represents the mean of two separate experiments. Pink, Ker.( -/ -); green, 
ker.( + / +); blue, HAT + UV selected pool and clones; red, HAT selected pool and 
clones. 
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5.3.5 Correction of UV hypersensitivity of Ercc1- deficient murine keratinocyte 
clones following transfection with Erccl MG #20 
If the CT repeat deleted from Erccl MG #20 is required for expression of the upper 
transcript then transformation of Erccl null keratinocytes, which normally express 
the upper transcript at high levels, is interesting because it will demonstrate the effect 
of the deletion upon UV survival and Erccl expression. The hypothesis is that if the 
deleted region is important then the transformed cells will not be able to express the 
upper transcript or will express it at a reduced level. If the deleted region is not 
important to expression of the upper transcript then, assuming all the sequence 
elements necessary for correct expression of Erccl are present in the minigene, the 
cells will have an expression pattern that will match that of the wild type 
keratinocytes. 
The controls are the same as in the previous experiments. Because of a fungal 
contamination problem one of the HAT + UV selected clones was lost. All the 
clones transfected with Erccl MG #20 show corrected UV sensitivity with the 
survival curves shifted towards the wild type curve (see fig. 5.7). The clones that 
underwent HAT selection only following transfection had the following survival 
index percentages for the UV doses of 6, 10, 15 and 20 Jm 2; Erccl MG #20 clone 1 
had survival index percentages of 112, 111, 105 and 95% respectively, Erccl 
MG #20 clone 2 survival index percentages for those doses were 86, 72, 67 and 34% 
(D50 =17.5 Jm 2), Erccl MG #20 clone 3 had survival index percentages of 108, 91, 77 
and 45% (D50 =19 Jm 2) and Erccl MG #20 clone 4 percentages were 109, 105, 107 
and 97 %. The survival index percentages of the HAT + UV selected Erccl MG #20 
clone 5 for UV doses of 6, 10, 15 and 20 Jm 2 are 85, 42, 18 and 10% respectively 
(D50 value 11 Jm2). These survival curves show that transfection with Erccl 
MG #20 corrected the UV hypersensitivity of the Erccl/Hprt null keratinocytes, 
although the curve of clone #5 shows lower correction than the other clones. There is 
a statistically significant difference between clone #5 and the mean of the HAT 
selected clones at the UV dose of 20 Jm 
2 (P= 0.0186). As the error bars of the clones 
do not overlap until very low UV doses, this indicates that the survival of the 
HAT + 
UV selected clone 5 is very different from the HAT only selected 
clones, especially 
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at the higher UV doses. Without information from other clones selected with HAT + 
UV and transfected with MG #20 it is not possible to tell if this clone had abnormally 
low expression of the minigene or is a typical survival curve for those conditions. As 
clone 5 was selected by HAT + UV it is unlikely that the selection regime resulted in 
selection of a clone with low UV survival. It is possible that the minigene has 
integrated into a less transcriptionally accessible part of the genome, leading to lower 
expression and that this statistically significant difference between this clone and the 
HAT only selected clones is a sampling effect. It makes no biological sense that 
selection with HAT only should result in clones with higher correction of UV 
hypersensitivity in contrast to selection with HAT and UV. The clones selected by 
HAT following transfection with Erccl MG #20 have survival curves that are very 
similar to that of the wild type keratinocytes in the cases of clones 1 and 4. Clones 2 
and 3 also have high UV survival ability. RT -PCR analysis was required to 
investigate which transcripts the transfected clones were producing. 
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Figure 5.7 Correction of UV sensitivity of clones of Ercc1 -null 
keratinocytes (Ker.( - / -)) following transfection with Erccl MG #20 
The UV survival curves for wild type (Ker. + / +), Erccl- deficient (Ker. -/ -) murine 
keratinocytes, four clones which had HAT selection only following transfection with 
MG #20 are shown in red (clones 1, 2, 3 and 4) and one clone which had HAT and 
UV selection is shown in blue (clones 5). Pink, Ker.( -/ -); green Ker.( + / +; red, clones 
from HAT only selection regime; blue, clone from HAT +UV selection regime. Each 
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5.3.6 Correction of UV hypersensitivity of Ercc1- deficient murine keratinocyte 
pools following transfection with Ercc1MG #20 
The survival curves of the pools of clones transfected with Erccl MG #20 that 
underwent HAT or HAT and UV selection post transfection are shown in figure 5.8. 
The number of colonies from each selection regime that went into each pool are 
shown in Table 5.1. The survival curves of the two pools show correction of UV 
hypersensitivity by transfection with Erccl MG #20. The survival index percentages 
for the pool that underwent HAT only selection following minigene transfection 
(HAT pool) had the following survival index percentages of 99, 100, 88 and 56% for 
UV doses of 6, 10, 15 and 20 Jm 2. The survival index percentages for the pool that 
underwent HAT and UV selection following transfection for the same UV doses are 
93, 89, 86 and 62% respectively. There is overlap between the UV survival curves of 
the two pools and both show equal correction of UV hypersensitivity, indicating that 
including UV in the selection regime post transfection did not lead to a shift in the 
population of cells towards those with greater ability to repair DNA damage 
following UV irradiation. 
When the survival curves of the pools transfected with Ercc1 MG #20 are compared 
to those of the clones (figure 5.9), the curve distribution overlaps, indicating very 
similar UV survival capabilities, with the exception of clone #5 which has a lower 
UV survival curve than the other pools and clones. The error bars of the pool 
selected with HAT + UV and the clone selected with HAT + UV (clone 5) do not 
overlap above the low UV dose of 5 Jm 2, indicating that at higher UV doses there 
was a difference in the survival between the clone and the pool. At the UV dose of 
20 Jm 2 there is an extremely significant difference between the clone and the pool 
(P= 0.0009). However, if may be that clone #5 was not correctly transformed and 
that other clones transfected with the minigene and selected with HAT +UV may not 
have such low correction of UV hypersensitivity. It is not possible to tell how typical 
clone #5 is of cells transfected and selected in this way as this could be a sampling 
effect. 
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When the clones and pool that underwent HAT only selection following transfection 
are compared the survival curve of the pool lies within those of the clones, indicating 
that the UV survival ability of the cells is very similar. The fact that the clone 
selected by HAT + UV has the lowest UV survival of all the clones and pools 
(including those selected by HAT alone) is odd as the clone obviously survived the 
UV selection regime post electroporation. It is possible that the minigene inserted 
into a site that was transcriptionally difficult to access yet the later results of the RT- 
PCR (figure 5.12) show that the clone is expressing Erccl transcripts at levels 
comparable to the other clones. 
The distribution of survival curves indicate that selection by UV does not influence 
the UV survival of the resulting clones when compared to clones selected by HAT 
(which due to the original 3:1 Erccl: Hprt DNA ratio are likely to contain the Erccl 
gene if they survive HAT selection). The RT -PCR results would demonstrate which 
Erccl transcripts were being expressed. Due to the deletion in the minigene the 
hypothesis was that these cells would be expressing only the 1.1kb transcript or both 
transcripts with a reduced level of upper transcript when compared to the cells 
transformed with Erccl MG #13. 
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Figure 5.8 Correction of UV sensitivity of pools of Erccl -null 
keratinocytes (Ker.( -/ -)) following transfection with Erccl MG #20 
The UV survival curves for wild type (Ker. + / +), Erccl- deficient (Ker. -/ -) murine 
keratinocytes, the pool which had HAT selection only following transfection with 
MG #20 (pool HAT) and the pool which had HAT and UV selection (pool HAT + 
UV) are shown. Each UV point represents the mean of two separate experiments. 
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Figure 5.9 Correction of UV sensitivity of clones and pools of Erccl -null 
keratinocytes (Ker.( - / -)) following transfection with Erccl MG #20 
The UV survival curves for wild type (Ker. ( +/ +)), Erccl- deficient (Ker.( -/ -)) murine 
keratinocytes, one pool plus four clones (clones 1, 2, 3 and 4) which had HAT 
selection only following transfection with MG #20 are shown in red. One pool plus 1 
clone (clone 5) which had HAT and UV selection are shown in blue. Each UV point 
represents the mean of two separate experiments. Pink, Ker.( -/ -); green, Ker.( + / +); 
blue, HAT + UV selected pool and clones; red, HAT selected pool and clones. 
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5.4 Expression of minigenes in Ercc1- deficient keratinocytes - RT -PCR 
analysis 
5.4.1 Expression of Erccl MG #13 in transfected keratinocyte clones- RT- 
PCR analysis 
As wild type keratinocytes have a high upper to lower transcript ratio the expected 
result of transformation with Erccl MG #13, assuming it contains all the elements 
necessary for correct expression in the cell type, is that the expression pattern would 
mimic that of the keratinocyte control. There should be product bands for all three 
primer reactions, with the presence of the 1.5kb transcript indicated by a product 
band in the A/5 reaction, high levels of the upper transcript resulting in product from 
the B/5 reaction and product from the 2/5 reaction indicating the presence of either 
the 1.1 or 1.5kb transcripts. The B/5 reaction is not as efficient as the A/5 reaction 
and this is why a band only appears if there are high levels of 1.5 transcript. 
The expression patterns of the controls in the experiment are correct. Expression of 
Erccl MG #13 was appropriate for the cell type with all 5 clones expressing both the 
upper and lower transcript, there were strong A/5 bands in clones 1 and 2, less 
intense bands in clones 3 and 7 and a pale band in clone 5. The clones selected by 
HAT only (clones 1, 2 and 4) were all producing upper transcript at levels 
comparable to the keratinocyte wild type control. The clones selected by HAT and 
UV were expressing both transcripts although clone 5 had a low intensity A/5 band. 
This was interesting because clone 5 also had a lower UV survival curve than the 
other clones (figure 5.1). Perhaps this is because it was expressing a lower level of 
upper transcript than the other clones (it is not possible to know without performing 
quantitative PCR). However, there is not a correlation between the intensity of the 
A/5 band in the other clones and UV survival. For example, clone 1 has the most 
intense A/5 band but the 2nd lowest UV survival index score at the highest UV dose 
(figure 5.1) while clone 7 has the 2nd lowest A/5 band intensity but the 3`d highest 
UV survival index score at the highest UV dose, assuming that the 1.5kb transcript 
confers an advantage and that the transcript expressin level is proportional to the 
intensity of the product band. Because the RT -PCR used was not quantitative, the 
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intensity of the product bands may not correlate with the expression level of the 
corresponding transcript. The band intensity pattern is the opposite of what would 
have been expected if the presence of the upper transcript confers an advantage when 
repairing UV damage. If UV irradiation was selecting clones on that basis then the 
hypothesis would be that the clones which were co- selected with HAT and UV 
would have more intense A/5 bands than those selected by HAT alone. However, if 
the 1.1kb is the most important for DNA damage repair capability then the UV 
irradiation would select clones with a lower 1.5kb to 1.1kb transcript ratio and the 
RT -PCR pattern would be correct for that hypothesis. 
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Figure 5.10 Expression of Erccl MG #13 in keratinocyte clones - RT -PCR 
RT -PCR analysis of RNA extracted from Erccl-null keratinocyte clones transfected 
with Ercc1MG #13. Total RNA was prepared and reverse transcribed using oligo -dT 
primers. The Erccl cDNA was then PCR amplified from the cDNA pool of each 
clone. Three PCR reactions were performed on cDNA from each clone using the 
following forward primers respectively; primer `A' is specific a region upstream of 
the normal transcriptional start site, primer `B' is specific to a region upstream of the 
Kpnl restriction site and primer `2' is specific to exon 2. Primer `5' is specific to a 



















































































































































































5.4.2 Expression of Erccl MG #11 in transfected keratinocyte clones- RT- 
PCR analysis 
The deletion in Ercc1 MG #11 resulted in the expected expression pattern with none 
of the clones able to express the 1.5kb transcript and, therefore, lacking A/5 bands in 
the RT -PCR (fig. 5.11). The clones selected by HAT alone had only the 2/5 band, 
indicating that only the 1.1kb transcript was being produced. The clones selected by 
HAT and UV had 2/5 bands but there was also a B/5 band in both of these clones. 
This was intriguing as it indicates the possible presence of a transcript that initiated 
above the 1.1kb transcript but was not the 1.5kb transcript as the skin TSS is missing 
in this minigene. As the controls have the correct pattern it is unlikely that this is due 
to contamination of the primer master mix or an artefact of the reaction. B/5 bands 
had not appeared in the earlier Erccl MG #13 transfections of fibroblasts and CHO 
cells. It was possible that because the minigene was being expressed in a cell line 
which normally has a high upper transcript expression and because the clones were 
the products of the UV selection regime, perhaps abnormal clones were 
preferentially selected. However, the UV + HAT selected clones did not have 
significantly higher UV survival index percentages than the clones selected with 
HAT alone and clone 4 had the lowest UV survival curve although it had the 
brightest B/5 bands. There was, therefore, no correlation between the presence of 
B/5 product and increased UV survival ability. This suggests that the cells with the 
B/5 products would not have had a survival advantage under the UV selection regime 
following transfection. 
159 
Figure 5.11 Expression of Erccl MG #11 in keratinocyte clones - RT -PCR 
RT -PCR analysis of RNA extracted from Erccl-null keratinocyte clones transfected 
with Ercc1MG #11. Total RNA was prepared and reverse transcribed using oligo -dT 
primers. The Erccl cDNA was then PCR amplified from the cDNA pool of each 
clone. Three PCR reactions were performed on cDNA from each clone using the 
following forward primers respectively; primer `A' is specific a region upstream of 
the normal transcriptional start site, primer `B' is specific to a region upstream of the 
Kpnl restriction site and primer `2' is specific to exon 2. Primer `5' is specific to a 
region in exon 5 and is the reverse primer for each of the three reactions. 
The lower band in the A/5 and B/5 lanes of clone 4 are likely to be spills from the 2/5 
























































































































































































5.4.3 Expression of Erccl MG #20 in transfected keratinocyte clones- RT- 
PCR analysis 
If the CT repeat region deleted in Erccl MG #20 was required for expression of the 
upper transcript then keratinocytes transformed with this minigene should not 
express the upper transcript or express it at a reduced level in comparison with those 
transformed with Erccl MG #13 (the expression level could only be verified by 
means of quantitative RT -PCR). When the RT -PCR results are examined (fig. 5.12) 
it is apparent that the deletion has not prevented expression of the upper transcript in 
transformed keratinocytes. The three clones selected by HAT and the two clones 
selected by HAT + UV following transfection all have A/5 and B/5 bands indicating 
that they are producing the upper transcript. There are also B/5 bands, which 
suggests that the upper transcript is probably being expressed at high levels. 
Remembering that the observations upon band intensity is presented for interest only 
and in the ansence of data from quantitative RT -PCR these observations must not be 
over -interpreted, the clones selected by HAT and UV have high intensity A/5 bands 
and two of the three clones selected by HAT and UV (clones 1& 3) have high 
intensity A/5 bands while one has a slightly less intense A/5 band. These 
observations may suggest that the lack of the CT repeat did not impair the ability of 
the transformed cells to produce upper transcript as would have been expected had 
this region been a crucial part of the skin specific transcript promoter but the actual 
expression level of the transcripts has not been ascertained so this is speculation 
only. The results do demonstrate that it is possible to express the skin -specific 
transcript despite deletion of the CT repeat region. 
There is no correlation between the intensity of the A/5 band and the UV survival 
ability of the clone. The clones in decreasing order of A/5 band intensity are 5, 3, 2, 
1 and 4. In order of highest UV survival index score at the highest UV dose, the 
clones in decreasing order are 4, 1, 3, 2 and 5. Those with the highest A/5 band 
intensity had the lowest UV survival. 
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Figure 5.12 Expression of Erccl MG #20 in keratinocyte clones - RT -PCR 
RT -PCR analysis of RNA extracted from Erccl-null keratinocyte clones transfected 
with Ercc1MG #20. Total RNA was prepared and reverse transcribed using oligo -dT 
primers. The Erccl cDNA was then PCR amplified from the cDNA pool of each 
clone. Three PCR reactions were performed on cDNA from each clone using the 
following forward primers respectively; primer `A' is specific a region upstream of 
the normal transcriptional start site, primer `B' is specific to a region upstream of the 
Kpnl restriction site and primer `2' is specific to exon 2. Primer `5' is specific to a 




























































































































































































5.5 Expression of Erccl minigenes in transfected keratinocyte pools - 
RT-PCR analysis 
There were six pools - two for each minigene. In each minigene pair, one pool was 
selected with HAT + UV while the other was selected with HAT only (fig.5.12). 
Because Erccl MG #13 is thought to contain all the sequence required for expression 
of both transcripts in keratinocytes the hypothesis is that both transcripts will be 
expressed in pools transfected with this minigene. If the UV selection post 
transfection was favouring clones with higher DNA repair ability and this was 
because they expressed a higher level of upper transcript then, assuming that more 
intense product bands are directly proportional to transcript expression level, a 
comparison of the pool selected with HAT and the pool selected with HAT + UV 
would show a more intense A/5 band in the HAT + UV selected pool. However, in 
the absence of quantitative RT -PCR the following observations based upon the 
premise that band intensity is proportional to transcript expression level remain mere 
speculation. 
Minigene#13 was expressed in a manner appropriate for the transfected cells in both 
pools. There were bands in all three PCR reactions for both pools and these bands 
were of a similar intensity to the control Ker +/+ reactions. This suggests that the 
minigene is being expressed appropriately for the cell type and contains all of the 
elements required for correct expression of the 1.5kb transcript. There was no 
difference between the RT -PCR results for either pool selection method indicating 
that the co- selection with UV did not result in a pool with a different Erccl 
expression pattern. Both pools transfected with Erccl MG #13 had similar DNA 
repair ability as evidenced by the overlapping UV survival curves and both pools 
expressed the MG in the same transcript pattern and levels. 
Erccl MG #11 lacks the skin transcript TSS. This means that it should not be 
possible for cells transfected with this MG to express the 1.5kb transcript. The pools 
of cells transfected with Erccl MG #11 do not have a product band for the A/5 
reaction indicating that the upper transcript is not being expressed. Both pools have 
2/5 bands indicating the presence of the normal 1.1kb transcript. However, there is a 
163 
pale band in the B/5 reaction of the HAT +UV selected pool and a very pale B/5 band 
is also present in the HAT selected pool. This is intriguing as it is a possible 
indication of a transcript which is initiating between the primer A and primer B 
hybridisation sites and, therefore, upstream of the normal transcript. This cannot be 
the 1.5kb transcript as the TSS of that transcript is not present in Erccl MG #11. 
There is no B/5 band in the HM -1 control indicating that the PCR mix was not 
contaminated. If the production of the transcript detected by the B/5 reaction confers 
an advantage under conditions of UV exposure then perhaps the UV selection regime 
caused cells expressing the MG in such a way to be favoured over cells expressing 
only the 1.1kb transcript (the B/5 band is brighter in the HAT + UV pool when 
compared to the HAT pool, although without quantitative RT -PCR this must not be 
over -interpreted). Any such selective advantage is not apparent in the UV survival 
assay of the two pools (fig. 5.5) as the pool that was selected with HAT had a higher 
UV survival curve that the pool selected with HAT and UV. The presence of the B/5 
band in HAT + UV selected clones was discussed in section 5.4.2 and the same 
explanation applies here. The band either indicates that a transcript is initiating 
upstream of the normal transcript and this could be due to selective pressure for such 
a transcript in the absence of the normal 1.5kb transcript in keratinocytes. 
Alternatively, the transcript could be initiating in the plasmid sequence upstream of 
the primer B hybridisation site, in which case it is merely an artefact. 
Erccl MG #20 lacks the CT repeat region that could be part of the promoter of the 
1.5kb transcript. If this region is required for correct expression of the transcript then 
RT -PCR on the pools transfected with this MG should show reduced expression or 
complete absence of the 1.5kb transcript evidenced by the level of the A/5 product 
band. If the UV selection regime following transfection was responsible for the 
selection of cells which had higher UV survival ability and this was because of the 
level of upper transcript then this would also be detected in the RT -PCR when the 
HAT selected pool results and HAT + UV pool results were compared. 
Erccl MG #20 was expressed appropriately for the cell type with A/5 product bands 
in both pools. Again, observations upon the band intensity remain speculations when 
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correlated with transcript expression levels in the absence of quantitative RT -PCR. 
The intensity of the A/5 bands in the HAT + UV pool was similar to that of the Ker. 
( + / +) control but the intensity of the A/5 band in the HAT selected pool was lower 
than in the Ker. ( + / +) control and the HAT + UV selected pool. The intensity of the 
A/5 bands in both pools transfected with Erccl MG #20 were lower than the pools 
transfected with Erccl MG #13 and this could indicate reduced 1.5kb transcript 
production due to the absence of the CT repeat region in Erccl MG #20 (without 
follow -up experiments using quantitative RT -PRC this remains speculation). 
However, because there is a difference between the results in the RT -PCR patterns 
for the two pools transfected with Erccl MG #20 it is also possible that the UV +HAT 
selection regime is biased towards cells expressing the upper transcript. Because the 
UV survival curves of the two pools were so similar (fig. 5.8) any survival advantage 
under UV conditions conferred by the presence of upper transcript is not apparent. It 
is, therefore, possible that deletion of the CT repeat region could cause a reduction in 
upper transcript production but does not preclude production of this transcript 
entirely. 
The following for interest in 
the absence of quantitative RT -PCR data no conclusions may be drawn. The A/5 
bands in the Erccl MG #13 pools are equally bright for both selection regimes. 
However, it is interesting that the pools which underwent HAT + UV selection had 
more intense A/5 bands than the HAT only selected pools in the case of cells 
transformed with MG #20, indicating that the UV +HAT pools could potentially be 
expressing the upper transcript at higher levels if the band intensity is proportional to 
transcript expression level. If the upper transcript increases the DNA repair ability of 
the cells then this was not apparent in the UV survival assays performed upon the 
pools. In order to investigate the possibility that UV could induce upper transcript 
production the pool set with the greatest difference in upper transcript band intensity, 
the Erccl MG #20 pools, were used in a follow -up experiment (5.6). The pools 
should be more representative of cells transformed with the minigenes than the 
clones alone, so these results suggest that Erccl MG #13 contains all the sequence 
elements required for correct expression of the upper transcript in keratinocytes and 
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correct the UV hypersensitivity of transformed cells. The deletion in Erccl MG #20 
may cause slightly reduced upper transcript production (if band intensity is 
proportional to transcript expression level) in transformed keratinocytes but this 
minigene is capable of correcting the UV hypersensitivity of transformed cells 
equally effectively as transformation with Erccl MG #13. Erccl MG #11 lacks the 
skin TSS so keratinocytes transformed with this MG cannot express the upper 
transcript. However, transfection with this minigene was equally effective at 
correcting the UV hypersensitivity of the cells as transfection with Erccl MG #13 
and 20. This was surprising since keratinocytes normally express the upper 
transcript at high levels. The absence of this transcript did not reduce the UV 
survival levels of these cells. 
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Figure 5.13 Expression of Erccl minigenes in keratinocyte pools - RT- 
PCR 
RT -PCR analysis of RNA extracted from Erccl-null keratinocyte pools transfected 
with Erccl minigenes #11, #13 and #20. Total RNA was prepared and reverse 
transcribed using oligo -dT primers. The Erccl cDNA was then PCR amplified from 
the cDNA of each pool. Three PCR reactions were performed on cDNA from each 
pool using the following forward primers respectively; primer `A' is specific a region 
upstream of the normal transcriptional start site, primer `B' is specific to a region 
upstream of the Kpnl restriction site and primer `2' is specific to exon 2. Primer `5' 
















































































































































































































































5.6 Possible UV induction of upper transcript in keratinocyte pools 
transfected with Erccl minigenes - RT -PCR 
RT -PCR analysis of the keratinocyte pools had revealed a difference between the 
expression pattern observed following different selection regimes in the skin -specific 
transcript band intensity. However, because the RT -PCR technique used was not 
quantitative, this observation is reported for interest only and must not be over - 
interpreted. The following experiment was interesting but no conclusions may be 
drawn without follow -up experiments using quantitative RT -PCR. This is explained 
in more detail in the discussion. Assuming that band intensity is proportional to 
transcript level (remembering that the RT -PCR technique is not qualitative and that 
the differences in band intensity could be artefacts of the RT -PCR), the pools that 
were produced following co- selection with HAT and UV had brighter skin- specfic 
transcript product bands, possibly indicating that these pools expressed more 1.5kb 
than the pools resulting from selection with HAT alone. The higher skin -specific 
product band intensity (which may reflect a greater production of upper transcript) in 
the UV selected cells did not appear to provide an advantage in the UV survival 
assays as the UV survival of these pools was equal to that of the HAT selected pools. 
In the clonal analysis such differences in band intensity (and possibly transcript 
expression pattern) could be attributed to the small sample number but in the pool 
analysis all the pools contained over 500 clones, meaning that the resultant 
expression pattern was representative of the transformed cells. The difference in 
expression in the UV selected pool was, therefore, worthy of further investigation. It 
was possible that the UV survival assay was not replicating the environmental 
conditions that resulted in selection of clones expressing upper transcript at high 
levels over those with low or no upper transcript expression (again, assuming the 
band intensity was a true reflection of transcript expression levels). At this stage of 
the experiments, work by another member of the Melton Lab. had suggested that the 
upper transcript appeared approximately two days post -partum in the mouse skin and 
this, along with the results of the RT -PCR presented, suggested that production of the 
transcript could be induced by UV. To test this hypothesis the pool transfected with 
Erccl MG #20 was chosen for further study. This was because there the expression 
patterns from the two selection regimes resulted in the greatest difference in skin- 
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specific transcript product band intensity, possibly reflecting greater upper transcript 
expression in this sample. The hypothesis was that if the HAT selected pool was 
irradiated with UV then the RT -PCR band intensity pattern would change to that of 
the UV + HAT selected pool. If the presence of the upper transcript conferred a 
survival advantage upon the cells under conditions of UV exposure and the level of 
transcript was directly proportional to band intensity then UV irradiation would 
either result in expression of the upper transcript, should induction of expression be 
possible, or selection for cells expressing higher levels of upper transcript in the pool. 
The HAT selected pool was expanded and split into two immediately prior to the 
experiment. One half received multiple UV -C doses of 6.5Jm 2 while the other half 
had no UV exposure. RT -PCR 24 hours following the final UV exposure 
demonstrated that the pool that had been UV irradiated had a 4 fold higher skin - 
specific product band intensity than the pool that had not been UV irradiated. If the 
level of product is a true reflection of the level of transcript then this is an indication 
of UV induction but correct analysis of the results from this non -quantitative RT- 
PCR is in terms of absence or presence of product only and in that case there is no 
difference. The suggested increase in expression of the skin -specific transcript can 
only be proven or refuted by means of follow -up quantitative RT -PCR. If band 
intensity was reflecting transcript expression level then the UV irradiated cells had 
more upper transcript than the non -irradiated cells and UV irradiation appears to 
either be capable of inducing upper transcript expression or selecting for cells that 
express the upper transcript at higher levels. If this is the case then the presence of 
the upper transcript in skin could be explained by the biological requirement of the 
skin for DNA damage repairing following UV irradiation from sunlight. However, 
these observations on band intensity changes following UV exposure are reported for 
interest only and in the absence of quantitative RT -PCR no conclusions may be 
drawn from this experiment. 
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Figure 5.14 Possible induction of Erccl upper transcript expression by 
means of UV irradiation. 
A HAT selected pool transfected with Erccl MG #20 (section 5.5) was split into two 
halves. One half received multiple UV -C doses of 6Jm2. 24 hours following the 
final UV irradiation RNA samples were extracted from both the UV irradiated pool 
and the non UV- irradiated control for RT -PCR analysis. The 2/5 reaction gives a 
positive result for both the 1.1 and 1.5kb transcripts. The A/5 reaction gives a 
positive result for only the skin -specific 1.5kb transcript. Two controls were 
included; Ker.( + / +) expresses both transcripts and HM -1 (ES cell) express the 1.1kb 
transcript. 
Total RNA was prepared and reverse transcribed using oligo -dT primers. The Erccl 
cDNA was then PCR amplified from the cDNA pool. Three PCR reactions were 
performed on cDNA from each clone using the following forward primers 
respectively; primer `A' is specific a region upstream of the normal transcriptional 
start site, primer `B' is specific to a region upstream of the Kpnl restriction site and 
primer `2' is specific to exon 2. Primer `5' is specific to a region in exon 5 and is the 
reverse primer for each of the three reactions. 
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HM-1 Ker -/- POOL Ker -/- POOL Ker +/+ 
(ES cells) Erccl MG#20 Erccl MG#20 
NO UV UV 
A/5 2/5 A/5 2/5 A/5 2/5 A/5 2/5 
w1111.111P 
£7 Conclusions 
Transfection with Erccl MG #11 may not have corrected the UV hypersensitivity of 
Erccl- deficient keratinocyte cells as effectively as transfection with Erccl MG #13 
and #20, as fewer cells survived the UV selection post electroporation in this group. 
This is demonstrated by the low ratio of HAT +UV selected colonies to HAT selected 
colonies in the Erccl MG #11 pool compared to the Erccl MG #13 and #20 pools. 
The ratio of HAT + UV selected colonies to HAT selected colonies in the pools of 
cells transfected with minigenes #13 and #20 was almost double that of the pool 
transfected with Erccl MG #11. This difference may be indicative of the importance 
of the upper transcript to keratinocyte survival of the UV selection regime post 
electroporation, since the deletion in minigene#11 results in an inability to express 
the 1.5kb transcript, the primary transcript in wild type keratinocytes. This large 
ratio difference (almost 2 -fold) between minigenes was not observed in the other cell 
types studied (in which the primary transcript is the 1.1kb, normal transcript rather 
than the 1.5kb skin -specific transcript). However, without repeating the experiments 
with a greater number of dishes plated with cells for each transfection, no 
conclusions regarding the statistical significance of the ratio differences can be 
drawn. 
Unlike the results of the UV survival assays performed in the PF24 and CHO43.3B 
(TG #1) experiments, transfection of Erccl- deficient keratinocytes with the 
minigenes did not result in as much clustering of UV survival curves around the 
wild -type curve. This could possibly indicate that the minigenes were not as 
effectively correcting the UV hypersensitivity of the cells. However, it is also 
possible that the difference is merely due to the longer time interval between the UV 
survival assays on the controls and the pools /clones. The longer interval was caused 
by the slower growth rate of keratinocytes, in comparison to fibroblasts and CHO 
cells. Alternatively, the highest UV data point for the wild type keratinocytes may 
just be an aberrantly high value. 
The B/5 PCR product in the MG #11 HAT + UV selected clones (clones 4 and 5) in 
figure 5.11 are interesting. The cells were transfected with Erccl MG #11 and this 
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minigene lacks the TSS of the 1.5kb transcript. The absence of an A/5 PCR product, 
despite of the correct control pattern in the wild type keratinocytes, indicated that the 
positive B/5 reaction was not due to the presence of 1.5kb transcript. The B/5 
reaction was detecting a transcript which had to be initiating upstream of the normal, 
1.1kb, transcript since it contained the primer B hybridisation site. Possible 
explanations for this are detailed in the discussion. 
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Chapter 6 
Erccl primary culture experiments 
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Investigation of expression of the novel Erccl transcript in murine 
tissues and primary cultures 
The identification of a novel Erccl transcript in the skin is intriguing due to the high 
biological requirement for the removal of UV- induced DNA damage in this tissue. 
Of all the body tissues, it is the skin that is uniquely exposed to this source of 
damage. It is reasonable to assume that, in order to meet the greater biological 
requirement for the repair of UV- induced DNA damage in the skin, Erccl expression 
could be altered. The hypothesis is that the novel transcript confers an advantage to 
the skin. In order to understand the possible biological significance of the transcript 
in skin, it is necessary to understand the structure of the skin and the biological 
effects of the different types of UV. The following experiments investigate changes 
in Erccl expression in culture, whether UV exposure could induce novel transcript 
expression, the effect of serum starvation upon novel transcript expression and also 
the difference in the size of the novel transcript produced by cells isolated from 
different mouse strains. In order to understand the experimental design, the 
following sections introduce the ideas that different wavelengths of UV are absorbed 
by different layers of the skin and that the cell cycle can be influenced by serum 
starvation to investigate expression changes due to proliferation in culture. The 
preliminary work leading to the various hypotheses is also explained. 
The UV component of the solar spectrum 
The solar spectrum and its interaction with skin is summarised by Hawk and 
McGregor, 2000. The ultraviolet component of the electromagnetic spectrum is the 
100 -400nm X range. This range is further subdivided into three categories; UV -C is 
100- 290nm; UV -B is 290 -320nm and UV -A is 320- 400nm. DNA absorbs UV light 
in the region of 200 -300nm (absorption peaks at 260nm), meaning that UV -C and 
UV -B are strongly absorbed by DNA and result in the same types of DNA damage, 
UV photons, being more energetic than visible light photos provide enough energy to 
alter the DNA chemical bonds. The UV -C component of solar radiation is 
completely filtered out by the ozone layer and, therefore, skin is not naturally 
exposed to this wavelength. Artificial sources of UV include, for example, 
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fluorescent lamps. Of the UV radiation that does penetrate to ground level, 
approximately 5% is UV -B and the remaining 95% is UV -A (with variation 
depending upon the time of day, year, latitude and other factors). Although the UV 
component of solar radiation that reached ground level is small ( -5 %) it is 
biologically important because of its absorption by DNA. 
The layers of the skin 
Because the skin is composed of several layers, UV radiation of different 
wavelengths can have different biological effects. The layers of the skin from the 
surface inwards are the stratum corneum, the epidermis, the dermis and the 
hypodermis. The stratum corneum is a layer of dead cells that move up from the 
underlying epidermis and is continually replaced; it protects the underlying layers of 
the skin from injury. The epidermis is composed of several cell types, mainly 
keratinocytes, and these cells gradually move up to form the stratum corneum. At 
the base of the epidermis are evenly scattered melanocytes which produce melanin, a 
UV- absorbing pigment that has a protective function. The cells of Langerhans are 
also present in this layer and these cells are part of the immune system (protecting 
against infection and tumours). Keratinocytes, melanocytes and cells of Langerhans 
are all nucleated cells and damage to the DNA of these cells, especially those of the 
basal layer, can lead to skin cancer. The underlying dermis supplies the epidermis 
with nutrients and oxygen via the blood vessels. The dermis contains sweat glands, 
hair follicles, lymphatic vessels, blood vessels and supporting fibres and the 
hypodermis is composed of loose connective tissue and fat. 
Interaction between UV and the skin layers 
Skin reflects approximately 5% of the UV that it is exposed to. The remaining 95% 
penetrates the tissue and is scattered then either passes out again or is absorbed by 
the molecules of the various skin layers. The penetrative ability of the UV is 
dependent upon the wavelength; short wave UV -B is mainly absorbed by the stratum 
corneum and epidermis, particularly by the melanin and DNA. A small fraction of 
the UV -B can penetrate to the dermis while longer wavelength UV -A penetrates 
mainly to the dermis where it is primarily absorbed by haemoglobin in the blood or 
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reflected back out of the skin. Absorption of UV -C or UV -B by DNA can lead to 
damage formation, especially pyrimidine dimers. This type of damage is very 
disruptive to cellular processes and hinders cell division until repaired. Therefore in 
vivo, cells of the epidermis (keratinocytes) are exposed to greatest proportion of the 
DNA -damaging UV -B, while the cells of the dermis (fibroblasts) are exposed to less. 
The most likely outcome of DNA damage by UV is complete repair by NER and 
most damage is repaired within hours to days. The alternative to repair is cell death. 
If the DNA is inaccurately repaired, permanent mutations may be introduced that 
could eventually lead to the development of cancer. The presence of the skin - 
specific transcript in skin could potentially confer an advantage in the removal of 
UV- induced DNA damage but if it is simply that production of the skin transcript 
results in higher protein levels, why could this not be achieved by simply producing 
more of the normal transcript? 
Observations leading to hypothesis that UV could possibly induce skin 
transcript expression 
Preliminary work in the laboratory by Dr. A. Winter had demonstrated that the ratio 
and expression level of normal and novel Erccl transcripts in mouse skin changes 
dramatically in the period between day 16.5 of embryonic development and 12 
weeks after birth. Until two weeks after birth the level of the normal transcript is low 
and constant while the level of the skin -specific transcript is very low. However, 
following birth the level of the skin -specific transcript increases until both the novel 
and normal transcripts are expressed at equal levels. The level of the skin transcript 
then rapidly increases while the level of the normal transcript begins to decrease until 
the adult expression pattern of a very high skin -specific to normal transcript is 
achieved (unpublished data). This change in expression of the skin -specific 
transcript expression is intriguing due to the possibility that the novel transcript is 
induced by exposure to light/UV following birth. The possibility that the skin - 
specific transcript could be induced by UV had to be investigated to gain further 
understanding of the role of the novel transcript in the skin. In order to investigate 
the possibility that light exposure induced skin -specific transcript production, the 
following experiments were designed. Primary fibroblasts isolated from various 
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developmental stages were protected from exposure to light and then exposed to UV/ 
visible light repeatedly. The resulting transcript expression pattern was then 
examined by means of northern blot. UV -B, UV -C and visible light were tested as 
possible induction agents in the following experiments. If Erccl transcription was 
regulated by exposure to UV then transcription would be very neatly coupled to 
biological need for Erccl activity. Induction of the skin -specific transcript by UV 
would particularly suggest that the reason for the skin -specific transcript's presence 
in the skin could be due to evolutionary selection pressure for increased UV- induced 
damage repair by Erccl in this tissue. Erccl induction experiments would more 
easily be performed in vitro than in vivo but the possibility of changes in Erccl 
expression during culture required investigation. 
The cell cycle response and serum starvation. 
A simple description of the cell cycle in mammals is that it is divided into four 
discrete phases. The two fundamental parts of the cell cycle are interphase (occupies 
the majority of the cell cycle) and mitosis (which ends with the division of the cell). 
During interphase a number of growth processes occur continuously. There are also 
a number of stepwise processes that occur only once per cell cycle and interphase 
can be subdivided into three parts according to these events. The first part of 
interphase is referred to as G1 and this stage precedes DNA synthesis. DNA 
synthesis occurs during the S phase, which takes place in the middle of interphase. 
The stage following S phase is G2. Mitosis occurs following G2. Postembryonic 
cells can stop growing and leave the cell cycle for long periods (days, weeks or 
years); cells can enter a resting phase during G1 called GO. It is also possible for 
cells to enter a resting state in G2, although most non -dividing cells in the body are 
in GO. The cell cycle is subject to a number of growth and proliferation controls and 
cell division is mediated by growth factors (since uncontrolled cell division leads to 
tumour formation). In culture of mammalian cells these growth factors are supplied 
by serum and can be broad -acting growth factors or specific to particular cell types. 
When tissue is placed in a petri dish with serum cells migrate away from the tissue, 
usually fibroblasts. As serum supplies the cells with growth factors, serum starvation 
causes arrest in GO. Populations of somatic cells are usually not synchronous and to 
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study expression of genes it the cell cycle is necessary to induce synchronisation (the 
cell cycle and response to serum starvation is discussed in Murray and Hunt, 1993). 
In the following Erccl cell cycle response experiment, the cells were synchronised 
by serum starvation and subsequent release from starvation. Reintroduction of serum 
permits the arrested cells to proceed with the cell cycle in relative synchrony. 
Observations leading to hypothesis that expression of skin -specific transcript is 
dependent upon proliferation in culture 
Earlier work in the laboratory by Dr. A Winter had shown that Erccl transcript levels 
of primary dermal fibroblasts isolated from 19.5- day -old mouse embryos (E19.5) and 
3- day -old mouse pups (P3) were altered by serum starvation, with the level of the 
skin -specific transcript decreasing in serum starved cultures and then being rapidly 
restored following re- introduction of serum. This observation suggested that there 
was possibly an Erccl expression cell cycle response. Because Erccl is involved in 
DNA damage repair and a healthy cell can respond to DNA damage by alteration of 
the cell cycle (e.g. arrest until damage is repaired), the possibility of a cell cycle 
response in Erccl expression was worthy of further investigation. 
Size of novel transcript in different cells 
During the course of the following experiments, the observation that the skin -specific 
transcript expressed by cultured wild type keratinocytes (originally isolated from a 
BALB /c mouse), adult skin from a CD -1 mouse and dermal fibroblasts isolated from 
C57B1/6 mice was of difference sizes was made. This led to sequencing of 5' 
flanking region of the Erccl gene in various mouse strains and the discovery that the 
size of the CT repeat region differed between strains. 
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6.1 Difference between in vitro and in vivo Ercc1 expression patterns 
To investigate the possibility that culturing primary dermal and embryonic 
fibroblasts could lead to changes in their Erccl transcript expression pattern, a 
northern blot was performed. To determine if the Erccl expression of cultured 
fibroblast cells isolated from various developmental stages changed following 
culture, whole RNA from primary embryonic and dermal fibroblast cultures grown 
from tissue isolated at three different developmental stages (from C57B1/6 mice) was 
compared to whole RNA from freshly dissected tissue from corresponding 
developmental stages (Figure 6.1 & Table 6.1). The primary cultures used for this 
experiment were cultured in near darkness (although they were briefly exposed to 
low light levels during sacrifice of the embryos /pups and separation of the dermis 
from the dermis). 
Throughout the following analysis, the skin -specific Erccl transcript (1.5kb) is 
referred to as the upper transcript (U) and the normal transcript (1.1kb) is referred to 
as the lower transcript (L). The age of embryos and pups are in days and are 
prefixed by the letters `E' and `P' respectively e.g. a 13.5 day old embryo is E13.5 
while a 2 day old pup is P2. In the northern analysis tables of data are presented 
below the corresponding figure. The rows of the table highlighted in grey contain 
the data analysis of the bands on the northern following loading correction and 
background subtraction. This is the information that is referred to in subsequent 
analysis. The data presented in the non -highlighted rows of the table is the band 
analysis before loading correction and background subtraction and is not referred to 
in the analysis (provided for information only). The loading correction values are 
provided and the calculations are explained in the footnotes below the tables. 
For the in vitro samples, the number of days in culture and the number of times the 
cells have been passaged is recorded in the figure legend (Figure 6.1). The P2 and 
P3 data was incomplete, due to RNA degradation, so lanes containing RNA (from an 
earlier northern blot) were spliced into the image. As this is a composite image, only 
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the upper to lower (U:L) Erccl transcript ratios are examined, as this calculation is 
not proportional to RNA load. 
If the in vivo Erccl expression patterns are examined initially, to establish how the 
Erccl expression changes during development, a trend is evident (see table 6.1); the 
U:L transcript ratio increases as development progresses in vivo. The U:L transcript 
ratios for the in vivo samples (E15 total embryo, E19 skin, P3 skin) are respectively 
0.1, 0.1 and 0.4. This demonstrates a large increase in the U:L Erccl transcript ratio 
during development. The sum Erccl decreased from EIS (whole embryo) to E 19 
(skin) in vivo (this calculation is dependent upon RNA load so no figure could be 
provided for the P3 sample since it is from another northern). No adult C57B1/6 
mice could be spared at the time this experiment was performed so RNA from adult 
skin of a CD -1 mouse was included to provide an example of the final pattern of 
Erccl expression observed in vivo; the high ratio of upper to lower transcript is 
observed in adult skin, although the U:L ratio reached in adult skin from CD -1 mice 
is higher than that of adult C57B1/6 mice (Dr. A. Winter, Melton Lab., unpublished 
data). 
If the in vitro samples are compared to the closest developmental in vivo sample then 
differences in Erccl expression are evident. If the E13.5 in vitro sample is compared 
to the E15 total embryo in vivo sample, the sum Erccl expression was more than 2X 
greater in vitro and the U:L transcript ratio was 3X higher in vitro than in vivo. If the 
E18.5 in vitro sample is compared to the E19 skin in vivo sample, the sum Erccl 
expression was more than 4X greater in vitro than in vivo and the U:L transcript ratio 
was 12X greater in vitro. If the P2 in vitro sample is compared to the P3 in vivo 
sample then the U:L transcript ratio was more than 100X greater in vitro than in vivo 
(the sum Erccl calculation is dependent upon RNA load so no figure could be 
provided for the P2 and P3 samples since they are from other northern blots). The in 
vivo adult skin (CD -1) showed the typical high U:L transcript ratio observed in adult 
CD57B1/6 adult skin (Dr. Winter, Melton lab. unpublished data) and the ES cells had 
the expected low U:L transcript ratio. In summary, the Erccl expression in vitro was 
different from the corresponding in vivo pattern as both the U:L Erccl transcript 
ratios and sum Erccl expression levels were higher in vitro than in vivo for 
corresponding samples. 
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Figure 6.1 Difference between in vitro and in vivo Erccl expression 
patterns in murine primary cultures and tissues 
Northern blot analysis of RNA extracted from primary cultures and tissues of mouse 
line C57B1/6 at different developmental stages. Upper panel, total RNA (30µg) was 
prepared, electrophoresed on a 1.4% agarose -formaldehyde gel, transferred onto a 
genescreen membrane and probed with an 800bp BamHI fragment of the Erccl 
cDNA, corresponding to exons 1 to 8. The position of the 18S rRNA is indicated. 
Cultures isolated from macerated E13.5 embryos, E18 dermis and P2 dermis. The 
E13 culture had been passaged 3 times and cultured for 45 days. The E18.5 culture 
had been passaged 4 times and cultured for 25 days. Lower panel, ethidium bromide 
staining to illustrate RNA loads. The P2 culture had been cultured for 33 days and 
passaged 3 times. Because an adult skin sample from a C57B1/6 mouse was not 
available, the adult skin RNA is from a CD -1 mouse (provided by Dr. Winter, 
Melton Lab.). ES cells are derived from mouse strain 129 /Ola. 
Table 6.1 Analysis of Erccl bands in figure 6.1 
Analysis of the Erccl transcript bands from each lane of the northern blot. Each 
column of the table corresponds to the lane of the figure (northern blot and EtBr 
staining) directly above. Analysis was performed using Image J software. 
* As P2 and P3 lanes are from separate northern blots only the U:L transcript ratio 









838 304 4447 241 9259 1361 4334 178 
L before 
correction 
3063 5229 3580 2585 585 9154 104 449 
EtBr18s 1715 6175 4831 7660 3443 1903 * * 
Loading 
correction' 
1.0 0.3 0.4 0.2 0.5 0.9 * 
U corrected 838 84 1579 54 4612 1227 * * 
L corrected 3063 1452 1271 579 291 8251 * * 
Ratio2 of U:L 0.3 0.1 1.2 0.1 15.8 0.1 42.7 0.4 
Sum3 U +L 3901 ' °' 1537 2849 633 4903 9478 * 
' Loading variation correction values calculated with first lane being assigned a value of 1. 
2 Ratio of upper to lower transcripts following background subtraction and loading correction 
3 Sum of upper and lower transcripts following background subtraction and loading correction 
6.2 Effect of time in culture upon Erccl transcription in cells isolated 
from different developmental stages. 
Many factors could be responsible for the observed differences between in vivo and 
in vitro Erccl expression described in section 6.1. To investigate whether time in 
culture was responsible for the changes the following experiment was performed. 
Because exposure of cultured cells to ambient light could hypothetically effect Erccl 
expression, by means of UV or visible light induction, the primary cultures used for 
this experiment were cultured in near darkness (although they were briefly exposed 
to low light levels during sacrifice of the embryos /pups and separation of the dermis 
from the epidermis). Following isolation, the murine primary cultures grow 
vigorously but in the ensuing weeks in culture the growth rate decreases until it 
eventually the cells stop dividing. 
The cells used for this experiment were isolated from C57B1/6 mice. Every effort 
was made to minimise light exposure of cells during isolation and culture so that any 
observed changes in Erccl transcript expression could be attributed to culture 
conditions other than ambient light exposure. For each culture an extra dish was 
plated and this `viewing dish' was cultured synchronously with the experimental 
dishes to monitor cell density during the experiment, minimising exposure to 
microscope light. See method 2.6.26 for other precautions taken to minimise light 
exposure. 
See figure 6.2 and table 6.2. The number of passages and days in culture are shown 
for each sample above the figure. If the E13.5 primary culture samples are 
examined, the ratio of U:L transcript increased with progression of time in culture 
and the sum Erccl expression also increased. In the E18.5 primary culture, the U:L 
transcript ratios increased with time in culture while the sum Erccl transcription 
level fluctuated over time. The U:L transcript ratio of the P2 culture increased with 
progression of time in culture. As the 33 day P2 sample is inserted from another 
northern image only the ratio can be compared as the total sum Erccl calculation is 
dependent upon RNA load. 
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In summary, U:L transcript ratio increased with progression of time in culture for 
cells isolated from all three developmental stages. There was an increase in the sum 
Erccl transcription levels with progression of time in culture in the E13.5 sample. 
The sum Erccl level in the E18.5 culture fluctuated but both the 15 and 16 -day 
cultures had lower Erccl expression than the 9 -day culture. The changes observed 
over time in culture occurred in conditions of minimal light exposure. 
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Figure 6.2 Effect of time in culture upon Erccl transcription in cells 
isolated from different developmental stages and cultured in near 
darkness. 
Northern blot analysis of RNA extracted from primary cultures of mouse line 
C57B1/6. Cultures from macerated E13.5 embryos, E18 dermis and P2 dermis were 
cultured in near darkness. RNA was isolated at various times during culture. Upper 
panel, Total RNA from each culture (30µg) was prepared, electrophoresed on a 1.4% 
agarose -formaldehyde gel, transferred onto a genescreen membrane and probed with 
an 800óp BamHI fragment of the Erccl cDNA, corresponding to exons 1 to 8. The 
position of the 18S rRNA is indicated. Lower panel, ethidium bromide staining to 
illustrate RNA loads. 
Table 6.2 Analysis of Erccl bands in figure 6.2 
Analysis of the Erccl transcript bands from each lane of the northern blot. Each 
column of the table corresponds to the lane of the figure directly above (northern blot 
and EtBr staining). Analysis was performed using Image J software. 
* Due to a sample problem, the P2 33 -day sample in lane 7 is spliced in from 
another northern. The sample spliced in is the same as the one that was to be 
presented in the original panel (from an earlier northern blot). It is, therefore, 
directly comparable to the 10 day old P2 sample. 
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No. days in 
culture 
14 27 9 15 16 10 33 









475 2494 8416 10349 11553 2768 12799 12820 
L value 
Pre -correction 
5683 11133 15067 12032 8472 9218 1550 0 
EtBr 18S 
2010 2799 3911 5195 4243 4396 3217 3187 
Loading 
Correction' 
1.4 1.0 0.7 0.5 0.7 0.6 * 0.9 
U corrected 
662 2494 6024 5576 7622 1763 * 11260 
L corrected 
7916 11133 10785 6483 5589 5870 * 0 
Ratio of U:L2 0.1 0.2 0.6 0.9 1.4 0.3 8.3 All U 
Sum3 U + L 8578 13627 16810 12059 13211 7633 * 11260 
' Loading variation correction values calculated with second lane being assigned a value of 1. 
2 Ratio of upper to lower transcripts following background subtraction 
3 Sum of Erccl upper and lower transcripts corrected for loading variation 
6.3 Comparison of E18.5 cultures maintained in darkness to cultures 
exposed to visible light or multiple UV -B or UV -C irradiation. 
The primary cultures used in experiments 6.1 and 6.2 were cultured in near darkness. 
In order to test whether or not exposure to light could induce changes in Erccl 
expression levels and transcript ratios, primary cultures of E18.5 murine dermal 
fibroblasts were cultured in near darkness and repeatedly exposed to UV -B, UV -C or 
visible light for short intervals. The UV -C dose delivered during each irradiation 
was 6 Jm 2. The UV -B irradiation was performed with the UV lamp at the same 
height as for the UV -C irradiations and cells were irradiated for 5 minutes. The 
`light control' cells were not protected from light exposure while every effort was 
made to minimise exposure of the `dark control' cells to light during culture and UV 
irradiation was not performed on these cells. All the data sets are directly 
comparable as the experiment was performed using a primary culture isolated from a 
pool of E18.5 dermis extracted from 7 skins. The passaging, irradiations and RNA 
extractions were performed in synchrony. RNA samples were extracted 48h after the 
last UV /light irradiation. 
See Figure and table 6.3. At day 9 of culture (following 1 irradiation) the sum Erccl 
expression level and the U:L transcript ratio was higher in the dark control than in 
the UV -B and UV -C irradiated cultures. On day 13 of culture (following 2 
irradiations) the sum Erccl expression and U:L transcript ratio was higher in the UV- 
C irradiated sample than in the dark control and UV -B irradiated sample. The U:L 
transcript ratios had increased in the UV- irradiated samples but was unchanged in the 
dark control. Caution is required when interpreting results at later stages of the 
experiment because the repeated UV -C irradiations were resulting in high levels of 
cell mortality and the UV -B sample was also undergoing apoptosis, although to a 
lesser extent than the UV -C irradiated sample. This is why there is no 24 day UV -C 
sample and the UV -B culture was one passage behind the dark and light cultures at 
24 days in culture (following 4 irradiations). By day 16 of culture (following 3 
irradiations) the sum Erccl expression of the UV irradiated samples and the light 
control was lower than that of the dark control. The U:L transcript ratio was higher 
in the UV -B and UV -C irradiated samples than in the dark control while the U:L 
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ratio in the light control was lower than in the dark control. The very high U:L 
transcript ratio in the UV -C culture is worthy of note (it even exceeded the ratio of 
the keratinocyte control by more than 3 fold). At 24 days in culture the U:L 
transcript ratio and the sum Erccl transcription level was highest in the light control 
and lowest in the UV -B irradiated sample. There was no data for the UV -C 
irradiated sample due to total cell death. 
In summary, the sum Erccl expression decreased during the course of the 
experiment in both the dark and light controls. In the UV- irradiated samples the 
sum Erccl expression levels initially increased following irradiation and then 
decreased. The U:L transcript ratio increased in all cultures. However, in the UV -B 
irradiated culture the increase was followed by a decrease while in the UV -C 
irradiated culture there was a very large increase in the U:L ratio during the course of 
the experiment (before the culture apoptosed completely). 
Reproducibility of data in experiment 6.3: The experiment presented in figure 6.3 
was performed once due to time constraints as the end of the research period 
approached and the associated difficulties of culturing keratinocytes for an extended 
period of time (increased risk of contamination). A number of northern blots were 
performed on the samples presented and, although these early blots were of low 
quality, where samples could be compared between blots the ratio of U:L transcript 
was consistent. Although there are dramatic ratio changes during the course of the 
experiment, confirmation of reproducibility would strengthen the observations. In 
the absence of a repeat experiment, caution is required when interpreting the results. 
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Figure 6.3 Comparison of E18.5 cultures maintained in darkness to 
cultures exposed to visible light or multiple UV -B or UV -C irradiations 
Please note that figure and table continues over two pages. 
Northern blot analysis of RNA extracted from a primary culture of C57B1/6 E18.5 
dermis which had been cultured in darkness, darkness + repeated UV -B or UV -C 
irradiations or light. RNA samples were taken from controls and UV irradiated 
samples 48h post irradiation. Upper panel, total RNA from each sample (151.ig) was 
prepared, electrophoresed on a 1.4% agarose -formaldehyde gel, transferred onto a 
genescreen membrane and probed with an 800bp BamHI fragment of the Erccl 
cDNA, corresponding to exons 1 to 8. The position of the 18S rRNA is indicated. 
Lower panel, ethidium bromide staining to illustrate RNA loads. 9 -day old cultures 
= passage 1, 13- day -old cultures = passage 2, 16- day -old cultures = passage 3, 24- 
day -old cultures = passage 4 (light and dark controls, passage 3 (UV -B). 
Table 6.3 Analysis of Erccl bands in figure 6.3 
Analysis of the Erccl transcript bands from each lane of the northern blot. Each 
column of the table corresponds to the lane of the figure (northern blot and EtBr 
staining) directly above. Analysis was performed using Image J software. 
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9 days in culture 13 days in culture 
Conditions Dark 
Control 
UV -B UV -C Dark 
Control 
UV -B UV -C Ker +/+ 











1.0 0.7 0.6 0.6 1.4 1.4 0.8 
U before 
correction 
4275.7 2411.9 2773.7 5915.4 4478.7 4545.7 16775.6 
L before 
correction 
2727.6 3837.5 3677.1 3796.0 1679.9 1052.3 611.1 
U corrected 4275.7 1622.8 1677.4 3628.7 4014.1 6281.4 13549.2 
L corrected 2727.6 2582.0 2223.7 2328.6 1505.6 1454.1 493.5 
Ratio' of U:L 1.6 0.6 0.8 1.6 2.7 4.3 27.5 
Sum3 U +L 7003.2 4204.7 3901.1 5957.2 5519.7 7735.6 14042.7 
' Loading variation correction values calculated with first lane being assigned a value of 1. 
2 Ratio of upper to lower transcripts following background subtraction and loading correction 
3 Sum of upper and lower transcripts following background subtraction and loading correction 









UV -B Ker 
+1+ 







 # ' 




1.0 0.9 0.6 1.9 0.4 0.5 0.5 0.4 
U before 
correction 
4148 2263 2512 1557 3024 3473 845 16415 
L before 
correction 
1523 1146 779 16 1451 1190 1452 534 
U corrected 4148 2042 1511 2883 1313 1601 456 5803 
L corrected 1523 1034 469 30 630 549 783 189 
Ratio2 of U:L 2.7 2.0 3.2 97.3 2.1 2.9 0.6 30.7 
Sum3 U +L 5671 3076 1979 2913 1944 2150 
1239 5803 
' Loading variation correction values calculated with first lane being assigned a value of 1. 
2 Ratio of upper to lower transcripts following background subtraction and loading correction 
3 Sum of upper and lower transcripts following background subtraction and loading correction 
6.4 Effect of serum starvation on Ercc1 expression in E18.5 murine 
primary culture 
The cells for this experiment were isolated and cultured in near darkness and were 
expanded from the same primary culture pool as the cells in experiment 6.3. 
Following the observation that the Erccl expression pattern of primary cultures of 
dermal fibroblasts changed during culture and that this occurred in the absence of 
light, the following experiment was performed to investigate the possibility that 
expression could be changing in response to the cell cycle. 
Previous work in the laboratory by Dr. A. Winter (unpublished data) had 
demonstrated that the Erccl expression levels a primary dermal murine culture 
changed in response to low serum levels in the growth media. To further investigate 
this observation, a serum starvation experiment on a primary culture of E18.5 dermis 
was performed. Cells grown under optimal serum conditions were compared to cells 
that had been subjected to very low serum levels for 48 hours before being released 
from serum starvation by the application of fresh medium of optimal serum level. 
Fresh medium was also added to the control dish at this time. RNA samples from the 
non -starved and the serum -starved cultures were taken during the course of the 
experiment. The final RNA sampling took place before the control group became 
confluent, ensuring that any transcriptional changes could be attributed to the effect 
of serum starvation rather than confluence level. 
Please see figures 6.4, 6.5 and table 6.4. The U:L Erccl transcript ratio of the 
control is almost double that of the serum starved sample at the Oh time point 
(immediately following release from serum starvation). As time progresses there is 
an initial decrease in the U:L transcript ratio of the starved culture but this is 
followed by a very rapid increase in the U:L transcript ratio (by 3 hours post release), 
reaching a maximum 6 hours post release. See additional figure 6.6. Between Oh 
and 24h post release from serum starvation the sum Erccl level of the serum starved 
culture almost doubles, reaching a maximum at 24h. Between 24h and 48h post 
release from serum starvation there is a decrease in the U:L transcript ratio and sum 
Erccl in the serum starved culture. However, the final values for the U:L transcript 
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ratio and sum Erccl 48h post release are higher than those of the control at this time. 
The U:L transcript ratio of the control at 48h is half the value at Oh, so the ratio 
decreases in the control during the course of the experiment while the sum Erccl 
level increases. 
In summary, following release from serum starvation there was a decrease in the 
lower transcript production and a large increase in upper transcript production with 
the highest U:L transcript ratio 6h post release and highest Erccl production 24h post 
release. The levels of the U:L transcript and sum Erccl transcript remain higher in 
the serum starved sample than in the control sample during recovery from serum 
starvation. Therefore, the post -serum starvation expression level of the skin 
transcript is higher than the pre -serum starvation expression level. 
Reproducibility of data in experiment 6.4: The changes in Erccl expression levels 
reported in experiment 6.4 are consistent with the work of Dr. Winter in the Melton 
lab. Serum starvation experiments not presented in the thesis were performed on 
E18.5 cells isolated earlier in the research time and, although the quality of the 
northern blots was lower, the changes in expression following release from serum 
starvation occur in the same order. The correlation in expression changes in the 
earlier experiments performed during the research time and those of Dr. Winter 
suggest that the changes in the level of expression and ratio of U:L transcript are 
reproducible. 
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Figure 6.4 Effect of serum starvation on Erccl expression in E18.5 
murine primary culture maintained in darkness 
E18.5 cells were cultured in low serum for 48 hours. After 48 hours fresh medium of 
the optimal serum level was applied to all cultures (fresh medium was also applied to 
control dishes at this time). RNA samples were extracted at intervals post release 
from serum starvation. The control sample is from the same culture as the starved 
sample. Two samples are shown at 0 hours; the control has not been starved whereas 
the starved sample has been serum starved for 48 hours. Upper panel, total RNA 
from each sample (15µg) was prepared, electrophoresed on a 1.4% agarose- 
formaldehyde gel, transferred onto a genescreen membrane and probed with an 
800bp BamHI fragment of the Erccl cDNA, corresponding to exons 1 to 8. The 
position of the 18S rRNA is indicated. Lower panel, ethidium bromide staining to 
illustrate RNA loads. The culture was 12- days -old and had been passaged 2 times 
when released from serum starvation. 
Table 6.4 Analysis of Erccl bands in figure 6.4 
Analysis of the Erccl transcript bands from each lane of the northern blot. Each 
column of the table corresponds to the lane of the figure (northern blot and EtBr 





















1.0 1.0 1.0 0.6 0.5 1.1 0.8 1.4 
U before 
correction 
4639 2692 5015 14249 19796 5706 2863 10482 
L before 
correction 
4599 4761 1852 1890 3693 3253 5949 1680 
U corrected 4639 2563 4828 8791 9377 6250 2268 14720 
L corrected 4599 4534 1783 1166 1749 3562 4713 2359 
Ratio'` of U:L 1.0 0.6 2.7 7.5 5.4 1.8 0.5 6.2 
Sum3 U +L 6238 7097 6610 9957 11126 9812 6981 17080 
' Loading variation correction values calculated with first lane being assigned a value of 1. 
2 Ratio of upper to lower transcripts following background subtraction and loading correction 
3 Sum of upper and lower transcripts following background subtraction and loading correction 
Figure 6.5 Plot of the changes in Erccl U:L transcript ratios in E18.5 
following release from serum starvation. 
Plot of Erccl U:L transcript ratios in E18.5 presented in table 6.4. E18.5 cells were 
cultured in low serum for 48 hours. After 48 hours fresh medium of the optimal 
serum level was applied to all cultures (fresh medium was also applied to control 
dishes at this time). RNA samples were extracted at intervals post release from 
serum starvation. The control sample is from the same culture as the starved sample. 
Two samples are shown at 0 hours; the control has not been starved whereas the 
starved sample has been serum starved for 48 hours. The culture was 11- days -old 
and had been passaged 3 times at the start of this experiment. 
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Figure 6.6 Plot of the changes in sum Erccl transcript levels in E18.5 
following release from serum starvation. 
Plot of sum Erccl (U +L) transcript ratios in E18.5 presented in table 6.4. E18.5 
cells were cultured in low serum for 48 hours. After 48 hours fresh medium of the 
optimal serum level was applied to all cultures (fresh medium was also applied to 
control dishes at this time). RNA samples were extracted at intervals post release 
from serum starvation. The control sample is from the same culture as the starved 
sample. Two samples are shown at 0 hours; the control has not been starved whereas 
the starved sample has been serum starved for 48 hours. The culture was 11 -day- old 
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6.5 Difference in Erccl upper transcript size in murine dermal 
fibroblasts and epidermal keratinocytes 
During the course of the experiments it became clear that there was a difference 
between the size of the skin -specific Erccl transcript of murine keratinocytes 
(originally isolated from a BALB /c mouse), dermal fibroblasts isolated from C57B1/6 
mice and adult skin from a CD -1 mouse. A comparison of embryonic stem cells, 
dermal fibroblasts, adult skin and keratinocytes by northern blot analysis 
demonstrates the size difference. 
See figure 6.7. The tissues all have the expected pattern of Erccl expression for their 
type with ES cells having only the lower transcript, P2 dermal fibroblasts having 
both upper and lower transcripts at roughly equal levels and the keratinocytes and 
adult skin having predominantly upper transcript. However, closer examination of 
the upper transcripts in the fibroblasts, skin and keratinocytes reveals that the upper 
transcript in the fibroblasts is approximately 50 -100 base pairs smaller than that of 
the keratinocytes and skin. The upper transcript band in the adult skin is larger than 
in the other samples. Because this discovery was made at the very end of the 
research period, subsequent analysis of this size difference was performed by Dr. 
Winter, Melton Lab. (unpublished data). This work revealed that the difference in 
size of the upper transcript in the C57B1/6 derived fibroblasts and the BALB /c 
derived keratinocytes is due to an extra 74 base pairs in the CT repeat region of the 
BALB /c gene, resulting in a larger skin specific transcript. BALB /c also contains an 
extra 183óp between nucleotides -1046 and -1047 of the 5' flanking sequence (5' to 
the CT repeat region). 
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Figure 6.7 Difference size of upper Erccl transcript in murine dermal 
fibroblasts and epidermal keratinocytes. 
Northern blot of murine ES cells, P2 dermal fibroblasts, adult skin and wild type 
keratinocytes. Upper panel, total RNA was prepared from each sample (30µg), 
electrophoresed on a 1.4% agarose -formaldehyde gel, transferred onto a genescreen 
membrane and probed with an 800óp BamHI fragment of the Erccl cDNA, 
corresponding to exons 1 to 8. The position of the 18S rRNA is indicated. Lower 















* N.B. during interpretation of upper transcript size difference that gel is smiling slightly 
6.6 Conclusions from Erccl primary culture experiments 
Difference between in vitro and in vivo Erccl transcript expression (experiment 6.1) 
The U:L transcript ratio increases as development progresses in vivo (observation 
supported more detailed analysis by Dr. Winter, unpublished data). Proliferation in 
culture of embryonic and dermal fibroblasts isolated from developmental stages 
E13.5, E18.5 and P2 results in differences between in vitro and in vivo Erccl 
expression patterns, especially with regard to the skin -specific transcript production 
and this occurs in conditions of minimal light exposure. The U:L Erccl transcript 
ratios and sum Erccl expression levels were higher in vitro than in vivo for 
corresponding samples, indicating culture -related changes in skin -specific transcript 
expression. 
Effect of time in culture upon Erccl transcription in cells isolated from different 
developmental stages (experiment 6.2). 
The U:L transcript ratio increases with time in culture in dermal fibroblasts isolated 
from E13.5, E18.5 and P2. There was an increase in the sum Erccl transcription 
levels with progression of time in culture in the E13.5 and P2 cultures but the E18.5 
culture did not share this trend. These changes occurred in conditions of minimal 
light exposure and indicated culture -related changes in the skin -specific transcript 
expression. The results also indicated that cells isolated from developmental stages 
at which the skin -specific transcript is not normally expressed at high levels have the 
ability to express the skin - specific transcript at higher levels. 
Effect of light or multiple UV -B or UV -C irradiations upon Erccl expression of 
E18.5 in comparison to culture maintained in darkness (section 6.3) 
A dramatic increase in the U:L transcript ratio was observed in the UV -C irradiated 
culture during the course of the experiment. This could indicate UV -C induction of 
the skin -specific transcript. The peak U:L transcript ratio of the light control and 
UV -B irradiated samples (2.9 and 3.2 respectively) were only marginally greater than 
the peak U:L ratio achieved by the dark control (2.7). This suggests that neither 
ambient light nor UV -B induce novel transcript production. The U:L transcript ratio 
initially increased in the dark and light controls and the UV- irradiated samples then 
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decreased (except in the UV -C culture for which no data is available for 24 days). 
The sum Erccl expression levels of the UV -B and UV -C irradiated samples initially 
increased following the first irradiations and then decreased while the sum Erccl 
expression decreased during the course of the experiment in both the dark and light 
controls. The results may be indicative of a wavelength- dependent response to UV 
irradiation. 
Effect of serum starvation upon Erccl expression 
Following release from serum starvation there was a decrease in the L transcript 
production and a large increase in upper transcript production with the highest U:L 
transcript ratio 6h post release and highest Erccl production 24h post release in the 
serum starved sample. The U:L transcript ratio and the sum Erccl transcript 
remained higher in the serum -starved sample than in the control sample during 
recovery from serum starvation. The U:L transcript ratio of the non -starved control 
decreased during the course of the experiment while the sum Erccl level increased. 
These results indicated possible cell -cycle regulation of Erccl skin -specific transcript 
production. 
Size difference between novel skin -specific transcript expressed by cells isolated 
from different mouse strains. 
The size difference between the skin -specific transcript expressed by fibroblasts 
(derived from C57B1/6) and keratinocytes (derived from BALB /c) was demonstrated 
by means of northern blot. Later work by Dr. Winter (unpublished data) found that 
this size difference is due to a strain difference between the mice from which the 
cells were isolated. An extra 74 bps are present in the CT repeat region of the Erccl 





The aims of the work presented in this thesis were firstly to investigate the role of 
sequences present in the 5' flanking sequence of the Erccl gene in expression of the 
skin -specific transcript and secondly to investigate the role of the skin -specific 
transcript in the skin. The novel, skin -specific transcript is the predominant 
transcript in the skin. The normal Erccl transcript is expressed constitutively at low 
levels throughout the body. This led to the hypothesis that the skin -specific 
transcript may have biological significance since the Ercc 1 protein is part of the NER 
pathway, the primary pathway for removal of UV- induced DNA damage, along with 
other categories of DNA damage. Since out of all the body tissues, the skin is 
uniquely exposed to UV and consequently has the highest biological demand for 
repair of this type of damage the expression of the skin -specific transcript at high 
levels and at a high ratio to the normal transcript in the tissue is intriguing. The 
presence of the skin -specific transcript could indicate that this transcript confers an 
advantage to the skin in helping to meet the biological demand for repair in this 
tissue. The coding region of both the skin -specific and normal transcripts is the same 
size and the expression level of the transcript in the skin is directly proportional to 
protein level (Dr Winter, Melton Lab., unpublished data). The relationship between 
transcript level and protein production is interesting because if the purpose of the 
high expression level of the skin -specific transcript is merely to increase the level of 
Erccl protein in the skin then why could this not be achieved more simply by up- 
regulation of normal transcript production? Since the skin -specific transcript is 
expressed at high levels in the skin and is the predominant transcript in this tissue, 
there may be something unique about the control of expression of this transcript in 
the skin. The skin -specific transcript would, therefore, have a role in the skin that 
cannot be performed by the normal transcript, i.e. upregulation of expression in 
response biological demand or a tissue -specific expression signal. These possibilities 
are addressed during this discussion. The original hypothesis behind the work 
presented in this thesis was that the skin -specific transcript conferred an advantage to 
the skin in meeting the biological demand for repair of UV- induced damage in this 
tissue. 
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Gene expression can be constitutive and when this is the case the gene is expressed 
all the time in all tissues. This is how the normal transcript is expressed in the body, 
constitutively at low levels. In contrast, gene expression may be tissue -specific or 
induced by environmental stimuli. The control of gene expression in eukaryotes was 
described in the introduction to chapter 3 (section 3.1). The work presented in 
chapters 3, 4 and 5 was performed to investigate the importance of regions in the 5' 
flanking region of the Erccl gene to expression of the skin -specific transcript. The 
Erccl gene's 5' flanking region contains none of the classical promoter elements 
such as TATA, CAAT or GC boxes (aside from a TATA box and a GC box that are 
very distal from the TSS of either the skin -specific or normal transcript and unlikely 
to be functional). This is in keeping with the situation in other NER genes as the 
lack of classical promoter elements in the promoter regions of such genes had been 
previously reported. The promoter of the normal human ERCC1 transcript was 
characterised and found to reside within 170bp of the normal transcript's TSS (van 
Duin et al., 1987). This 170bp fragment of 5' genomic DNA was capable of driving 
expression of a complete human cDNA and corrected the DNA damage repair 
deficiency of Erccl deficient CHO43 -3B cells. However, the discovery of the skin - 
specific transcript which initiates upstream of this 170bp region suggested the likely 
presence of a second, skin -specific promoter. Because of the lack of classical 
promoter elements, other sequence elements are likely to be responsible for 
regulation of skin- specific transcript expression. A number of interesting sequence 
elements have been identified in the 5' flanking sequence of the Erccl gene, 
including the CT repeat and a more distal (CA) repeat (Hsia, Melton Lab. 
unpublished data). The CT repeat, due to its proximity to the skin -specific transcript 
TSS and the role of such regions in regulation of expression in other genes, was 
chosen for investigation as possibly being involved in skin -specific transcript 
expression. The use of minigenes was preferable over other methods of investigation 
of the skin -specific promoter for a number of reasons. Firstly, as explained in 
section 3.1, the likely presence of two promoters precluded the use of reporter genes 
for characterisation of the skin -specific promoter. This was because the presence of 
the normal promoter would interfere with detection of reporter gene product resulting 
from the skin -specific promoter activity. 
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Both the murine Hprt and Erccl loci, having respective spans of 33kb and 15kb, are 
too large for standard cloning and transfection to be successful. In contrast, the Hprt 
minigene, PGKHprt, spans a region of only 2.7kb and contained convenient 
restriction sites that enabled linearisation prior to transfection without disruption of 
the coding region. This made this minigene an ideal selectable marker for the 
transfections. In addition to the problem of the size of the murine Erccl locus, the 
region was not available as a single cloned genomic fragment. Minigenes are a 
better choice for transfection than large cloned fragments. Three minigenes had been 
constructed; Erccl MG #13 was 4.4kb smaller than the Erccl locus while the 
deletions in Erccl MG #11 and #20 resulted in these constructs being even more 
compact than MG #13. Identification of cell lines which expressed the skin -specific 
transcript, as well as cell lines which did not normally express the skin -specific 
transcript, alongside Erccl/Hprt null corresponding cell lines provided an in vitro 
environment for performing deletion analysis using the Erccl minigenes. 
The Erccl minigenes #11, #13 and #20 were available for investigation of regulation 
of skin -specific transcript expression. A transfection experiment involving Erccl 
MG #13 had previously been performed by Dr. Jim Selfridge (Melton Lab.) and this 
demonstrated that the MG corrected the UV hypersensitivity of Erccl- deficient 
fibroblasts, CHO cells and keratinocytes. This earlier experiment differed from those 
presented here in that the analysis of transcript production was by means of northern 
blot rather than RT -PCR. RT -PCR was preferable over northern blot analysis 
because it can be performed more quickly and does not involve the use of 
radioactivity Size differences between transcripts due to differential polyadenylation 
would not prevent identification of the two different transcripts by RT -PCR either. 
The Erccl MG #13 work demonstrated that the 5' flanking region included in this 
minigene contained the elements necessary for skin -specific transcript expression. 
Erccl MG #11 and #20 presented new opportunities for more detailed investigation 
of the Erccl expression patterns and skin -specific transcript production. 
Details of how the minigenes were constructed are presented in Chapter 3. To 
summarise, the three minigenes were constructed from a cloned genomic fragment, 
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pKpnl 9.3 (containing exons 1 -7) ligated to the 3' end of the Erccl cDNA 
(containing exons 7 -10) and a short 3' UTR that contained the polyadenylation 
signal. These parts were joined to the 5' flanking sequence of the Erccl gene that 
was likely to contain the skin -specific transcript's promoter. However, the CT repeat 
region, possibly part of the skin -specific transcript's promoter, was deleted from the 
flanking sequence in Erccl MG #20. The entire sequence upstream of a Kpnl 
restriction site in the flanking sequence, including the skin -specific transcript's TSS 
and the region likely to contain the promoter, was deleted in Erccl MG #11. In this 
way, deletions in the flanking sequence enabled the importance of the missing 
sequences to skin -specific transcript expression to be ascertained by performing RT- 
PCR, while the functionality of the minigenes was demonstrated by the degree of 
correction of UV hypersensitivity of Erccl deficient cells in the UV survival assays. 
The three minigenes allowed a number of issues to be addressed: 
5. Were all three minigenes functional in the three different cell lines, including that 
of the non -murine species? 
6. Were the three minigenes expressed in a manner appropriate to the cell type 
transformed? 
7. Assuming expression of Erccl MG #13 was appropriate for the cell type, did the 
deletions in Erccl MG #11 and #20 result in altered transcript expression 
patterns/UV survival when compared to cells expressing Erccl MG #13? 
The minigene transformations of the three different cell types were performed 
consecutively; the fibroblast experiments were followed by the CHO experiments 
and finally the keratinocyte experiments. Alterations to the experimental design in 
areas such as plating density were made according to the growth rate and 
requirements of the cell type. Where new possibilities for investigation of skin - 
specific transcript production arose, additional features were added to run in tandem 
with the main experiments. This allowed such issues as the possible impact of the 
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selection methods post electroporation upon clonal expression patterns and whether 
or not the selected clones were representative of transformed cells to be addressed in 
the later experiments. 
The three minigenes were used for electroporation of three cell types with varied 
Erccl expression patterns in wild type counterparts. The minigenes permanently 
integrate into the genome of the transformed cells. The three cell lines were chosen 
for their Erccl and Hprt null status. The Erccl and Hprt deficient murine embryonic 
fibroblast cell line (PF24 + #2D -4) provided an environment for testing whether 
transfection would result in production of both transcripts, as occurs in wild type 
fibroblasts. Fibroblasts were used in the early experiments because they have a 
similar pattern of expression to skin (expressing both transcripts but with a lower 
skin -specific to normal transcript ratio). Fibroblasts also have faster growth rate than 
keratinocytes and are much less technically demanding to culture. Transfection of 
Erccl and Hprt -deficient CHO cells, CHO43.3B, was performed to demonstrate the 
species specificity of the minigenes and whether they would be expressed 
appropriately in a cell line that normally only expresses the 1.1kb transcript. The 
final cell type used for transfection was Erccl and Hprt deficient murine 
keratinocytes. Wild type keratinocytes have a high skin -specific (1.5kb) to normal 
(1.1kb) transcript ratio, the expression pattern observed in skin. As long as the 
expression pattern of Erccl MG #13 was correct for the cell type, alterations in levels 
of the skin -specific transcript between cells expressing Erccl MG #13, #11 and #20 
could be attributed to the deletions in those minigenes, indicating whether deleted 
regions formed part of the skin -specific transcript's promoter or enhancer regions 
and whether lack of skin- transcript affected correction of UV- hypersensitivity. 
The UV survival assays differed slightly between the three cell lines. The initial 
plating density was determined by the growth rate of the cells. CHO cells, having 
the greatest rate of growth, were plated at a lower density than fibroblasts while 
keratinocytes were plated at a higher density. The UV range used was determined by 
the survival curves of the wild type and UV hypersensitive lines. The highest UV 
dose needed to be such that the wild type cells showed little, if any, cell death and the 
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doses were clustered where the most useful information could be obtained. Since 
wild type keratinocytes oriìgìnate from the skin they are very UV resistant when 
compared to embryonic fibroblasts and CHO cells that would not in their native state 
be exposed to UV. This meant the IN doses received by the keratinocytes were 
higher than in the fibroblast and CHO LTV assays. The keratinocytes required 
different trypsinisation conditions as they adhere strongly to the dish. surface. Plating 
conditions were also different because these cells do not grow well at low density 
(meaning that expansion of clones post transfection was complicated). Additional 
experiments on selection method post electroporation and the representative nature 
of the clones were performed on keratinocytes and these results are discussed after 
the UV and RT -PCR clone work in the three cell `lines. 
Following electroporation and selection, the ratio of HAT +UY selected colonies to 
HAT only selected colonies for the minigenes in each cell type (table 3.2,. 4.1 ana 
5.1) demonstrated that the presence of the Erccl minigene conferred resistance to 
UV because the ratio was much higher in the i wi -gene electropaiations than in the 
pBTOPGK -HPRT only electroporations. In the fibroblast ana keratinocyte 
transformations (table 3.2 and 5.1), the ratio HAT +IV selected colonies to HAT 
selected colonies was lower in the ErcclMG#11 transfection than in the Erccl 
MG #13 and 20 transfection. This is interesting o se transfection with 
Erccl MG# 11 meant the cells could not express the skim -s á i c transcript. (which is 
the wild type expression pattern). Perhaps the inability to express this apt 
resulted in fewer cells surviving the ¡IV selection than in the case of the transfectious 
with Erccl MG #13 and #20 (which enabled e wo - ion of the skin-specific 
transcript). The ratio of HAT +UTV selected colonies to HAT selected colonies was 
higher in the CHO cells transfected with Ercel MG#13 and Mc . o than with 
ErcclMG#11 and this could indicate that the cells transf with Erccf MG#Ii 
were less resistant to UV- irradiation post electroporation than those expressing Erccl 
MG#13 and #20 (table 4.1). However, without repeating the experiments with a 
greater number of dishes plated with cells for each transfection,. no conclusions 
regarding the statistical significance of the ratio differences can be drawn.. In results 
discussed later, transformation of CHO cells wit on mini-genes ##13 Ord #20) resulted in 
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production of an abnormal transcript which initiated upstream of the normal 
transcript but was not the skin -specific transcript. The hypothesis that the UV 
selection post electroporation could be selecting non -representative clones in this cell 
type led to alteration of experimental design in the keratinocyte experiments. 
The three minigenes corrected the UV hypersensitivity of the Erccl- deficient 
fibroblasts, CHO cells and keratinocytes in the clonal analysis and there was little 
difference in the level of correction between the minigenes. The only notable 
difference was a slightly greater variability in the UV survival of fibroblast and 
keratinocyte clones transfected with Erccl MG #20 in comparison to Erccl MG #13 
(figures 3.6, 3.8, 5.1 and 5.7). The correction of UV hypersensitivity presented in 
chapters 3, 4 and 5 indicated that the three minigenes were being transcribed in the 
transfected cell lines and that functional Erccl protein was being produced. These 
results also indicated that the three minigenes were functional in both murine 
(fibroblasts and keratinocytes) and non -murine (CHO) cells. Although UV survival 
assays demonstrated that the transfected cells were producing functional protein it 
was also necessary to investigate which transcripts were being expressed. These 
results indicated whether the minigenes were being expressed appropriately for the 
cell type and whether the deletions in Erccl MG #11 and #20 resulted in altered 
expression patterns in transfected cells. 
The RT -PCR results for the transfections with Erccl MG #13 (showed that the 
minigene was being expressed appropriately in the transformed fibroblasts and 
keratinocytes (figures 3.10, 5.10 and 5.13). This meant that all the elements required 
for correct expression of the skin - specific transcript were contained in the minigene. 
The expression pattern observed in transformed CHO cells was not appropriate for 
the cell type as skin -specific transcript was expressed in the clones, although the 
bands detecting skin -specific transcript were very faint in 3 out of 4 of the clones (so 
there was a semblance of the correct expression pattern as long as this is proportional 
to transcription level) (figure 4.5). This indicated that low levels of skin -specific 
transcript were being produced. Speculation upon the possibility that post 
electroporation UV- selection could be selecting clones that had abnormal expression 
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led to the use of pools of cells and a comparison of cells selected with and without 
UV in later experiments. Any advantage conferred by the expression of the skin - 
specific during the UV selection post -electroporation was not demonstrated by the 
UV survival assays as the presence of skin- specific transcript in the CHO cells did 
not improve the UV survival ability of the cells when compared to the wild type 
(figure 4.2). The abnormal expression could also be due to the sequence in the 
minigene being murine in origin or lacking in a sequence element required for 
correct expression in CHO cells. 
The effect of the deletion in Erccl MG #11 upon transcript expression needs to be 
considered when the RT -PCR results are analysed. Because the deletion removes the 
TSS of the skin -specific transcript it is not possible to express the skin transcript 
following transfection with this minigene, even in cell lines where the skin -specific 
transcript is produced in wild type cells. Transfection with the minigene resulted in 
production of the normal (1.1kb) transcript in fibroblasts, CHO cells and 3 of the 5 
keratinocyte clones (the exceptions are discussed later) (figures 3.11, 4.6, 5.11 and 
5.13). This expression patterns were as expected in the three cell types with 
fibroblasts and keratinocytes unable to express the skin -specific transcript due to the 
deletion in MG #11. The lack of skin -specific transcript in the cell types that express 
it in their wild type state, fibroblasts and keratinocytes, did not result in less 
correction of UV hypersensitivity when compared to cells transfected with Erccl 
MG #13 expressing both transcripts. 
The deletion in Erccl MG #20 was made to investigate the importance of the CT 
repeat region for production of the skin -specific transcript. The results have to be 
interpreted in parallel with those of Erccl MG #13 since the only difference between 
the two minigenes is the deletion in Erccl MG #20. The RT -PCR work on Erccl 
MG #13 demonstrated correct expression of both transcripts in fibroblasts and 
keratinocytes (figures 3.10 and 5.10 and 5.13). Transfection with Erccl MG #20 
resulted in an altered expression pattern in three out of four fibroblast clones and the 
normal fibroblast expression pattern in one clone (figure 3.12). Of the three clones 
expressing the skin -specific transcript, the level of skin -specific transcript was 
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greatly reduced in 2 of the clones when compared to the RT -PCR pattern observed in 
fibroblasts transformed with Erccl MG #13 (figure 3.10). Because the RT -PCR 
technique used in these experiments was not quantitative it is only possible to 
speculate upon this observation. If the reduced brightness in the bands of the RT- 
PCR performed upon the cells transfected with MG #20 is proportional to the original 
level of transcript expressed in the cells then the CT repeat region deleted in Erccl 
MG #20 may be important for correct expression of the skin -specific transcript in 
fibroblasts. However, the clones were all expressing the upper so, in a purely 
qualitative interpretation, there is no difference between the cells transfected with 
MG #13 or #20. As stated earlier, the qualitative reporting on band levels is for 
interest only and any observations upon differences between minigene transfection 
results drawn from the level of RT -PCR product bands rather than the absolute 
absence or presence of bands would have to be confirmed or refuted by use of 
quantitative RT -PCR. The deletion in MG #20 did not prevent skin -specific 
transcript production so this region is not absolutely crucial for skin- specific 
transcript production but it may be required for regulation of expression and this 
could be further investigated using qualitative RT -PCR. The expression pattern of 
Erccl MG #20 in transformed keratinocytes was correct for the cell type. A 
difference in the level of brightness in the RT -PCR on one HAT only selected clone 
was observed, the level of skin -specific transcript appeared to be lower than in the 
other clones (5.12), but this could be an artefact of the RT -PCR reaction and would 
need to be further investigated by use of quantitative RT -PCR to discover if this was 
a true reflection of a difference in the original expression level of the transcript. As 
in the case of the Erccl MG #11 transfections, lack of skin -specific transcript in cells 
that would normally express this transcript did not lead to a reduction in correction of 
UV hypersensitivity in comparison to cells transfected with Erccl MG #13 (figures 
5.1 and 5.7). The expression pattern in Erccl MG #20 transfected CHO43.3B cells 
was incorrect for the cell type in 3 of the 4 clones (figure 4.7 as the presence of 
product bands detecting expression of the upper transcript demonstrated an incorrect 
expression pattern in the 3 clones. Although the level of band intensity for the skin - 
specific transcript product varied between the clones and was generally quite low, 
this is a qualitative interpretation and would have to be confirmed/refuted using 
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Keratinocytes clones transformed with Erccl MG #13 or #20 did not demonstrate 
greater skin- specific transcript production in clones selected by UV post - 
electroporation when compared to clones selected by HAT only (figures 5.10 and 
5.12). In the clones transfected with Erccl MG #11, a transcript initiating upstream 
of the normal transcript (but not the skin -specific transcript) was present in the clones 
selected by UV but not HAT alone (figure 5.11). Keratinocyte pools transfected with 
the Erccl MG #11 also had this unusual expression pattern (figure 5.13). These cells 
were producing the expected 1.1kb transcript but the cells that had undergone UV 
and HAT selection were also expressing a transcript that was detected by the B/5 
reaction but not the A/5 reaction, meaning it was not the skin -specific 1.5kb 
transcript. There are two possibilities that could explain transcripts initiating 
upstream of the 1.1kb transcript in cells transformed with MG #11; transcripts were 
initiating somewhere between primer A and primer B's hybridisation sites or in the 
adjacent plasmid sequence. Because the primary transcript in keratinocytes is the 
skin -specific transcript there may be selective pressure for initiation of transcripts 
upstream of the normal transcript if this confers a survival advantage when the cells 
are irradiated with UV. Perhaps in the absence of the skin- specific transcript, the B/5 
reaction was able to detect transcripts initiating downstream of the primer A 
hybridisation site. Because the B/5 products were only observed in the UV selected 
clones this may indicate that this is the case and that there was selection for cells 
expressing upstream transcripts in the post electroporation UV selection regime. If 
the transcript being detected by the B/5 reaction was initiating between the Kpnl site 
and the primer B hybridisation site then it would not contain the primer A 
hybridisation site. The skin -specific transcript is heterogeneous and not all the skin 
transcripts start at the `skin' TSS. This heterogeneity could spread as far as the 
region between the Kpnl site and the primer B hybridisation site. Such transcripts 
can only be detected by RT -PCR if the 1.5kb transcript is missing and would reflect 
a pressure to initiate upstream of the normal transcript in keratinocytes. 
Alternatively, there could be a structural explanation for the positive B/5 reaction. 
The transcripts detected could be initiating in the plasmid DNA upstream of the 
primer B hybridisation site. In this case the transcripts would be mere artefacts. The 
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cells which had not been subjected to UV irradiation did not have any transcript 
initiating upstream of the 1.1kb transcript. The presence of the unusual transcript in 
the keratinocytes transfected with Ercc1 MG #11 did not confer greater correction of 
UV hypersensitivity when these clones were compared to those that were expressing 
only the 1.1kb transcript. The lack of skin -specific transcript did not reduce the UV 
hypersensitivity in the keratinocytes and fibroblasts transfected with Erccl MG #11, 
which expressed only the 1.1kb transcript. The results of transfection with Erccl 
MG #11 are intriguing because the selection with UV post electroporation in 
keratinocytes appeared to result in selection of clones which were expressing any 
transcript initiating upstream of the 1.1kb transcript when compared to keratinocytes 
that had HAT selection only. This suggested there could be a selective advantage to 
possession of such a transcript in conditions of UV exposure. 
A second experiment was running in conjunction with the keratinocyte clonal 
transfections. The clones chosen for expansion were representative in terms of size 
when compared to other clones in the dish but perhaps due to the small number of 
clones studied, random selection resulted in expression patterns that differed slightly 
from the `average' expression pattern of transfected cells. Shifts in expression 
patterns could possibly be more obvious in entire populations of clones treated as 
pools and an `average' expression pattern of transfected cells could be observed. For 
each minigene two pools were available - one selected with HAT only post 
electroporation and one selected with HAT + UV. There was no difference between 
the UV survival between transfected clones and pools (figures 5.3, 5.6 and 5.9) or 
between pools selected by UV and pools selected without UV (figures 5.2, 5.5 and 
5.8). However, when the RT -PCR results for the pools were analysed there was a 
difference between the two selection methods (figure 5.13). Pools transfected with 
Erccl MG #13 and selected by either method had the normal pattern of expression. 
Of the keratinocyte pools transfected with Ercc1MG #11, the pool that underwent 
HAT selection expressed only the 1.1kb transcript while the pools selected with HAT 
+ UV was expressing a transcript detected by the B/5 reaction but not the A/5 
reaction, as with the keratinocyte clones transfected with Erccl MG #11. The pool 
transfected with MG #20 and then exposed to HAT was expressing both transcripts, 
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as was the pool transfected with this minigene and exposed to HAT + UV. In 
quantitative terms, both were the same. There were differences in the intensity of 
product bands for the skin -specific transcript, with the pool exposed to HAT only 
having much a lower intensity product band than that of the pool selected with HAT 
+ UV. This could be an indication of selection for higher expression of the skin - 
specific transcript following UV exposure during selection if the intensity of the 
band is directly proportional to the level of transcript or it could be a mere artefact of 
the RT -PCR process. This would be confirmed or refuted by quantitative RT -PCR 
but can only be speculated upon in the absence of such data.. 
Assuming the difference in expression of skin -specific transcript was genuine and 
due to the UV component of the selection post electroporation, it was hypothesised 
that UV irradiation of a pool selected with HAT only should induce a shift in 
expression pattern (in terms of band intensity) towards that of the pool selected with 
HAT + UV. In the absence of follow -up experiments using quantitative RT -PCR to 
demonstrate whether the intensity of product band was a true reflection of the 
original transcript levels or merely an artefact of the reaction the following 
observations are merely speculative. This is because in terms of quantitative 
differences, the bands are present in both pools and , therefore, there is no difference 
between the pools . There were qualitative differences in the intensity of the bands 
but the RT -PCR used was not quantitative so these are reported for interest only and 
should not be over -interpreted. The keratinocyte pool transfected with Erccl 
MG #20 showed the greatest difference in skin -specific transcript production between 
the two selection regimes in terms of band intensity, with less skin -specific transcript 
following HAT only selection. Following RT -PCR on RNA extracted from the HAT 
selected pool 24 hours after a UV dose of 6 Jm 2 was applied, an increase in the 
intensity of the skin -specific transcript product band was observed when compared to 
the non -irradiated sample (figure 5.14). Speculatively, this could indicate that UV -C 
irradiation had resulted in increased expression of the skin -specific transcript. 
However, in the absence of follow -up experiments using quantitative RT -PCR no 
conclusions may be drawn from observations upon product band intensity, only upon 
the absolute presence or absence of product in RT -PCR reaction. The pattern of 
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expression observed with keratinocyte pools transfected with MG #20 and treated 
with UV + HAT or HAT alone was interesting, as there was a possible suggestion 
that UV irradiation led to an up- regulation of upper transcript production. To study 
this using quantitative RT PCR would confirm that the results reported here are a 
reflection of actual differences in expression level rather than artefacts of the RT- 
PCR process. 
Following my departure form the Melton Lab. the cells used in these experiments 
were re- tested to check the reproducibility of the results I reported with regard to 
MG #20 transfection and HAT or HAT +UV selection; RT -PCR performed upon 
RNA extracted from cells frozen during my research period (which had been 
transfected with MG #20 then treated with HAT + UV or HAT alone) generated the 
same RT -PCR results both in terms of the absence or presence of bands and the 
intensity level of the bands as reported here, but this was not quantitative RT -PCR. 
It is accurate to say that the patterns of expression visualised by the RT -PCR process 
presented here were consistent during the course of the experiment between clones; 
i.e. the same pattern of expression was obtained for any particular clone /pool as long 
as the cycle number and initial quantity of RNA was identical. Increased cycle 
number or quantity of RNA used for the RT -PCR resulted in brighter bands but this 
amplification was consistent across the samples and the pattern of expression was 
still preserved. However, without the use of quantitative RT -PCR, the observations 
regarding the level of transcript expression when investigated with RT -PCR 
presented in this thesis must be interpreted with caution and are reported for interest 
only. The RT -PCR technique used is not quantitative and interpreting levels 
following non -quantitative RT -PCR is not an appropriate use of the technique. 
However, the actual presence or absence of transcript detected via the RT -PCR 
experiments presented is an appropriate use of the technique and reproducible. 
Strictly adhering to reporting only the absence or presence of transcript renders the 
difference in 'levels' reported irrelevent, making the differences between pools of 
keratinocytes transfected with MG #20 and treated with HAT or HAT +UV zero. 
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The work in the minigenes, therefore, indicated that the 1.05kb Erccl gene flanking 
sequence contained all the elements necessary for production of the skin -specific 
transcript. The work also slightly indicated that the CT repeat region may be 
important for correct expression of the skin -specific transcript. Deletion of this 
region resulted in an absence of skin -specific transcript expression in comparison the 
cells transfected with MG #13 in one of the fibroblast clones. Observations upon 
differences in product band intensity in the RTPCR analysis of the transfected clones 
and pools are of reduction in the intensity of skin -specific transcript product bands in 
cells that normally express the skin -specific transcript when transfected with MG #20 
in comparison to MG #13. The work also slightly indicated that expression of the 
skin -specific transcript may be UV -C inducible in the keratinocyte pool transfected 
with Erccl MG #20 (lacking the CT repeat region) but this observation is also drawn 
from product -band intensity differences in the RT -PCR results and, for the reasons 
explained, in the absence of follow -up work with quantitative RT -PCR no 
conclusions may be drawn from such observations and they remain mere speculation. 
Further work with the minigenes could include deletion of the 170bp region that 
harbours the normal transcript's promoter to investigate the effect of removing the 
normal transcript upon correction of UV hypersensitivity of Erccl -deficient cells. 
Deletion of the CA repeat region located upstream of the skin -specific transcript's 
TSS would be interesting because CA repeats can function as enhancers in the same 
way as CT repeats, which had been shown to be involved in skin -specific transcript 
production. The CT repeat region is discussed in more detail later. 
In addition to the minigene deletion work for identification of regions of importance 
to expression of the skin -specific transcript, the role of this transcript in the skin was 
also investigated. The normal developmental pattern of Erccl expression in C57B1/6 
mice is a gradual increase in expression of the normal transcript early in development 
to a final constitutive, low level of expression. In the skin, the level of skin -specific 
transcript rapidly increases after birth and the ratio of skin -specific to normal 
transcript increases until the adult pattern of a high skin -specific to normal transcript 
ratio is achieved. At the time the experiments presented in this thesis were planned, 
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the hypothesis was that exposure to light after birth could induce the change in 
expression of the skin- transcript in the skin. Because investigation of factors 
affecting expression of the skin -specific transcript could more easily be performed in 
vitro, primary culture experiments were carried out on cells isolated from C57B1/6 
mice from various developmental stages. The normal transcript is not UV inducible 
but the skin -specific transcript required investigation. No skin -specific transcripts 
have been reported for the other genes involved in NER but skin is a difficult tissue 
to work with due to the high levels of nucleases that degrade RNA (another reason 
why in vitro investigations of transcript induction are preferable) and it may simply 
be that expression patterns in skin have not received much attention. The work on 
the keratinocyte pools in the minigene transfections had shown an increase in upper 
transcript production in response to UV -C irradiation and the observation that the 
level and ratio of skin- transcript increased after birth suggested that the novel 
transcript could, indeed be UV inducible. 
Isolation of cells from various developmental stages required different methods 
because of the difficulty associated with separation of the skin from the rest of the 
tissue in the early stages. This meant that E13 -E15 isolated fibroblast cells were 
from dissaggregated whole embryos rather than dermis. In the later stages of 
development the dermal fibroblasts were isolated by removal of skin and separation 
of dermis from epidermis. In the primary culture analysis, northern blots were 
performed rather than RT -PCR because northern blots enable more quantitative 
comparison of expression levels. 
In experiment 6.1 the Erccl transcript expression patterns of the primary cultures 
were compared to that of the corresponding developmental stage and differences 
were observed. The developmental pattern observed in the in vivo samples followed 
that described earlier (Dr. Winter, unpublished data), with increasing levels of skin - 
specific transcript and ratio of skin -specific to normal transcript as development 
progressed. However, the expression pattern observed in the cultures isolated from 
the developmental stages differed and was more similar to developmental expression 
patterns observed later in development in vivo. It was as if culturing the cells 
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accelerated the change in skin -specific expression observed in vivo. What was more 
remarkable was that this happened in the absence of light as these cultures had been 
isolated and cultured with minimal light exposure and the small exposure during 
isolation had been to natural daylight through glass (rather than direct sources of UV 
such as fluorescent lighting). This either meant that this small exposure to visible 
light had induced the changes or that these changes occur in the absence of light and 
UV. What was clear was that a factor related to culture of the cells induced a change 
in skin -specific transcript expression. 
The changes occurring in culture were related to proliferation in culture. In 
experiment 6.2, E13.5, E18.5 and P2 cells were isolated and cultured, with RNA 
sampling taking place during culture. The level of skin -specific transcript and the 
ratio of skin -specific to normal transcript increased with time in culture for cells from 
all three developmental stages (even though the later skin -specific transcript 
expression pattern was atypical for the corresponding developmental stage) and this 
occurred in the absence of light/UV. This indicated that the level of the transcript 
was affected by proliferation in culture. The possibility that growth factors in the 
serum could be involved is discussed later. 
UV -B and UV -C were both tested as possible skin -specific transcript induction 
factors (experiment 6.3). As detailed in the introduction to chapter 6, UV -B and UV- 
C are both components of the solar spectrum and exposure to either results in DNA 
damage in the skin. UV -C is not naturally encountered as it is filtered out by the 
ozone layer while UV -B exposure varies according to a number of factors, for 
example, angle of the Sun in the sky). Both types of UV irradiation result in the 
same sort of damage but both were tested because UV -B is encountered in nature. 
For a set source height, a dose (Jm 2) is more quickly supplied by UV -C than UV -B 
because UV -C has a shorter wavelength. Irradiation results in the same types of 
DNA damage with both UV -C and UV -B, primarily CPDs and (6- 4)PPs. Interstrand 
crosslinks are very disruptive to cellular processes such as transcription and division 
as the DNA strands cannot be separated at the site of the interstrand cross -link. In 
the multiple irradiation experiments, dermal fibroblasts isolated from E18.5 dermis 
were cultured in darkness and repeatedly exposed to either UV -C, UV -B or visible 
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light. In vivo, cells from this developmental stage have a very low skin -specific 
transcript ratio and because the embryos are in utero they are not exposed to light. If 
cells for this experiment had been isolated from pups, the exposure to light following 
birth would have been a variable in the experiment. Because the skin -specific to 
normal transcript ratio and the level of transcript had been shown to increase in the 
absence of light in experiment 6.1, irradiated samples could only be compared to 
non -irradiated samples that had been cultured in darkness for the same length of time 
as the irradiated sample. The `dark controls' were also the controls for time in 
culture changes. The experiment showed that there was only a very small difference 
between the skin -specific to normal transcript ratio and expression level when light 
and UV -B irradiated cultures were compared to dark controls and this was unlikely 
to be significant. However, there was a massive increase in the skin -specific to 
normal transcript ratio (U:L) in the UV -C irradiated sample when compared to the 
dark control. This suggested that expression of the skin -specific transcript could 
possibly be induced by UV -C irradiation. This result supports the earlier observation 
that skin- specific transcript production was increased by UV -C irradiation of 
keratinocyte pools transformed with Erccl MG #20 (experiment 5.6). Because the 
CT repeat region is deleted from Erccl MG #20, UV induction of the skin transcript 
could not involve interaction between transcription factors expressed/activated 
following UV irradiation and the CT repeat region. UV- induction of the skin - 
specific transcript would have to be via another part of the 5' flanking sequence. The 
apparent induction of skin -specific transcript expression would require further 
experimentation before firm conclusions regarding the UV -C inducibility of the skin - 
specific transcript could be made. UV -C has a shorter wavelength than UV -B and 
DNA absorbs maximally within the wavelength range of UV -C. It is possible that 
the skin -specific transcript is induced by UV in a DNA damage- dependent manner. 
Equivalent doses of UV -C and UV -B are not absorbed equally by DNA so perhaps a 
higher dose of UV -B would have resulted in induction of skin -specific transcript 
expression. This possibility could be addressed in future work. 
The non -light related changes in skin -specific transcript expression observed in 
cultured cells were also investigated further. The effect of serum starvation upon 
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Erccl expression in E18.5 murine primary culture was interesting (experiment 6.4). 
During serum starvation the level of both the skin -specific and normal transcripts 
dropped. However, following release from serum starvation there was a decrease in 
the normal transcript production and a large increase in skin -specific transcript 
production with the highest skin -specific to normal transcript ratio 6h post release 
and highest Erccl production 24h post release. What was also interesting was that 
the skin -specific to normal transcript ratio and the sum Erccl transcript level 
following release from serum starvation exceeded the pre -starvation level. In 
comparison, the skin -specific to normal transcript ratio of the non -starved control 
decreased during the course of the experiment while the sum Erccl level increased. 
Serum starvation causes arrest of the cell cycle in the G1 stage and this response is 
due to the reduction in the supply of growth factors. Following release from serum 
starvation there are two categories of gene response; the first genes to be expressed 
following release are the `early response' genes and these are mainly transcription 
factors required for subsequent expression of the `late response' genes. The recovery 
pattern of Erccl expression following serum starvation fits with the `late response' 
pattern and it is therefore likely that the transcription factor of Erccl is an `early 
response' gene. If the level of transcription factor following recovery from serum 
starvation was higher than prior to serum starvation then that would be a method by 
which expression of the skin -specific transcript could be higher following release 
from serum starvation than prior to starvation. Serum may also explain the 
observation that Erccl expression changes following isolation and culture, with 
expression of the skin transcript in cells isolated from developmental stages at which 
the skin- transcript would not normally be expressed. As long as the cells are in vivo 
the growth factors are being supplied in a developmentally regulated way. Once the 
cells are isolated and cultured in serum, it may be that the growth factors supplied 
cause production of transcription factors that would not normally be produced in vivo 
until later in development. The cells could then react by increasing production of the 
skin -specific Erccl transcript. This response would be programmed into 
development and the pattern of skin -specific Erccl transcript expression observed in 
the skin would then be tissue -specific rather than induced, although the two 
mechanisms need not be mutually exclusive. 
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It is possible that the CT repeat acts as a tissue -specific enhancer of skin -specific 
transcript production. Although the CT repeat is 3' to the skin -specific transcript's 
TSS, CT repeats can act from downstream so the location of the CT repeat need not 
preclude this activity. This speculation is supported by the discovery that followed 
from experiment 6.5, the discovery being a size difference between the skin -specific 
transcript expressed by fibroblasts (derived from C57B1/6) and keratinocytes 
(derived from BALB /c). Unfortunately this difference was identified very late in the 
research period, so the sequence work to investigate the difference in size was 
carried out by Dr. Winter (unpublished data). The size difference was found to be 
due to a strain difference between the mice with an extra 35 bps present in the CT 
repeat region of the Erccl gene's 5' flanking region in BALB /c mice. 
Expression of upper transcript in different mouse strains: Strain specific differences 
in the size of the Erccl upper transcript were discovered during the course of the 
experiments presented in this thesis. BALB /c mice have an extra 74 base pairs in 
their CT repeat region of their Erccl gene when compared to C57B1/6 mice. 
BALB /c mice also have an extra 183bp between nucleotides -1046 and -1047 of the 
5' flanking sequence (5' to the CT repeat region) - see figure 6.7 for size comparison 
of Erccl upper transcripts. C57B1/6 mice and 129 /Ola mice have the same size of 
CT repeat, while BALB /c mice have an extra 35 bps. The CD -1 CT repeat 
information is not available at this time. Figure 7.1 shows that the upper transcript 
expression level in the skin of mice from the mentioned strains increases with the 
level of skin -specific Erccl transcript expressed, although quantification would be 
required before conclusions on proportionality can be drawn. In figure 7.1, the 
loading is equal. There are differences in the level of upper transcript expressed 
between the mouse strains. The level of upper transcript is lower in the mouse 
strains that have the smaller number of CT repeats. C57B1/6 and 129 /Ola have low 
levels of upper transcript expression and both have 35 fewer bp in their CT repeat 
regions that BALB /c; BALB /c mice have a high level of upper transcript expression. 
The number of CT repeats in the CD -1 mice has not been determined but this strain 
has a higher level of upper transcript expression than the BALB /c mice, which may 
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be due to strain variation in the 5' promoter region of the Erccl gene. As removal of 
the CT repeat region seemed to cause a reduction in upper transcript expression in 
transformed keratinocytes (chapter 5, assuming RT -PCR product band intensity is 
proportional to transcript level), the observations relating to strain variation in CT 
repeat number and Erccl upper transcript expression would appear to support the 
importance of the CT repeat region to expression of the upper transcript, assuming 
product band intensity is proportional to transcript level in the RT -PCR data. 
CT repeats result in formation of non -B -DNA structures and increasing the number 
of CT repeats has been shown to increase non -B -DNA structure formation and 
resulting transcription of a reporter gene (Xu and Goodridge, 1998). CT repeats are 
often found in promoters that lack classical promoter elements and are capable of 
initiating transcription (Weis and Reinberg, 1992 and 1997). Developmentally 
regulated and tissue specific transcription from genes with CT repeat regions has also 
been reported (Bevilacqua et al., 2000). It would be interesting to investigate whether 
the skin -specific transcript expression could be induced by higher levels of EGF in 
growth medium via the CT repeat region. Growth factors, including EGF, have been 
shown to interact with a protein that binds to CT repeats (Wyse et al., 2000) and CT 
repeats have been identified in genes that have more than one TSS, such as the 
chicken malic enzyme gene, where the (CT)7 repeat binds single- stranded DNA - 
binding protein and is essential for promoter activity (Hodnett et al., 1996; Xu and 
Goodridge, 1996). CT repeats regulate transcription of genes in a diverse range of 
organisms, (CT) = (GA)n, including the Drosophila heat shock proteins hsp26 and 
hsp70 in which GAGA transcription factor (GAF) binds the site where it can cause 
promoter distortion (Lu et al., 1993; Wilkins and Lis, 1998 and 1999). A novel 
murine GAGA box -binding factor, which is structurally related to the Drosophila 
GAGA factor has been reported. This factor was isolated by in vivo transcription 
factor titrations with double- stranded oligodeoxyribonucleotides and antibodies, 
perhaps a similar method could be used to isolate any factors interacting with the CT 
repeat region in the mouse Erccl gene (Bevilacqua et al, 2000). The skin -specific 
expression pattern of the Erccl skin- transcript could result from control of 
expression in a tissue -specific manner via the CT repeat region. 
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An obvious difference between the mouse strains mentioned is their coat colour. 
C57B1/6 mice are black, 129 /Ola are light yellow, BALB /c and CD -lmice are non - 
pigmented (albino). The two albino strains had higher expression of upper transcript 
than the pigmented strains. If there was greater biological demand for high skin - 
specific transcript expression in mice lacking protective dark pigmentation then this 
would be good evidence for the importance of the upper transcript in the skin to 
meeting biological demand for UV damage repair. Experiments performed 
subsequent to the end of my research involved crossing BALB /c and C57B1/6 mice 
to segregate the Erccl gene from those determining coat colour. Analysis of the F2 
mice revealed that the C57B1/6 or BALB /c Erccl allele (or something tightly linked 
to it) determines the level of expression. Recombinant black mice containing the 
Balb /c Erccl allele and recombinant white mice containing the C57B1/6 Erccl allele 
are being studied to determine the biological significance of the level of skin -specific 
Erccl transcript expression on a non -pigmented background. 
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Figure 7.1 Level of expression of Erccl skin -specific transcript is 
directly proportional to the level of Erccl protein in skin. 
This work was performed by Dr. Winter, Melton Lab. The upper panels show the 
northern analysis of the Erccl expression in four mouse strains (C57BL /6, CD -1, 
BALB /c and 129 /Ola) with keratinocyte and ES cell controls. The ethidium bromide 
staining of the 18S rRNA is shown as a loading control. The western analysis shows 
the corresponding level of Ercc 1 protein in the skin and the GAPDH reprobe is the 
loading control. 
With regard to a possible correlation between CT repeat region and skin -specific 
transcript expression, C57BL /6 mice and 129 /Ola mice have the same size of CT 
repeat while BALB /c mice have an extra 35bps. The CD -1 mouse CT repeat 















































































The possible UV -C induction of the skin -specific transcript expression, speculatively 
reported in this thesis, may involve a different method of skin -specific transcript 
expression control. The possible UV -C induction of skin -specific transcript 
expression in keratinocytes pools transformed with Erccl MG #20, which lacks the 
CT repeat region, suggests the possibility of a CT repeat independent mechanism of 
UV -C induction. Such a method of regulation would allow the steady -state level of 
skin -specific transcript to be high and under control of e.g. the CT repeat region, 
while also allowing for induction of skin transcript expression at times of high UV- 
induced damage by a separate mechanism. It may be that the skin -specific transcript 
is required in the skin because the constitutive low -level of normal transcript is under 
the control of a transcription factor that is expressed at a set level and this cannot be 
altered to meet the higher biological demand for DNA damage repair in the skin. 
Speculatively, a possible way that UV- induced DNA damage could be linked to skin - 
specific transcript production would be if p53 or a downstream transcription factor 
was a transcription factor for the skin -specific transcript. p53 is a multifunctional 
protein and is a transcription factor for over 100 genes. The protein is involved in 
regulation of apoptosis, the cell cycle and DNA repair. The work linking p53 to 
regulation of DNA damage repair is very recent and is reviewed in Adimoolam and 
Ford, 2003. Following exposure to DNA damaging agents such as UV, the p53 
protein is stabilised via post translational modifications and downstream target genes 
containing the p53 response element are activated. The products of these genes may, 
in turn, act as transcription factors for other genes. p53 can also interact via protein - 
protein interactions. p53 has been shown to increase expression of a number of 
genes involved in the early stages of NER. mRNA and protein products of the XPC 
gene increase in a p53 and DNA damage- dependent manner (Adimoolam and Ford, 
2002). This ratio of skin -specific transcript to normal transcript was dramatically 
increased by UV -C irradiation in experiment 6.3, so perhaps the same mechanism of 
induction could be taking place as with the XPC gene. The XPC gene promoter 
contains a p53 response element and the Erccl gene's 5' flanking region could also 
be searched for such an element. p53 directly binds to the NER proteins XPB and 
XPD (subunits of TFIIH), where it has been reported to inhibit helicase activity 
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(Wang et al., 1995). The product of the BRCA1 gene has also been shown to 
increase expression XPC in response to DNA damage and is, therefore, involved in 
the DNA damage recognition step of NER independently of p53 (Hartman and Ford, 
2002; Adimoolam and Ford, 2003). The responsiveness of skin- transcript expression 
to this gene product could also be investigated. XPC is required for GGR but is not 
essential for TCR (Venema et al, 1990 and1991) and cells deficient in p53 are 
deficient in GGR. XPC is essential for removal of CPDs and (6 -4) PPs in vivo 
(Emmert et al., 2000). Within minutes of UV irradiation, XPC binds to UV- induced 
CPDs, along with another protein expressed in response to p53 levels called p48. 
The basal level of these proteins controls the initial rate of GGR of CPDs. It has 
been suggested that the function of the UV- induction (via p53) of these proteins is to 
replenish the level of these repair factors following proteosome mediated degradation 
to ensure that the levels are sufficient for lesion repair. It has also been suggested 
that for these genes, the basal level of expression is important for the repair of the (6- 
4) PPs while the inducible levels are more important for the repair of CPDs. It may 
be that the high level of skin -specific transcript in the skin (perhaps caused by a 
tissue -specific response to the CT repeat region) is important for the removal of (6 -4) 
PPs while the possible UV- induction of the skin transcript (perhaps by p53 mediated 
expression in response to UV- induced DNA damage) is important for removal of 
CPDs in the same manner as with the p53 mediated XPC and p48 response 
mentioned. 
The skin -specific Erccl transcript expression appeared to be induced by UV -C 
irradiation and also by proliferation in culture in experiments (6.1 -6.4). UV -C 
induction of the DNA ligase I gene, which is involved in NER, has also been 
reported and expression of this gene is also induced by cellular proliferation. This 
work was performed in human fibroblasts and p53 was proposed as a possible factor 
in the UV- induction (Montecucco et al., 1992 and1995). Further work on the UV- 
induction of the Erccl skin -transcript need to be carried out. Because of the 
possibility that immortalised cell lines have distrupted p53 response /production and 
the possibility that p53 could be involved in skin -specific transcript expression in 
response to DNA damage, the p53 status of cells used for the experiments should 
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perhaps be ascertained prior to the UV- induction experiments with the Erccl skin - 
specific transcript. If p53 was required for induction of the skin -specific transcript 
following UV irradiation, DNA damage could accumulate more quickly in skin cells 
that were becoming cancerous and had lost p53 activity, due to lack of p53 resulting 
in loss of the UV- induction response of the skin -specific transcript causing lower 
Erccl protein levels and less DNA damage repair. A link between proliferation in 
tumour cells and skin -specific transcript production could be important biologically 
as a means to reduce the rate of damage accumulation in such cells; DNA ligase I is 
expressed at higher levels in human tumours than in benign normal tissues and it has 
been suggested to be more important in proliferating tissue than in resting cells (Sun 
et al., 2001). The levels of skin -specific transcript and the ratio of skin -specific to 
normal transcript increased in response to proliferation in culture and release from 
serum starvation (exp. 6.1, 6.2 and 6.4) so the presence of the skin -specific transcript 
may also be more important in proliferating tissues than resting cells. 
Interestingly, considering the possible induction of the skin transcript in response to 
UV -C irradiation but not UV -B in experiment 6.3 and, a wavelength specific effect 
has been observed in the p53 mediated -NER. Two similar experiments in which 
CPDs were introduced to both the transcribed and non -transcribed strand of the p53 
gene demonstrated that when the lesions were introduced using UV -B, GGR and 
TCR was enhanced by the addition of functional p53, suggesting that p53 was 
required for both GGR and TCR. However, when UV -C was used the results 
suggested that p53 was only involved in TCR (Mathonnet et al., 2003). This 
highlights a difference in NER control by p53 in response to UV -B or UV -C induced 
DNA damage. In the UV- irradiation experiment 6.3, the skin -transcript to normal 
transcript ratio rose dramatically in response to the UV -C irradiation but not the UV- 
B irradiation. If the skin -specific transcript expression is induced by p53 then this 
might be why there was a difference between the skin -specific transcript expression 
response to UV -C and UV -B induced DNA damage. The choice of UV source will 
need to be considered in future work on Erccl if this is the case since induction of 
the skin -specific transcript may be wavelength- dependent. Work on skin- transcript 
induction in vivo in our laboratory used UV -B and the transcript was not induced. 
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However, because UV -B is encountered in nature while UV -C is filtered out of the 
solar spectrum before reaching ground level, UV -B is the more biologically relevant 
DNA damage source. The possibility of induction of the skin -transcript by UV -C 
but not UV -B means that the choice of UV source for future work on the skin - 
specific transcript and more generally in terms of modelling cancer development in 
mice will require consideration. If the novel -transcript is induced by UV -C and not 
UV -B this would be once of very few examples of a UV- C/UV -B specific response 
reported. This is interesting because these sources are presumed to cause similar 
biological effects in most studies of this kind. 
To revisit the original aims of the research presented in this thesis, the minigene 
work was performed to identify elements of the 5' flanking region of the Erccl gene 
that could be responsible for the observed skin -specific Erccl expression pattern. 
Erccl MG #13 has been shown to contain the necessary sequences for skin -specific 
transcript expression. Deletion of the CT repeat region resulted in alteration of skin - 
specific transcript expression. The complete absence of skin -specific transcript 
following transfection with MG #20 in contrast to expression of this transcript in cells 
transfected with MG #13 was reported. However, most differences were in terms of 
the intensity of product band in RT -PCR (generally a reduction in intensity) in cells 
that normally express the skin -specific transcript. As explained previously, the 
possible link between the level of transcript and the band intensity is speculative in 
the absence of quantitative RT -PCR. The CT repeat region may be part of the skin - 
specific transcript promoter or an enhancer region for the skin -specific transcript but 
further work is required, especially quantitative RT -PCR, before any conclusions 
may be drawn upon the importance of this region to expression of the skin -specific 
transcript. In the absence of such work, the observations upon the effects of deletion 
of this region are intriguing but remain speculations only. The response of the skin - 
specific transcript to proliferation in culture and UV -C irradiation led to speculation 
upon the possibility that the transcription factor p53 could be involved in UV- 
induced skin -specific transcript expression. This transcription factor is known to be 
involved in expression of a number of the genes involved in NER, although a role in 
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Erccl expression has not been reported and investigation of the skin -specific 
transcript expression has not been reported. 
Wider approaches that could be used to study the importance of the novel Erccl 
transcript and indeed the normal Erccl transcript include tissue -specific complete 
knock -out or disruption of the Erccl gene in the skin, knock -out of one of the 
transcripts in the skin or tissue -specific expression of one or both of the transcripts 
in vivo and expression of only the skin -specific transcript in vitro. There are a 
number of approaches that can be used to disrupt the Erccl gene or introduce it in 
vitro and in vivo. Genes can be disrupted or knocked out in a number of different 
ways and the choice of technique depends upon the suitability of the delivery vector 
and the purpose of the modification. The role of the Erccl gene has been 
investigated in a number of ways in the Melton laboratory prior to the research 
presented in this thesis and further progress has been made into the investigation of 
of Erccl expression in the skin during and since the end of the research reported 
here, so these discussions are not hypothetical. 
Techniques for introduction of genetic material into cultured cells include the use of 
viruses and minigenes. Retrovirus- mediated gene transfer of functional Erccl into 
Erccl-null cultured cells was attempted prior to my arrival in the Melton lab. A 
recombinant retrovirus containing the Erccl coding sequence was manufactured 
using the murine leukaemia virus derived, MFG viral vector (to ensure specificity of 
the vector for the murine system) and the viral packaging cell line WCRE. The in 
vitro experiments in which Erccl- deficient fibroblasts were exposed to the 
retroviruses and then tested for rescue of UV hypersensitivity were performed as a 
precursor to in vivo gene therapy with liver specificity for Erccl null mice to extend 
their lifespan and allow long -term study of the effect of Erccl knockout in other 
tissues. Retroviruses are useful as viral genomes which integrate into the host cell 
should be stably expressed for the lifetime of the infected cell. Following retroviral- 
mediated gene transfer there was partial correction of the UV- hypersensitivity of the 
cells but it was decided that a better technique for introduction of a gene was use of a 
minigene system. Because skin does divide rapidly the skin is a suitable tissue for 
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infection by a retrovirus designed to have tropism for this tissue (cell division is a 
prerequisite for infection). However, this would be a technically demanding, 
expensive course to take and would involve overcoming many obstacles before 
progress would be likely. In vitro investigation of the role of the skin -specific 
transcript could be performed in the same manner as the minigene work presented if 
the sequences responsible for expression of the transcripts could be accurately 
identified and deleted. Minigenes containing the Erccl DNA and the promoter for 
only one of the transcripts could be used to transform any of the cells used in these 
studies to investigate the ability of the skin -specific transcript, in the absence of the 
normal transcript, to correct UV hypersensitivity of Erccl-null cells. As the novel 
transcript is not normally found alone in vivo, there would be little to gain from 
developing mice that expressed only the novel transcript in terms of investigation of 
the biological significance of the novel transcript. 
If the skin -specific Erccl transcript is biologically significant then the most obvious 
way of detecting this is by loss of function via targetted deletion. However, 
depending upon the question being investigated the normal transcript's function may 
or may not be required and this has implications for the knock -out method. The 
Erccl complete knockout mice are discussed in details in Chapter 1; due to their 
reduced lifespan and the complicating effects of the loss of Erccl in other tissues, 
their usefulness for specific investigation of the skin -specific transcript function is 
limited. A better way of investigation this transcript's role is a tissue specific 
knockout. Another consideration in production of a tissue -specific knockout is 
whether temporal control of the deletion is desirable (conditional knock -out) as such 
a deletion enables study of the consequences of deletion at specific developmental 
stages. Another way to investigate the biological significance of removing one or 
both of the transcripts would be to use a technique called RNA interference (RNAi). 
A relatively new technique for investigation of gene function is RNA interference 
(RNAi). This technique results in 'knock -down' of genes - the genes are expressed 
but the mRNA is bound by synthetic short interfering RNAs that specifically target 
the mRNA for degradation. In this way an actively transcribed gene does not result in 
translation of a protein. This is a naturally occurring mechanism for gene silencing 
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in a number of species, e.g. in Caenorhabditis elegans dsRNA can silence 
homologous genes. The precursor long, dsRNA is synthesised and an enzyme called 
Dicer cleaves the dsRNA into 21 -23 nucleotide long duplexes called small 
interfering RNAs (siRNA). When these siRNAs are bound by a multiprotein 
complex called RNA induced silencing complex (RISC) the siRNA unwinds and 
binds complementary mRNA. This targets the bound mRNA for degradation by 
RISC via the mRNA degredation pathway (Cogini and Macino, 2000; Hammond et 
al, 2001; McManus et al, 2002). 
This naturally occurring gene silencing method can be adapted to knock down genes 
in mammals if synthetic siRNA is designed and transfected into cells directly. 
Introduction of the precurser long, double stranded RNA results in degradation via 
the interferon response in the cytoplasm. Knock down of genes in mice has been 
achieved by expressing small hairpin RNA (shRNA) from a polymerase HI 
promoter. 
Knock downs of a gene in a tissue -specific manner depends upon use of a tissue - 
specific promoter to drive expression of long dsRNA. Avoidance of the interferon 
response has been achieved by use of a vector called pDECAP. This vector 
expresses the dsRNA but removes the 5' and 3' caps, restricting the dsRNA to the 
nucleus. This dsRNA is cleaved inside the nucleus and the siRNAs are transported 
into the cytoplasm to knock down homologous mRNA. If a tissue specific promoter 
is used in the plasmid DNA vector then the RNAi can occur in the tissue of interest, 
resulting in tissue specific knock -down of a gene e.g. knock -down of Erccl in the 
skin. However, as the mechanism is though to occur via the 3' end of the short 
interfering RNA and the difference between the two Erccl transcripts lies in the 5' 
end, it may not be possible to knock -down the novel or normal transcript 
independently. The RNAi technique may be useful for complete knock -down of the 
Erccl gene in the skin, although this has already been achieved using another 
method, the Cre /lox system. 
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Because of the severe phenotype associated with the Erccl knockout mice, their 
usefulness for investigation of the skin -specific Erccl transcript is limited. Skin 
specific deletion of the novel transcript with the option of temporal control of 
expression would enable specific investigation of the biological significance of the 
transcript in the skin. Because both the novel and normal Erccl transcripts utilise the 
same coding region, knockout of only the novel transcript requires identification of 
sequences particular to the novel transcript so that their deletion does not interfere 
with normal transcript expression and function. 
The methods used for generation of the complete Erccl knockout are detailed in 
Chapter 1; the Melton lab. Erccl knockout was generated using the embryonic stem 
cell method and involved disruption of the Erccl gene using a neo- cassette which 
was targeted by homologous recombination. This resulted in loss of Erccl function 
in all tissues. For tissue specific deletion of Erccl, a conditional knockout method 
would need to be utilised. In Cre /lox, the cre gene (short for cyclisation 
recombination ) encodes a site specific DNA recombinase which has the property of 
recombining DNA located between specific sites in the DNA molecule, loxP sites 
(locus of crossover over Pl). loxP sites are 34óp long and are not found naturally in 
animals or plants as they originate from the P 1 bacterial phage. LoxP sites can be 
artificially introduced to enable precise excision of DNA using cre under control of a 
tissue -specific promoter. DNA excised, e.g. part of the novel Erccl transcript's 
promoter, is degraded and loxP sites flanking the excised region are ligated (Ghosh 
and Van Duyne, 2002; Kuhn and Torres, 2002; Le and Sauer, 2000; Sauer, 1998). 
Skin -specific hairless Erccl knockout mice have been produced in the Melton lab 
using the Cre /lox system. Male mice carrying the cre gene with the genotype Erccl 
KTA /+ crossed with an Erccl flox (Erccl flanked by loxP stites) result in progeny 
which include pups of the genotype A /flox + cre. The cre is under control of a CK5 
(a keratin) promoter so this skin specific promoter results in expression of the cre in 
the skin, resulting in excision of the floxed Erccl gene in a tissue specific- manner. 
The breeding scheme is complicated by the fact that the cre must be inherited from 
the father because of brief expression of cre in the oocyte of cre+ females (Ramirez 
et al., 2004). Depending upon the promoter used to drive the cre gene, tissue 
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specific or temporal control of cre expression can be achieved. The Cre /lox system 
involves deletion in the genome and for specific deletion of promoter sequences 
required for expression of the skin specific transcript there would be the possibility 
that expression of the normal transcript could also be disrupted, depending upon the 
exclusivity of the promoter's regions in the Erccl gene. There are, therefore, 
numerous ways in which the role of Erccl transcripts in the skin could be /are being 
investigated further. 
The research investigating the role of the skin -specific transcript presented in this 
thesis demonstrated that the level of transcript and the ratio of skin -specific to normal 
transcript rose in the absence of light in response to proliferation in culture and also 
to return of serum after serum starvation (a cell cycle dependent response). There 
were also results that suggested expression of the transcript could be induced by UV- 
C irradiation. The earlier question posed regarding the requirement for the skin - 
specific transcript in the skin has been addressed. If up- regulation of the normal 
transcript could lead to increased protein levels in conditions of high biological 
demand for DNA repair then the skin -specific transcript would not be required. The 
normal transcript is expressed constitutively in the body at low levels and is required 
for repair of endogenous DNA damage in tissues that are not exposed to light as well 
as in the skin. It may be that the control of expression of the normal transcript is 
incompatible with increased expression in the skin as a steady -state level of this 
transcript is achieved by a static expression level of the normal transcript's 
transcription factor. However, the increased biological demand for repair of UV- 
induced DNA damage in the skin, primarily CPDs and (6- 4)PPs, may have resulted 
in evolutionary selection for a different pattern of expression in this tissue. The 
development of the high expression level and ratio to normal transcript of the skin - 
specific transcript occurs in the absence of light and may be due to enhanced 
expression of the skin- specific transcript via a tissue -specific and developmental 
response regulated by interaction with the CT repeat region located near the TSS of 
the skin -specific transcript. This mechanism of control could enable a high basal 
level of skin -specific transcript resulting in a high level of Erccl protein for removal 
of UV (6- 4)PPs. The possibility that UV- induction could increase the expression 
229 
level has speculatively been linked to the requirement for rapid removal of CPDs 
following UV irradiation. Because these lesions are very disruptive to cellular 
processes and non -repair leads to accumulation of DNA damage and possibly 
carcinogenesis, the high level of skin -specific transcript (whether by means of tissue - 
specific expression pattern and/or UV- inducible expression) is likely to confer a 
considerable advantage to the skin in removal of UV- induced DNA damage and 
avoidance of carcinogenesis. Because of the possibility of skin cancer development, 
especially melanoma, in response to lack of repair of UV- induced DNA damage in 
the skin it is likely that there has been strong evolutionary selection pressure on the 
expression of Erccl in this tissue and the skin -specific pattern of expression has 
evolved as a result. 
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I Meant to Do My Work Today 
Richard LeGallienne 
I meant to do my work today - 
But a brown bird sang in the apple tree, 
And a butterfly flitted across the field, 
And all the leaves were calling me. 
And the wind sighing over the land 
Tossing the grasses to and fro, 
And a rainbow held out its shining hand - 
So what could I do but laugh and go? 
